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Chapter 1 
GENERAL INTRODUCTION 
Food Science and Technology, in part submitted 
GENERAL INTRODUCTION 
Cadmium (Cd) is an important occupational and environmental pollutant. Cd is widely 
distributed due to its environmental persistence. It has a long biological half-time 
which accounts for its bioaccumulation in organisms. Outside the industrial 
environment, the main route of human Cd exposure is through the food. Although most 
oral toxicity studies have been performed with inorganic salts of Cd, this is not the 
chemical form in which Cd occurs in the diet. In food of animal origin one of the main 
Cd binding ligands has been identified as the protein metallothionein. In plants 
cadmium is bound, at least partly, to proteins resembling metallothionein. The purpose 
of the present studies was to establish the toxicity and disposition of Cd-metallothionein 
in rats. For an assessment of human health risks it is of paramount importance to 
obtain more information about the bioavailability and toxicity of different Cd-complexes 
as found in the diet. 
1. ENVIRONMENTAL CADMIUM 
EXPOSURE 
1.1 USE AND OCCURRENCE OF CADMIUM 
Cd naturally occurs in small quantities 
throughout the lithosphère. However, the 
widespread industrial use of Cd has caused a 
sharp increase in emissions to the environment 
and consequently to relatively high levels of 
environmental contamination in many locations. 
Cadmium occurs in nature in conjunction with 
zinc and is found wherever zinc is found. Zinc 
is, in contrast to Cd, an essential metal for most 
forms of life. Zinc is ubiquitous and due to the 
close relationship with Cd, it is unlikely that any 
naturally occurring material will be completely 
free of Cd. (Elinder, 1985). 
Cd is mainly used in the electroplating industry 
(anti-corrosion agent) and alloy manufacturing, 
but also in alkaline batteries, pigments and 
plastic stabilizers. Cd is also a by-product of 
zinc and lead refineries. 
It should be stressed that most uses of Cd are 
completely dissipative and only a few percent of 
all Cd currently used, is recycled (Nriagu, 1980; 
Pageetal . , 1986) 
Cd in soil may occur naturally, but in most 
cases the pollution is a result of industrial 
emissions, mining operations, waste incineration 
and combustion of oil and coal. Sludge-based 
fertilizers and phosphate fertilizers are important 
sources of Cd contamination in agricultural soils. 
Crop grown on contaminated soils take up Cd 
very efficiently. Due to the bioaccumulation in 
soil, plants and animals and due to its 
environmental persistence, Cd can be considered 
as a food chain contaminant. 
1.2 CADMIUM EXPOSURE IN HUMANS 
Humans are exposed to Cd via the food, water, 
air and dust. Outside of the industrial 
environment, the main source of environmental 
Cd exposure for the general population is the 
intake via food. This is illustrated in table 1 
derived from Hallenbeck (1985) who has 
compiled data on the daily intake of cadmium by 
adults, together with sources contributing to the 
total. Cd levels in drinking water are generally 
low and water consumption does not contribute 
much to the total daily intake of Cd in adults. 
Smoking is another source which contributes 
substantially to the daily intake of Cd. Smoking 
of 20 cigarettes per day will cause an uptake of 
circa 4 /ig per day. In comparison to the intake 
via the food this does not seem to be that much, 
but one has to be aware of the fact that the oral 
absorption of Cd is much lower (4-8%) than 
inhalatory absorption (15-40%). Outside of 
smoking, absorption via the lungs can only 
contribute substantially to the daily intake when 
individuals are living closely near sources of Cd 
emission. 
Cd is present in virtually all foodstuffs. The 
highest concentrations can be found in internal 
13 
organs (kidney and liver) from cattle, in seafood 
(oysters, crab, mussels) and in some mushroom 
species. The Cd concentration in these products 
can be in the order of mg's per kilogram, even 
in nonpolluted areas (Elinder, 1985; Robards 
and Worsfold, 1991; Galal-Gorchev, 1991). In 
rice and wheat the Cd concentration varies 
between 10 and 150 jtg/kg. Meat, fish and fruit 
usually contain Cd levels in the order of 1 to 50 
/xg/kg. The concentrations in dairy products are 
generally low and in the order of a few 
micrograms per kilogram. Examples of excep-
tionally high Cd intake levels, exceeding the 
PTWI, have been reported due to the above 
average consumption of mussels, wild 
mushrooms or internal organs of cattle (Archi-
bald and Kosatsky, 1991; Andersen, 1981; Mc 
Kinzie et al., 1982). These cases show that the 
actual Cd intake of some human populations in 
unpolluted areas is consistently above average 
due to an atypical diet (dietary habit). 
Table 1. Calculated hypothetical total daily 
intake of cadmium and contributing sources 
Individual 
non-smoker living 
in rural area 
smoker living near 
cadmium source 
and eating 
contaminated food 
Source of 
cadmium 
air 
food 
water 
total 
air 
food 
water 
tobacco 
total 
Intake in 
/*g 
0,0005 
4 
2 
6 
25 
84 
2 
4 
115 
It should be stressed that in some Cd polluted 
areas the Cd concentration of cereals and meat is 
much higher than mentioned above. One of the 
most severe cases in which a population was 
exposed to highly Cd contaminated food has 
been reported from Japan and is known as the 
Itai itai disease (review of Kjellström, 1986). 
The Japanese rice incident demonstrated that 
chronic Cd poisoning constitutes a health hazard 
to the general public through environmental 
exposure and it showed that the hazard of Cd 
was not restricted to industrial workers (see also 
section 4.2). Increased levels of Cd in food as a 
result of Cd pollution have been reported from 
many other countries including the Netherlands 
(Lauwerijs et al., 1980, Sherlock et al., 1983, 
Elinder, 1985, Copius Peereboom Steegeman 
and Copius Peereboom, 1989). For instance, in 
the Netherlands one of the largest polluted areas 
is the area of the Kempen. The Cd conta-
mination of the soil is due to the Cd emissions 
from zinc factories; vegetables grown in that 
region contain fairly high Cd levels (up to 1.2 
ppm; Haskoning, 1985). As a consequence the 
cattle grazing there have elevated Cd levels in 
liver and kidneys (with maximum values up to 
7,66 mg/kg; Spierenburg et al,, 1988). Inhabi-
tants eating vegetables of their own gardens, 
show a higher daily intake than the provisionally 
tolerated weekly uptake of Cd (Copius Peere-
boom-Stegeman and Copius Peereboom, 1989). 
The calculated intake of Hallenbeck (1985) for 
an individual living in an unpolluted area is well 
below the provisional tolerable daily intake of 
60-70fig Cd recommended by the WHO (1972). 
Actual dietary intake levels in Europe and the 
U.S in the period 1980-1990 are in the order of 
15 to 50 jtg Cd/day with large individual 
variations (Gartrell et al., 1986a,b; Louekari et 
al., 1986; van Dokkum et al., 1989; Robards 
and Worsfold, 1991; Galal-Gorchev, 1991). Due 
to the small safety margin between the actual 
dietary intake and the tolerable level of Cd, 
dietary exposure to Cd is considered a health 
problem of major concern in humans. 
1.3 Cd-SPECIATION IN FOOD 
There is a clear lack of data describing the form, 
or chemical species, in which Cd occurs in dif-
ferent foodstuffs. In animal tissues of vertebrates 
and many invertebrates (mollusca, Crustacea, 
insecta) most of the Cd occurs as an inducible, 
about 7000 dalton (10.000 D apparent molecular 
weight) cysteine rich protein, called Cd, Zn-
thionein, or more generally, metallothionein 
(Kägi and Nordberg, 1978; Stone and Overnell, 
1986; Hamer, 1986; Webb, 1986; Kägi and 
Kojima, 1987). Vegetable food is even a more 
important source of dietary Cd intake than 
animal food. Yet we know little about the form 
in which Cd occurs in plants. 
In plants Cd is at least partially complexed by 
several metal binding complexes, such as 
organic acids, metallothioneins and phytoche-
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latins. There is increasing evidence that the 
phytochelatins are the major metal binding 
proteins in higher plants (Grill et al., 1987, 
Verkleij et al., 1990). These peptides consist of 
repetitive 7-glutamylcysteine units with a 
carboxyl-terminal glycine (poly(Y-EC)G's. 
Although phytochelatins have certain properties 
in common with metallothioneins ( Cd-cysteine 
complex, heat stability, inducibility, synthesis 
from glutathione or its precursor 7-glutamyl 
cysteine), they belong to a structurally different 
class of metal binding proteins (Wagner, 1984, 
Grill et al., 1987, Verkleij et al., 1990). Still, 
phytochelatins are functionally analogous to 
metallothioneins (Grill et al., 1987). 
It is not yet known whether or not Cd in certain 
food stuffs is less readily absorbed from the 
gastrointestinal tract when compared to Cd from 
other sources. A difference in Cd-availibility of 
different foodstuffs will certainly have a great 
impact on the risk evaluation of dietary Cd and 
on the estimation of tolerable Cd levels in 
different types of food products. 
2 ABSORPTION AND METABOLISM 
2.1 GASTRO-INTESTINAL ABSORPTION OF Cd 
A large proportion of the ingested cadmium 
passes the gastrointestinal tract without being 
taken up in the small intestine. Most 
toxicokinetics studies performed with inorganic 
Cd-salts have shown that the Cd retention in rats 
varies between 0.5 and 2% (Kello and Kostial, 
1977; Moore et al., 1973), in mice between 0.5 
and 3% (Engstrom and Nordberg, 1979, 
Andersen et al., 1988), and in apes probably 
between 2-6% (Nordberg et al., et al., 1971; 
Suzuki and Taguchi, 1980). These absorption 
data from experimental animals are highly 
dependent on the relative dose and the dietary 
composition (see chapter 3). In a group of 14 
human volunteers, the average net intestinal 
uptake of cadmium was found to be c. 4.5% 
(McLellan et al., 1978). In the study of Rahola 
et al (1972) the average Cd absorption in 5 
human volunteers was at least 6%. Lastly, in 
another study the net intestinal uptake of Cd was 
estimated to be 2.6% in males and 7.5 % in 
females (Flanagan et al., 1978). It should be 
emphasized that most studies of gastrointestinal 
absorption have merely compared the dose given 
with the amount retained in the body shortly 
after dosing. This might indicate that the 
retention in long term experiments is slightly 
different. Nevertheless, it seems very likely that 
the gastrointestinal absorption for man and 
monkeys is somewhat higher than for rodents. 
Mechanism of intestinal Cd uptake 
Essential metals are generally taken up actively 
by a carrier system. However, most non-
essential metals, including Cd seem to be taken 
up in non-specific way. There are no data in the 
literature that argue for an active carrier-
mediated uptake of Cd in the mucosal cell layer. 
In general, the Cd uptake can be divided in two 
steps: 
step 1 step 2 
luminal Cd — > mucosal Cd — > systemic Cd 
Step 1 represents the uptake from lumen into the 
intestinal mucosa. Foulkes and co-workers 
(1980; 1986) showed that step 1 may further be 
separated into step la, representing the electro-
static binding of Cd to the outside of the brush 
border, followed by step lb, representing 
internalization by a passive, temperature-
dependent process. Step lb is probably related to 
membrane fluidity and does not occur via 
pinocytose. This assumption was based on the 
finding (Foulkes, 1988, Bevan and Foulkes, 
1989) that Cd is internalized into brush border 
vesicles and erythrocytes in vitro; neither of 
these have appreciable pinocytic activity. 
Furthermore, it was shown that step 1 follow 
first order kinetics at luminal Cd concentrations 
up to 200 f*M (Foulkes et al., 1980) and at a 
oral dose of 10 /ig/kg body weight (Goon and 
Klaassen 1989). 
Step 2 represents passage across the basolateral 
membrane into the serosal fluid and blood 
stream and appeared to be rather constant at 
luminal Cd concentrations between 2 and 200 
fiM. It is proposed that the rate of step 2 is 
probably much lower than the rate of step 1, 
(Kello et al., 1978; Foulkes 1988) and thus step 
1 may have a regulatory role in the absorption of 
Cd. The difference between the rates of step 1 
and step 2 of the intestinal Cd uptake will result 
in the accumulation of Cd in the intestinal tissue. 
However, the actual Cd accumulation in the 
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intestine is probably much lower due to the 
continuous renewal of the intestinal epithelium 
and desquamation of the old mucosa (Valberg et 
al., 1976). 
Role of intestinal metallothionein 
in the control of Cd absorption 
It has been shown that the protein 
metallothionein in the intestine is inducible by 
both zinc (Zn) and Cd (Richards and Cousins, 
1975; Ouelette et al., 1982; Clarkson et al., 
1985; Min et al., 1991). It was originally 
proposed by Richards and Cousins that the 
intestinal metallothionein could help retain the 
excess of zinc in the mucosa and, in this 
manner, controls the zinc absorption. 
Consequently it was suggested that the intestinal 
Mt is also a major determinant of the intestinal 
Cd absorption (Squib et al., 1976; Engström and 
Nordberg, 1979). However, the findings on the 
possible role of Mt in the control of Cd 
absorption are contradictory. For example, Kello 
(et al., 1978) found no effect of the intestinal 
Mt induction on the ratio between step 1 and 
step 2 of the Cd uptake. In contrast the work of 
Foulkes and McMullen (1986) showed that 
induction of intestinal Mt decreases step 2 of Cd 
uptake. Andersen (1989) postulated that in the 
study of Foulkes the binding capacity of 
intestinal Mt was exhausted in uninduced 
animals, which were exposed to relatively high 
Cd levels. Consequently induction of intestinal 
Mt by zinc will lead to a reduction of step 2. In 
the study of Kello the relatively lower Cd doses 
could not saturate the intestinal Mt in unexposed 
animals. This hypothesis is not fully conclusive 
since a recent study of Goon and Klaassen 
(1989) using a Cd dose (100 ;ug Cd/kg 
recirculating perfusion) even higher than in the 
study of Foulkes and McMullen (5 -30 pig/kg 
body weight without recirculated perfusion) did 
not show any effect on Cd absorption by Zn-
preinduction of intestinal Mt. 
The analysis of Cd-transport and the role of 
intestinal Mt in isolated intestinal segments can 
provide information of only limited quantitative 
significance to evaluate the absorption in the 
intact animal. The difficulty arises from the fact 
that the absorption in vitro can not be influenced 
by dietary factors, by the changes in rate of 
intestinal transit and by the gastric and intestinal 
secretions. It should therefore be emphasized 
that it has been shown that in vivo metallo-
thionein does play a significant role in the 
intestinal uptake of Cd at a dose level of 5 
mg/kg (Min et al., 1991). The study shows that 
intestinal Mt is involved in the selective renal 
disposition of Cd. We will discuss this further in 
section 2.2. 
2.2 Cd-DISTRIBUTION 
After uptake (step 2 of gastrointestinal 
absorption), Cd is mainly transported via the 
blood plasma, although the main part (90-95%) 
of blood Cd is bound to the red blood cells. In 
plasma, the main part of Cd is present as Cd-
albumin and Cd-metallothionein. There are 
several studies reviewing the Cd distribution in 
animals and man and it is beyond the scope of 
this introduction to discuss this matter in detail. 
In short, two main sites of storage of Cd are the 
liver and kidneys. About 40-80 % of the body 
burden is found in these two organs and in the 
case of low level exposure, about 30-50% is 
stored in the kidneys alone (Bremner, 1979; 
Nordberg et al., 1985, Bernard and Lauwerijs, 
1986; Foulkes et al., 1990). Within the kidneys, 
the highest concentration is found in the cortex. 
Particularly high concentrations are found in the 
proximal tubular cells. 
In humans, it has been shown that in kidneys a 
maximum Cd level is reached at an age of 40-50 
and in liver the accumulation decreases after 30 
years of age. In most human studies the renal 
cortex level is about 10 to 30 times higher than 
that in liver at an age of about 50 (Nordberg et 
al., 1985; Elinder, 1985b). 
Role of intestinal metallothionein 
in distribution of cadmium 
It has been shown in mice (Engström et al., 
1979), rats (Lehman and Klaassen 1986) and in 
quails (Scheuhammer, 1988) that after 
absorption of very low amounts of ionic Cd 
through the intestine Cd is mainly deposited in 
the kidneys, whereas high doses of Cd pre-
dominantly result in hepatic Cd deposition. It 
was proposed that a low amount of Cd will 
mainly be bound to endogenous metallothionein 
of the intestine, which will be released in the 
systemic circulation and then be deposited in the 
kidneys. 
This theory is based on the findings that after 
intravenous injection of low molecular weight 
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complexes such as Cd-cysteine or Cd-
metallothionein, Cd in the blood stream remains 
bound to these low molecular weight proteins. In 
this form Cd will be efficiently taken up in the 
kidneys by glomerular filtration and subsequent 
reabsorption (Nordberg et al., 1975; Tanaka et 
al., 1975; Squibb et al., 1984). However, after a 
higher dose (100 /ig/kg or higher) the available 
endogenous circulating Mt pool is overloaded 
(see also 2.1) and Cd will bind to high 
molecular plasma proteins and then be deposited 
in the liver (Lehman and Klaassen, 1986; Ohta 
and Cherian, 1991). This is supported by the 
fact that intravenous injection of Cd-proteins 
with a low Cd-affinity or intravenous injection of 
Cd-ions, will result in a redistribution of Cd to 
high molecular weight plasma proteins such as 
albumin. These Cd-albumin complexes are 
indeed deposited in the liver (Garvey and Chang, 
1981; Suzuki, 1984). Thus, the binding form of 
Cd in blood is of crucial importance for the final 
distribution to the main storage organs. 
Just recently it has been shown that pre-
induction of intestinal Mt indeed causes a 
selective renal Cd accumulation (Min et al., 
1991). Moreover, the immunological 
identification of intestinal metallothionein in the 
blood plasma supports the theory that intestinal 
Mt is indeed released into the systemic 
circulation (Elsenhans et al., 1991). 
Role of hepatic metallothionein in 
the distribution of cadmium 
The distribution between renal and hepatic Cd is 
not only dose- and species- but also time-
dependent: with increasing time after exposure, 
the kidney levels will increase due to 
redistribution from the liver (Gunn and Gould, 
1957; Lucis and Lucis, 1969; Webb, 1979). The 
redistribution of Cd with time might be 
supported by the hypothesis, originally proposed 
by Piscator (1964), that Cd, Zn-metallothionein 
is transported from the liver to the kidneys. In 
the first few hours after uptake in the liver most 
of the cadmium in the liver is bound to high 
molecular weight proteins in the cytosol and then 
within 24 hours is reassociated to freshly 
synthesized metallothionein to form a Cd, Zn-
Mt. There is some evidence to believe that hepa-
tic Cd, Zn-Mt is indeed present extracellularly in 
liver sinusoids (Banerjee et al., 1982) which 
might be released from the liver due to normal 
turnover of hepatocytes or due to increased cell 
death (Dudley et al., 1985; Webb et al., 1986). 
It has been shown that hepatic metallothionein 
containing Cd and Zn released into plasma, 
contains merely Cd and copper (Cu). Due to it's 
high affinity to Cu it seems likely that zinc 
might be replaced by copper and the plasma me-
tallothionein serves under these conditions as 
a carrier protein for copper. (Webb, 1979; 
Suzuki, 1984). 
Thus, Cd-metallothionein derived from the 
intestine (after low oral doses of Cd) or liver 
(after high oral doses of Cd), is likely to be 
reabsorbed into the renal proximal cells after 
glomerular filtration. The metallothionein protein 
will be broken down by the lysosomes and 
nonmetallothionein-bound Cd will be released in 
the kidney cells. This will stimulate the (de 
novo) synthesis of renal, endogenous 
metallothionein. This Mt contains in contrast to 
the hepatic Cd, Zn- Mt both Cd, Zn and Cu 
(Suzuki, 1984). There is a constant renewal and 
turnover of endogenous and exogenous metallo-
thionein in the renal cortex. 
2.3 METALLOTHIONEIN: INDUCTION, 
BIOLOGICAL ROLE AND OCCURRENCE 
In animals, the protein Mt is most abundant in 
the cytoplasm of liver, kidneys, intestine and 
pancreas. The biologically half-life of Mt's 
generally ranges from 1 to 4 days, depending on 
the type of metal bound. The primary structure 
of Mt is characterized by a high content of 
cysteine, serine and glycine and its lack of 
aromatic amino acids and histidine. Most 
characteristics of Mt are shown in table 2. 
According to Fowler (et al., 1987) and Kägi and 
Schäfter (1988) mammalian and most metallo-
thioneins of mollusc and Crustacea belong to 
class 1 metallothioneins. Class 2 comprises Mt's 
from sea urchin, wheat and yeast, whereas class 
3 contains the atypical polypeptides such as poly-
•y-ECg's derived from plants (see section 1.3). 
Class 1 mammalian Mt's usually contain two 
major fractions called Mt-1, Mt-2, differing at 
neutral pH by a single negative charge. 
Due to its high affinity for and inducibility by 
non-essential metals such as Hg, Cd and Pt the 
protein serves as a detoxification agent for toxic 
metals. This hypothesis was originally proposed 
by Piscator (1964). Due to the short biological 
half-life there is a constant degradation and 
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renewal of Cd-Mt in the liver and kidneys 
explaining the long biologic halflife of Cd in 
these organs. As shown in section 2.2, Mt 
probably plays a key role in the transport and 
distribution of Cd throughout the body. There 
are numerous articles available reviewing 
both biochemistry and biological function of the 
protein (Webb, 1979; Webb, 1986; Kägi and 
Kojima, 1987; Richards, 1989; Waalkes and 
Goering, 1990). 
The physiological function of Mt is probably 
related to the Zn and Cu homeostasis, and it has 
indeed been shown that high Mt levels are 
present during periods of high Zn demand. It is 
thought that Mt supplies Zn within rapidly 
growing tissues which might declare the high Mt 
levels at birth (Wong and Klaassen, 1979). The 
role of Mt as an Zn and Cu donor might be 
supported by the finding that apoenzymes which 
require Zn and/or Cu have been activated in 
vitro after incubation with Zn,Cu-thioneine 
(Udom and Brady, 1980; Geller and Winge, 
1982; Goering and Fowler 1987). However, to 
the best of our knowledge at present no such 
evidence has been shown in vivo. 
Except Mt's role in metal metabolism, there are 
several other chemical and physical treatments 
Table 2 
Properties of metallothionein 
molecular weight 6000-7000 
metal clusters with thiolate ligands 
high cysteine and metal content 
deficient in aromatic acids and histidine 
inducible by metals and other treatments 
heat stability 
optical properties characteristic of metal-
thiolate bonds 
research, the exact function(s) of Mt is not yet 
known. Further research in the field of 
molecular biology, biochemistry and physiology 
is certainly required. 
The role of Mt in the transport and distribution 
of cadmium has been discussed in section 2.2 
The consequence of the presence of Mt in the 
diet will be discussed in 3.2. Lastly, the role of 
Mt in the nephrotoxicity of Cd will be discussed 
in section 4.1. 
Cd3 cluster Cd4 cluster 
Fig.l. Schematic representation of the structure 
of CdjMt from rat liver (From Winge and 
Miklossy, 1982) 
which are known to induce Mt synthesis (see 
review of Kägi and Schäffer, 1988). In the case 
of exposure to electrophilic attack (02, free 
radicals, alkylating agents) it has been suggested 
that Mt detoxifies reactive intermediates due to 
the presence of nucleophilic thiol groups which 
have a neutralizing activity. Mt has been shown 
to be an effective scavenger of oxygen radicals 
after radiation-induced oxidative stress 
(Thornalley and Vasak, 1985; Matsubura et al., 
1987). 
It should be stressed that, despite all the 
3 FACTORS INFLUENCING CADMIUM 
ABSORPTION AND DISTRIBUTION 
3.1 DOSE 
There is a surplus of evidence to suggest that the 
dose level and the body retention in laboratory 
animals are positively correlated. In the study of 
Engström and Nordberg (1979) mice exposed 
between 1 and 37000 fig Cd/kg show an 
intestinal absorption in the range of 0.4 and 
3.2 %. Lehman and Klaassen (1986) found a 
similar effect in rats since the percentage of the 
dosage retained 7 days after administration 
increased from 0.4% at the 1 /ig/kg dosage to 
1.65 % at the 100 /ig/kg and higher dosages. 
Similar observations were made in quails 
(Scheuhammer, 1988) and mice (Andersen 
1988). The studies of Scheuhammer (1988) and 
Goon and Klaassen (1989) have shown that the 
increase in absorption due to increased dosages 
does not appeared to occur gradually. It seems 
that at dosages lower than 10-100 /xg/kg the total 
absorption is quite constant, ranging from 0.4-
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0.8 % whereas at dosages of 100 /ig/kg and 
higher the intestinal absorption is at least 10 
times higher. 
It is believed that in step 1 of the intestinal 
uptake the endogenous Mt pool is not overloaded 
(see 2.1) and the uptake follows first order 
kinetics. However, at high dosages the intestinal 
Mt pool is saturated with Cd and the Cd uptake 
will be facilitated. Moreover, the same authors 
suggest that high doses of Cd are directly toxic 
to the mucosa which will causes the abrogation 
of the integrity of the intestinal wall, which 
might explain the enhanced Cd absorption. 
Histopathological changes as reported in other 
studies (Valberg et al., 1976; Richardson and 
Fox, 1975) indeed do occur at dose levels 
comparable to the high dosages used in the 
disposition studies mentioned above. 
In summary, the Cd concentration in the 
intestinal lumen determines the final Cd 
absorption in the body. In addition, as shown in 
section 2.2, the oral Cd dose is also a major 
determinant of the differential Cd distribution 
between liver and kidneys. 
3.2 SPECIATION 
Although most Cd disposition studies have used 
inorganic salts of Cd, this is clearly not the 
chemical form in which Cd occurs in the diet 
(see section 1.3). Several studies therefore dealt 
with the Cd-distribution after oral exposure to 
Cd salts compared to biologically incorporated 
Cd. For example, internal organs of Cd-exposed 
pigs, oysters, scallops and canned crab (table 3) 
have been used as source material for exposure 
to biologically incorporated Cd. It seems very 
likely that in this source material part of the Cd 
will be complexed with class 1 metallothionein. 
However, Cd-binding ligands were not 
characterized prior to use and the results of these 
studies are difficult to interpret. 
In several other reports the oral Cd absorption 
was studied after administration of purified 
CdMt (Cherian, 1979; Maitani et al., 1984; 
Ohta and Cherian, 1991). From these studies it 
appears that at Cd absorption from CdMt is 
lower than from inorganic Cd salts, at least at 
the dose levels chosen. Moreover, these studies 
show that the liver to kidney ratio of the Cd 
concentration is lower after exposure to CdMt 
compared to inorganic Cd salts. This effect was 
mainly due to the selective renal Cd disposition 
after oral CdMt exposure. Since it is well known 
that CdMt after iv administration preferentially 
accumulates in the kidneys, it has been 
suggested that oral CdMt or CdMt fragments can 
pass the intestinal mucosa and consequently 
show the same renal disposition as parenteral 
CdMt. In this regard some evidence suggest that 
the sequence of events for intestinal uptake of 
CdMt is different from that for CdCl2: It has 
been shown (Klein et al., 1986; Crews et al., 
1989) that indeed at least part of the CdMt was 
not affected by in vitro treatment with gastro-
intestinal proteolytic enzymes. Furthermore 
Cherian (1979) and Ohta and Cherian (1991) 
found after oral exposure to exogenous CdMt 
that a major portion of ingested Cd still was 
associated to a protein with a moleculair weight 
of c. 10,000 dalton, whereas after exposure to 
ionic Cd the majority of the Cd was bound to a 
protein with high molecular weight. This sug-
gests that exogenous CdMt (fragments) does in 
fact reach the intestine, which indicates that 
there is a difference in metabolic pathway 
between CdMt and CdCl2. However, rats 
exposed to low doses of CdCl2 show, similar to 
dietary CdMt, selective renal Cd accumulation 
and it is not clear whether the selective renal 
accumulation after CdMt exposure is also dose 
dependent. If the uptake of CdMt is dose-
dependent than it seems possible that the 
difference in renal Cd-accumulation between 
CdMt and CdCl2 is not due to a difference in 
metabolic routes, but simply due to the 
difference in intestinal Cd absorption. 
3.3 DIETARY FACTORS 
The effect of protein, fat and fibre. 
Rats fed semisynthetic diets, high in fat, low in 
fibre, show a much higher body retention of Cd 
than rats fed standard rat diets (Andersen, 
1989). Furthermore, rodents fed semi-synthetic 
diets with milk (Engström and Nordberg, 1979; 
Kello and Kostial, 1977b), or casein (Revis, 
1981; Uthe and Chou, 1979) retained a 
significant larger fraction of orally administered 
cadmium than animals fed a cereal based diet. 
Finally, Rabar and Kostial (1981) found a larger 
Cd retention in animals fed human diet 
components such as milk, meat and bread than 
in rats fed normal diets. It should be noted that 
these semi-synthetic diets are much closer to the 
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Table 3. Oral studies on 
Source material 
CdCl2 versus CdMt 
Cd-sulfate versus Cd-
lettuce leaves 
CdCl2 versus Cd 
Glutathione versus 
CdMt 
Cd-sulfate versus Cd-
scallops. (Chemical 
form of Cd unknown) 
CdCl2 versus Cd-
porcine kidney/liver 
versus Cd-lobster 
(Cd-form not 
identified) 
CdCl2 versus CdMt 
CdCl2 versus Cd-
oyster. Cd is bound to 
1000 D peptide 
CdCl2 versus CdMt 
CdCl2 versus Cd-
oyster (Chemical 
form of Cd in oyster 
unidentified) 
CdCl2 versus 
Cd3phytate 
CdCl2 versus Cd-crab 
(chemical form of Cd 
in crab unidentified) 
CdCl2 versus Cd-
spinach/Cd mussels 
CdCl2 versus CdMt 
the disposition of cadmium from inorganic and organic Cd sources 
Type of study 
open-ended duodenal 
perfusion, 60 min. 
semi-synthetic diet 
once for 5 hours in 
12 days experiment 
oral gavage, once 
for 4 hours 
semi-synthetic diet, 
28 days 
semi-synthetic diet, 
90 days 
oral gavage, five 
times in 5 weeks 
semi-synthetic diet, 
28 days 
oral gavage, once 
for 3 days 
semi-synthetic diet, 
14 days 
Gavage, once for 
10 days 
semisynthetic diet, 
6, 12, 24 weeks 
semisynthetic diet, 
4 weeks 
cannulated jejunum 
segments, 60 min. 
Dose, animal 
100 iM Cd, 
rat 
40-80 ftg/2.5 
g diet in rat 
60 ng Cd per 
mouse 
5 mg/kg diet, 
in rat 
21 mg Cd/kg 
diet in rat 
20 fig Cd/kg 
mouse 
1.8 mg Cd/kg 
diet, in 
mouse 
0.5 mg Cd/kg 
mouse 
0.4 mg 
Cd/kg diet in 
mouse 
1 mg/kg rat 
4 mg Cd/kg 
diet 
30 mg Cd/kg 
diet in rat 
50 jig/0.5 ml 
per rat 
Absorption and distribution 
Body retention CdMt twice as 
low. 
Slightly increased uptake of Cd 
from lettuce as compared to 
Cd-salt 
Intact isolation of ingested 
CdMt from intestinal mucosa? 
CdMt shows lower hepatic and 
higher renal Cd-accumulation 
No significant difference in 
retention between inorganic & 
biologically incorporated Cd 
Cd uptake from Cd-lobster 
digestive gland and from Cd-
porcine liver/kidney is lower 
than from inorganic Cd. No 
selective renal accumulation of 
biologically incorporated Cd. 
Total CdMt retention in body 
is lower. Renal Cd accu-
mulation for CdMt is higher 
Oyster Cd was retained at a 
lower rate in all tissues. 
Relative renal Cd accumulation 
for Cd-oyster higher. 
CdMt shows higher 
kidney/liver Cd ratio than 
CdCl2 due to the low Cd-
accumulation in liver 
No significant difference in Cd 
retention. Relative renal Cd 
accumulation for Cd-oyster is 
somewhat higher. 
At normal phytate 
concentration in diet no 
difference in body retention. 
Accumulation in liver and 
kidneys is twice as low for Cd 
incorporated in crab meat. 
Hepatic Cd accumulation from 
Cd-mussels is lower than from 
Cd-spinach or CdClj 
Intestinal and hepatic uptake of 
CdMt is lower than for CdCl2. 
Renal accumulation is similar 
for both Cd-forms 
References 
Valberg et al., 
1977 
Welch et al., 
1978 
Cherian, 1979 
Lagally et al., 
1980 
Uthe and 
Chou, 1980 
Cherian, 1983 
Siewicki et 
al., 1983 
Maitani et al., 
1984 
Sullivan et al., 
1984 
Jackl et al., 
1985 
Maage and 
Julshamn, 
1987 
Sinkeldam et 
al., 1989 
Ohta and 
Cherian, 1991 
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human "western type of diet" than standard 
rodent diet and therefore, the apparently higher 
intestinal uptake in humans as compared to ro-
dents is not necessarily due to a difference in 
uptake mechanism, but might be attributed to 
the differences in diet composition. Animals fed 
Cd in combination with sea food or meat 
products show a lower retention of cadmium 
than rats fed Cd combined with casein (Lagally 
et al., 1980; Uthe and Chou, 1979; Siewicki et 
al., 1983). This indicates a lower retention of 
cadmium bound to animal protein. It should be 
emphasized that in studies, comparing the Cd 
disposition of inorganic Cd-salt with organic Cd 
from seafood and meat, the animals exposed to 
inorganic Cd have to be fed a similar amount of 
uncontaminated sea food or meat. This in order 
to avoid the effect of the animal protein on the 
Cd-disposition. 
Interaction with minerals 
There is some evidence that several trace ele-
ments can inhibit step 1 of the Cd absorption in 
the intestine in vitro (Sahagian et al., 1967) and 
in situ (Foulkes, 1985). It is suggested that 
during step 1 of the absorption Cd is electro-
statically bound to the surface membrane and 
since this is a non-specific effect, many poly-
valent cations can inhibit the Cd uptake by 
neutralizing the membrane charge (Foulkes, 
1985; 1988). Over the past twenty years several 
elements like Zn, Cu, Fe, Ca, P, Mn, Mg and 
Se have been shown to interfere with the Cd-
metabolism in animals and in humans (Task-
group on Metal Interactions, 1978; Fox et al., 
1983; Chmielnicka and Cherian, 1986). It has 
been suggested that Cd competes with Zn, Ca 
and Fe for the specific carriers, but non of these 
specific interactions has been proven. 
Several studies have shown that diets with a low 
Calcium (Ca) content can increase the body 
retention of Cd (Larson and Piscator, 1971; 
Hamilton and Smith, 1978). Moreover it is 
shown after in situ perfusion of the intestine, 
that a high Ca dose can inhibit Cd absorption 
(Foulkes, 1980). The reversed reaction i.e. the 
inhibition of the Ca absorption by Cd has also 
been reported (Ando et al., 1977). This inter-
action is of special importance because of the 
suggested role of Cd in the osteomalacia of the 
Itai-itai disease. 
Interactions between the uptake of Cd and Fe in 
animals have also been reported frequently. For 
Fe-deficient animals it has been shown that both 
the uptake of Cd in the intestinal mucosa (step 1) 
and its transport into the body (step 2) is 
increased (Hamilton and Valberg, 1974; 
Flanagan et al., 1978; Fox et al., 1979). For 
man it has been shown that persons with low 
iron stores (mostly females) as indicated by low 
serum ferritin levels absorbed more Cd than 
persons with high iron stores (Flanagan et al., 
1978, Shaikh and Smith, 1980; Bunker et al., 
1984). On the other hand, it has been shown in 
labo-ratory animals that dietary supplements of 
iron protect against Cd accumulation (Fox et al, 
1971; Fox, 1980) and against Cd-intoxication 
(Pond and Walker 1972). The mechanism behind 
the competition of Fe and Cd is still not 
understood. 
Similar to Ca, Zinc (Zn) can inhibit the 
intestinal transport of Cd after in situ perfusion, 
although the concentration of Zn required for 
this effect is very high (Foulkes, 1980; 1985). It 
appears that animals fed Cd with low Zn levels 
show increased Cd absorption (Jacobs et al. 
1978b). Except for the site of absorption Cd and 
Zn interact at many other sites in the body, as 
might be predicted from their similar chemical 
properties. An important site for interaction can 
be found in the protein metallothionein (see 
section 2.3). It has been shown that the increase 
of Zn in the renal cortex of horses is related to 
the production of metallothionein which contains 
Cd as well as Zn (Nordberg et al., 1979). 
Human autopsy studies have shown that the Zn 
concentration increases in kidney cortex with 
increasing Cd concen-tration (Piscator and Lind, 
1972) probably due to formation of metallo-
thionein, binding both Cd and Zn. 
In conclusion, mineral-deficient diets can 
increase the gastro-intestinal absorption of Cd. 
However, information on the protective effect 
of mineral supplements in the diet, is rather 
restricted. Furthermore, most researchers have 
studied single metal-cadmium interactions and 
there are only few studies that have examined 
the effect of dietary combinations of minerals 
(Banis et al., 1969; Jacobs et al., 1978a; 1978b, 
1983). The impact of dietary minerals on the 
absorption of biologically incorporated Cd has 
not yet been investigated. 
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4 CHRONIC ORAL TOXICITY 
4.1 ANIMAL STUDIES 
The effects of repeated oral administration of 
inorganic cadmium, mainly as the chloride salt, 
have been extensively studied in laboratory 
animals and these studies have often been 
reviewed (Fielder and Dale, 1983; Friberg et 
al., 1986; Foulkes, 1986; Ros and Slooff, 1988). 
Target organs are the kidneys, the haemato-
poietic system, the bones and the liver. 
The carcinogenic potential of Cd is still under 
debate: the heavy metal is a potent carcinogen 
for the testis and prostate and at the sites of 
injection (see review of Waalkes and Ober-
dörster, 1990), but there is no evidence of 
carcinogenicity in rats and mice after oral 
administration (Collins et al., 1992). 
This section will be restricted to some comments 
on non-neoplastic lesions observed in the 
kidneys, the haematopoietic system and the liver. 
Renal effects 
The most characteristic toxic effect after oral 
exposure to cadmium is nephrotoxicity, the 
effects usually being limited to the proximal 
tubules. At high doses the glomeruli and the 
renal blood vessels may also be affected. Table 
4 summarizes some oral Cd studies in rats and 
monkeys showing the relationship between renal 
cortical Cd-concentration and the renal toxicity. 
Most animal data indicate that at a renal cortex 
Cd level of 100-200 mg Cd/kg tissue renal 
tubular damage will occur. For example 
Sugawara et al. (1974) found slight tubular 
damage at a renal Cd level of 91 mg/kg and 
severe renal effects were noted at 224 mg/kg 
renal tissue in Wistar rats. Primates appear to 
have similar sensitivity to renal effects in rats. 
However, the critical concentration of Cd in the 
renal cortex was higher in primates (±600 
mg/kg) than in the rat (Fielder and Dale, 1983). 
Atrophy and degeneration of tubular cells are the 
most striking histopathological lesions. Cd-
induced proteinuria is the most characteristic 
sign of renal tubular damage. This proteinuria is 
mainly due to impairment of renal tubular 
reabsorption, which affects the reabsorption of 
all proteins, but especially low molecular weight 
proteins such as microglobulines, lysozyme and 
retinol binding protein (Kjellström, 1986; 
Bernard et al., 1991). Another approach for 
early detection of nephropathy is the detection of 
enzymuria due to increased urinary excretions of 
kidney-derived enzymes. Increased enzyme 
activity in urine of enzymes such as LDH, NAG 
indicates cell damage, whereas the increase 
enzyme activity of ALP and GGT indicates 
desquamation of the brush border of proximal 
tubular cells (Nomiyama et al., 1975; Dubach et 
al., 1988; Gatta et al., 1989; Stonard, 1990). 
Role of CdMt in renal toxicity 
The main part of the Cd which reaches the 
kidneys is bound to metallothionein, which is 
either derived from the liver after degradation of 
Cd-albumin, or derived from the intestinal tract 
after transfer across the intestinal wall. The role 
of CdMt in the kidneys is somewhat paradoxeal 
since on the one hand it seems that synthesis of 
renal metallothionein protects against Cd 
toxicity, but on the other hand parenteral 
administration of CdMt leads to more 
pronounced nephrotoxicity than parenteral 
administration of inorganic Cd salts (Nordberg et 
al., 1975; Squib et al., 1979). This is due at 
least in part to a higher accumulation of Cd in 
the kidneys from CdMt exposure (Tanaka et al., 
1975). CdMt is reabsorbed into the proximal 
renal cells and after intracellular degradation 
(see section 2.2) free Cd is released within the 
cell, which probably interferes with zinc-
dependent enzymes and causes damage to the 
metabolism of the cell (Kjellström, 1986; 
Foulkes, 1990). Cd-toxicity is believed to 
depend on the amount of free ionic Cd present in 
the cell which is not sequestered by available 
endogenous metallothionein or glutathione (Jin et 
al., 1987; Suzuki et al., 1989). Alternatively, it 
has been suggested that CdMt will damage the 
brush border during reabsorption of the CdMt 
complex (Cherian, 1982) and indeed, a higher 
sensitivity of the kidneys to Cd in the form of 
CdMt has also been observed (Sendelbach and 
Klaassen, 1988). The Mt protein will be 
degraded by lysosomes and non Mt-bound Cd 
will be released in the cell, which will stimulate 
the synthesis of renal, endogenous Mt. As 
shown in section 2.2, there is a constant renewal 
and turnover of endogenous and exogenous 
metallothionein in the renal cortex. The critical 
renal Cd concentration is the particular Cd 
concentration after long term renal Cd 
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Table 4. Renal effects after long term oral exposure in relation to renal cadmium levels 
Species 
Rat 
Female 
wistar rat 
Female 
wistar rat 
Male 
Sprague-
Dawley 
rat 
Male 
wistar rat 
Male 
rabbit 
Male 
Rhesus 
monkey 
Admini-
stration 
CdCl2 in water 
CdCl2 in diet 
CdCl2 in water 
unspecified 
Cd-salt in 
water, high 
and low 
protein diets 
unspecified Cd 
salt in water 
CdCl2 in diet 
CdCl2 in diet 
Cd Dose, 
Duration before 
effect 
50-200 mg/1 water, 
8.5 months 
10 and 50 mg/kg 
diet, 41 weeks 
200 mg/1 
8 months 
50 mg/1, 90 days 
50 mg/1, 24 weeks 
300 mg/kg diet, 
4 and 10 months 
3-100 mg/kg in 
diet for 30 months 
Reported findings 
Renal histological changes 
at all doses levels 
High mortality at 22 weeks. 
After 41 weeks: severe 
tubule lesions at 50 mg/kg, 
slight effects at 10 mg/kg 
Proteinuria at 8 month . 
Histology at 11 months 
revealed no lesions 
Necrotic tubular cells 
Tubular necrosis, 
glomerular fibrosis, cell 
hypertrophy 
Aminoaciduria and 
enzymuria at after 4 
months. Proteinuria and 
glucosuria at 10 months 
ß2-microglobulinaria and 
aminoaciduria in week 40, 
glycosuria from week 60 
Renal cortex 
concentr. 
44-180 
mg/kg 
91 and 224 
mg/kg 
200 mg/kg 
15 mg/kg 
normal diet 
30 mg/kg 
high protein 
60 mg/kg 
200 and 300 
mg/kg 
560-635 
mg/kg in 
week 10-60 
Reference 
Kawai et 
al., 1976 
Sugawara 
& Sugawara 
1974 
Bernard et 
al., 1981 
Revis, 1981 
Aughey et 
al., 1984 
Nomiyama 
et al., 1975 
Nomiyama 
etal . , 1982 
accumulation at which the amount of free (non 
Mt-bound) cadmium is high enough to cause 
cytotoxicity (Nordberg et al., 1985; Foulkes et 
al., 1990). 
It has to be emphasized that acute nephrotoxicity 
due to parenteral administered bolus amounts of 
CdMt has only little relevance to the progressive 
renal accumulation of Cd in chronically exposed 
animals where the plasma CdMt levels are much 
lower. Whether the difference in renal toxicity 
between inorganic Cd salt and CdMt also applies 
to the oral route has not yet been investigated. 
It seems possible that part of the CdMt in food 
(i.e. exogenous CdMt) might also reach the 
kidneys intact (see section 3.2). This might be 
relevant for assessing the health risk of 
biologically incorporated Cd. 
Effects on the liver and the 
haematopoietic system 
Several studies have shown that signs of anaemia 
after long-term oral exposure to cadmium 
develop in male rats (Wilson et al. 1941, Pond 
and Walker, 1972; Prigge et al., 1977). 
Although nephrotoxicity is regarded as the 
characteristic effect, decreased haemoglobin 
concentration and decreased packed cell volume 
are among the early signs of chronic, peroral 
toxicity of Cd (Elinder et al., 1986). 
As discussed in section 2, after oral exposure to 
high Cd levels Cd-transport across the intestinal 
wall will be saturated and Cd bound to albumin 
in the blood will accumulate in the liver. 
Consequently, hepatic metallothionein will be 
induced, which then acts as a Cd-scavenger and 
decreases Cd toxicity. Therefore, overt signs of 
acute toxicity in the liver are most likely related 
to non-metallothionein bound Cd. 
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Studies of Dudley (et al., 1985) have shown that 
Cd is an effective hepatotoxin after chronic 
parenteral exposure. Moreover, other studies 
(Tanaka et al., 1981; Cain and Griffiths, 1980) 
have demonstrated that chemically induced 
hepatotoxicity in animals previously exposed to 
Cd, causes leakage of CdMt from the liver, 
which will be taken up in the kidneys (see 
section 2.2). 
Dudley (et al., 1985) emphasized that Cd-
induced hepatotoxicity may play a role in the 
nephrotoxicity seen in rats after long term 
exposure to Cd. However, the regulatory role of 
the liver is restricted when small amounts of Cd 
are ingested via the food, because the majority 
of the metal bypasses the liver and accumulates 
directly in the kidneys (section 2.2). It seems 
therefore not surprising that in mammals the 
level of Cd in the renal cortex is much higher 
than in liver (Elinder, 1985b). 
patients (low protein, Ca, Fe and Vitamin D) 
also was a necessary factor for the development 
of the high incidence of bone effects in that 
particular area. Since the improvement of the 
nutrional status of the local population and the 
decrease of the Cd contamination of food the Itai 
itai disease has disappeared (Kjellström, 1986b). 
Similar to what has been found in animal 
studies, proteinuria in humans is characterized 
by an increased excretion of low molecular 
weight proteins such as ß2-microglobuline retinol 
binding protein and/or metallothionein (Bernard 
and Lauwerijs, 1991). Moreover, urinary 
excretion of N-acetyl-ß-glucosaminidase (NAG) 
as indicator of renal dysfunction is also 
suggested to be a reliable indicator of Cd 
exposure in humans (Nogawa et al., 1983; 
Mutti, 1989; Kawada et al., 1989). 
4.2 OBSERVATIONS IN MAN 
There is an extensive data base of case-reports 
from Cd alloy factories, in the U.K., USA and 
Japan and nickel cadmium factories or cadmium 
production plants in the UK, Sweden, Japan and 
Belgium (Lauwerijs et al., 1980; Fielder and 
Dale, 1983; Kjellström, 1986; Foulkes, 1986, 
Ros and Slooff, 1988). In workers exposed to 
Cd for prolonged period the principal organs 
affected are the kidneys and lung. It is important 
to point out that, similar to the results with 
animals, in most long-term studies in humans, 
renal effects preceded or occurred simul-
taneously with other effects and seem to develop 
at lower doses than those needed to produce 
prostatic cancer or lung cancer (Kjellström, 
1986; Foulkes, 1990). Moreover, the 
relationship between Cd exposure and lung or 
prostatic cancer remains arbitrary (Sullivan and 
Waterman, 1988). 
The most extreme cases of human toxicity after 
environmental Cd exposure have been those with 
renal dysfunction and bone symptoms, often 
diagnosed as "Itai itai disease". This disease 
occurred in epidemic proportions among the 
inhabitants of the Fuchu area in Japan, who 
ingested chronically Cd contaminated rice. In 
several of these cases the Cd intake through rice 
ranged from 500-2000 jtig/day. The etiology of 
the disease does not only point in the direction 
of Cd-exposure, but the poor nutrition of the 
Dose-response relationship 
The critical renal concentration used in the risk 
assessment of Cd is 200 mg Cd/kg tissue and is 
mainly based on epidemiological studies with 
young, healthy workers in industry and on 
laboratory experiments with animals. In both 
cases the data concern exposure to inorganic Cd. 
It is difficult to extrapolate critical renal Cd 
levels to a critical daily intake level since Cd 
risk estimates are seriously hampered by 
uncertainties in both the assumptions (percentage 
absorption, intake levels, dietary form, etc.) as 
well the data base used for the calculations. For 
example, based on pharmacodynamic models 
(Kjellström and Nordberg, 1978; Kjellström, 
1986c) it is estimated that an oral intake of 300-
400 /ig/day will cause renal dysfunction after 
lifetime exposure. On the other hand 
epidemiologic studies from Japan (Nogawa et 
al., 1989) suggest that renal damage will occur 
at a daily Cd intake of 100-200 /ig/day. 
Thus, safety-limits should be used very 
cautiously (Kjellström, 1986; Ros and Slooff, 
1988; Archibald and Kosatsky, 1991). 
The provisionable tolerable weekly intake 
(PTWI) recommended by the World Health 
Organization (WHO) is 0.4-0.5 mg based on a 
tolerable intake of 1 fig/kg/day (60-70 pig 
Cd/day; WHO, 1972). An oral daily intake of 1 
Hg Cd/kg in non-smokers for 50 years will lead 
to a mean cortex concentration of circa 50 
mg/kg. 
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An average diet provides at least 100-250 
/ig/week and smoking of 20 cigarettes per day 
provides between 2-5/ig of absorbed cadmium, 
which corresponds to 50-300 /tg/week via oral 
intake. Smokers are therefore close to the WHO 
limit for tolerable Cd intake (Kjellström, 1986c). 
Inhabitants of the Dutch Kempen eating 
vegetables of their own gardens, show a higher 
daily intake than the PTWI of Cd of 400-500 
/ig/week (Copius Peereboom-Stegeman and 
Copius Peereboom, 1989). Inhabitants of the 
Kempen therefore may incur a higher health risk 
than the general Dutch population. This might be 
supported by the finding that renal function tests 
have indicated an increased excretion of RBP 
and NAG in the inhabitants of the Kempen 
(Kreis et al., 1987). Recent findings in Belgium 
have shown that almost 10% of the general 
population showed a Cd excretion higher than 2 
/ig/24 hours corresponding to an renal cortex 
level of 50 mg/kg at the age of 50 (Buchet et 
al., 1990). These Cd excretion levels are at least 
in 10% of the cases correlated to slight renal 
dysfunction (tested a.o. by the renal excretion of 
NAG and ß2-microglobuline). This is inconsis-
tent with the fact that a renal Cd concentration 
of 200 mg Cd/kg is believed to cause a higher 
incidence of renal dysfunction. The authors 
suggest that the difference might be due to the 
healthy worker effect leading to underestimates 
of the health risk for the general population 
(Buchet et al., 1990). The results have not been 
confirmed yet by other industrialized countries. 
5 ANALYTICAL ASPECTS: ISOLATION AND 
QUANTIFICATION OF METALLOTHIONEIN 
The protein metallothionein was first isolated 
from equine renal cortex (Margoshes and Vallée, 
1957) and further characterized by Kagi and 
Vallée (1960, 1961). Since then, the most 
common techniques used in isolation of the 
protein are gel-filtration and ion-exchange 
chromatography. 
To quantitate Cd binding proteins in mammalian 
tissue most studies make use of metal saturation 
techniques, gel-filtration techniques and immuno 
assays (Webb, 1986; Richards, 1989). The 
metal saturation assays appeared to be similar in 
precision and recovery of Mt to assays that 
directly measure the protein moiety, such as 
radioimmunoassays (Dieter et al., 1985). 
Molecular biology techniques have been 
developed to quantitate Mt mRNA levels 
(Hamer, 1986; Peterson and Mercer, 1988). 
In the last years clear analytical improvements 
have been made to study Mt heterogeneity. For 
instance, the use of reversed phase high 
performance liquid chromatography systems has 
been applied to characterize different Mt 
isoforms expressed by different organs and 
animal species (Klauser et al., 1983; Richards 
and Steele, 1987; van Beek and Baars, 1988). 
Although RP-HPLC does not achieve a detection 
sensitivity comparable with RIA techniques, its 
advantage over RIA and the other Mt-assay 
techniques is that it can, in one step, provide 
information concerning concentration of 
isometallothioneins in the tissue. Moreover the 
application of RP-HPLC to the isolation and 
characterization of Mt isoforms has 
demonstrated its superior capability in resolving 
additional isoforms not previously detected using 
conventional techniques. Lastly, the difference in 
chromatographic behaviour of different isoforms 
on HPLC offers the unique possibility to study 
simultaneously the metabolic fate of administered 
Mt and endogenous Mt. Figure 2 shows 
chromatograms of a reversed-phase HPLC 
system, demonstrating the UV-spectra of Mt-
isoforms purified from liver of various species. 
The spectral analysis shows that different 
isoforms have similar UV spectra. 
6 OBJECTIVES AND APPROACH 
The main source of human Cd exposure is the 
diet and in the diet Cd is to a large extent 
associated with the protein metallothionein. 
However, health risk assessment of Cd is mainly 
based on oral studies with inorganic Cd salts. 
Therefore information is required on the 
difference in bioavailability and toxicity between 
inorganic Cd salts and CdMt. The main 
objectives of the studies described in the present 
thesis were: 
- To compare toxicity of inorganic Cd and CdMt 
in rats and in cell cultures of target organs, 
- To compare the dose-dependent kinetics of Cd-
uptake from CdMt and inorganic Cd 
- To establish differences in metabolic pathways 
between CdMt and CdCl2 to predict disposition 
and toxicity at environmentally relevant doses. 
The following approach was used to accomplish 
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Fig. 2. Reversed-phase HPLC elution profile on a Hypersil ODS (250x6mm) column of purified hepatic CdMt 
isoforms. The separation was performed using 10 mM-sodium phosphate (solvent 1) and 10 mM phosphate 
buffer in acetonitrile (40:60, v/v solvent 2) as eluting solvents. Mt-samples -were eluted with a linear gradient of 
0-5% solvent 2 in 5 min and from 5 to 20% solvent 2 in 15 min with a flow rate of 1 ml/min. UV-spectrum 
(200-300nm) was determined with a diode-array spectrofotometer. X-axis=retention time, Y-axis=Absorbance, 
Z-Axis=UV-spectrum. A: Rat CdMt isoform-2, B= Pig CdMt isoform-2, C= Horse CdMt 
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these objectives. In Chapter 2 a 4-week feeding 
study in rats is described to detect differences in 
early signs of toxicity between CdCl2 and CdMt. 
The purpose of the studies described in Chapter 
3 was to establish the kinetics of the Cd uptake 
and to investigate the dose-dependent renal 
disposition of both CdCl2 and CdMt. This study 
provides more insight into the observed 
differences in toxicity between CdMt and 
CdCl2. Chapter 4 deals with the Cd-
accumulation and toxicity of CdMt and CdCl2 in 
cell culture of the target organs. It shows 
differences in sensitivity between both Cd-forms 
at a cellular level. Chapter 5 describes studies 
on interaction of minerals with the accumulation 
and toxicity of CdCl2. The study identifies those 
minerals which are most effective inhibitors of 
Cd uptake. The aim of Chapter 6 was to 
investigate the interaction of minerals with the 
absorption of CdMt. The results of Chapter 5 
and 6 together provide information on the 
metabolic uptake routes of CdMt and CdCl2. 
Chapter 7 deals with the metabolic fate of 
CdMt in the intestine and kidneys after oral and 
intravenous administration. The study puts the 
findings on differences in toxicity, disposition 
and mineral interaction between CdMt and 
CdCl2 into perspective. 
The long-term diet study of Chapter 8 was one 
of the end-points of the thesis to determine the 
nephrotoxicity after the chronic feeding of 
inorganic Cd and CdMt. 
The outcome of these studies is discussed in the 
"Concluding remarks" within the frame work of 
the risk assessment for the human consumer. 
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Abstract—The toxicity of cadmium was examined in rats fed diets containing either tissue-incorporated 
cadmium or cadmium salt for 4wk. The test diets contained 30 mg cadmium/kg either as cadmium 
chloride, or as cadmium incorporated in pigs' livers; the control group was fed a diet containing liver from 
a pig not treated with cadmium. Over 90% of the cadmium present in the pigs' livers was bound to 
metallothionein. Analysis of the diet and determination of the food consumption revealed that both 
cadmium-fed groups were exposed to similar dietary cadmium levels. There was no adverse effect on 
general health or survival. Feeding cadmium resulted in growth retardation and slightly decreased water 
intake. Moreover, both cadmium-treated groups showed clear signs of anaemia and increased plasma 
aspartate and alanine aminotransferase activities. For the group fed cadmium chloride, all of these effects 
were more pronounced than for the group fed cadmium incorporated in liver. Microscopic examination 
of the liver and kidneys, however, did not reveal any lesion that could be attributed to the cadmium 
treatment. After exposure to cadmium the spleen showed decreased extramedullar haematopoiesis, an 
effect that was also more pronounced after feeding of the cadmium chloride than after feeding 
liver-incorporated cadmium. The differences in the extent of the toxic effects between the inorganic and 
the tissue-incorporated cadmium were accompanied by differences in the cadmium concentrations in liver 
and kidneys: the feeding of cadmium incorporated in pigs' livers resulted in about half the accumulation 
of cadmium in the rats' livers that took place after intake of a diet containing cadmium chloride. In 
contrast a much less marked difference in cadmium accumulation was observed in the kidneys. Since 
humans are usually exposed to tissue-incorporated cadmium these findings deserve further investigation, 
with special attention to the observed difference in tissue accumulation. 
INTRODUCTION 
The major source of environmental exposure to 
cadmium for the general population is the intake in 
food (Foulkes, 1986). Although previous studies have 
evaluated cadmium toxicity after exposure to inor-
ganic cadmium, this is not the main chemical form in 
which cadmium is present in food. In vertebrates, 
some shellfish and many other animals one of the 
main cadmium-binding ligands has been identified as 
the protein metallothionein (Webb, 1986). In plants 
cadmium is bound, at least partly, to proteins with 
similarities to metallothioneins (Kägi and Kojima, 
1987; Wagner, 1984). The effects of repeated oral 
administration of inorganic cadmium, mainly as the 
chloride salt, have been extensively studied in labora-
tory animals. Although nephrotoxicity is regarded as 
the characteristic toxic effect, decreased haemoglobin 
concentration and decreased packed cell volume are 
among the early signs after chronic, peroral exposure 
to cadmium (Elinder, 1986). 
It is not known whether cadmium bound to 
metallothionein is as toxic as cadmium chloride. 
Several studies have examined the distribution of 
inorganic cadmium and purified cadmium-metallo-
thionein (Cd-Mt) after single oral doses of the metal 
Abbreviations: Cd-Mt = cadmium metallothionein; HPLC = 
high-performance liquid chromatography. 
compounds (Cherian, 1979; Maitani et ai, 1984). 
However none of these reports has compared the 
early signs of toxicity after continuous exposure to 
cadmium through the diet. Moreover, whether the 
absorption of a single dose of purified Cd-Mt is 
comparable with the absorption of Cd-Mt, as present 
in meat products or plants given chronically in low 
doses, has never been clarified. Studies of the toxicity 
of cadmium, in the different forms in which it is 
present in human foods, are therefore needed. 
The present study was intended to compare the 
toxicity, in rats, of cadmium as present in pigs' liver 
with that of cadmium chloride. To achieve a more or 
less continuous oral exposure the cadmium com-
pound was mixed with the diet. For a meaningful 
interpretation of the results the cadmium-binding 
ligand in pigs' liver was identified as a mixture of two 
metallothionein isoforms. In preliminary experiments 
the sensitivity of the strain of rats used was examined 
and a dietary level of 30 mg cadmium/kg food was 
established as suitable for use in subsequent, compar-
ative studies (E. J. Sinkeldam et ai, unpublished data, 
1986). 
MATERIALS AND METHODS 
Test substance. Cadmium chloride with a purity, as 
specified by the supplier, of at least 99% was obtained 
from E. Merck, AG, Darmstadt, FRG. 
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Preparation of cadmium incorporated in pigs' livers. 
Three young male pigs, initially weighing 50 + 4 kg, 
were housed separately in metabolism cages. The 
animals were injected intramuscularly with cadmium 
chloride dissolved in saline according to the following 
schedule: on days 0, 9, 12, 15 and 18 with 3mg 
cadmium/kg body weight and on days 3 and 6 with 
6 mg cadmium/kg body weight. Four weeks after the 
last injection the animals were killed and the livers 
were removed. The livers were pooled, homogenized, 
lyophilized and stored at — 20°C. Livers obtained 
from two untreated pigs were handled in the same 
way and served as control material. Cadmium analy-
sis of freeze-dried liver samples (see below) revealed 
that the cadmium and zinc contents were 950 and 
700mg/kg tissue, respectively. 
Characterization of the cadmium-binding proteins in 
pig liver. Lyophilized liver tissue was homogenized 
using a teflon pestle in two volumes of lOmM-Tris-
HC1 (pH 7.4, 4°C). The homogenate was centrifuged 
at 10,000 # for 15 min, decanted and again centri-
fuged at 100,000 g for 70 min. Cytosol (150 /xl) was 
then applied to a column of Superose 12 (30 x 1 cm, 
Pharmacia, Uppsala, Sweden) which was equilibrated 
with a 0.05 mM-Tris-KCl buffer (pH 7.4). The column 
was calibrated with standard proteins of known 
molecular mass (varying from 67 to 12.4 kDa). Frac-
tions of 0.35-ml eluent were analysed for cadmium 
content. Pigs' liver Cd-Mt was further analysed using 
a LKB liquid chromatography system. Pigs' liver 
cytosol was heat-treated (4 min, 90°C) and centri-
fuged for 10 min at 10,000g. The supernatant (50 /il) 
was separated on a Hypersil ODS (20 x 0.3 cm) 
column (Chrompack, The Netherlands) using a 
lOmM-sodium phosphate buffer (pH 7.2; solvent-1) 
and lOmM-sodium phosphate buffer in acetonitrile 
(60:40; solvent-2) as eluting solvents. A gradient from 
0 to 5% solvent-2 in 5 min and from 5 to 20% 
solvent-2 in 15 min was used with a flow-rate of 
0.4ml/min. The UV spectrum (190-280 nm) of the 
cadmium-binding molecule was determined with a 
diode array spectrophotometer (LKB 2140) coupled 
to the high-performance liquid chromatography sys-
tem. Purified rat metallothionein isoforms 1 and 2 
(Mt-1 and Mt-2) were used as standards on HPLC as 
described for purified chicken metallothionein by 
Richards and Steele (1987). Rat metallothionein was 
purified from the livers of rats that had previously 
been injected with CdCl2 dissolved in saline according 
to the following schedule: on day 0 and 12 with 
3 mg/kg sc and on day 4, 6, 8 and 10 with 1.2 mg/kg 
body weight. Two days after the last injection the 
livers were perfused with 0.9% NaCl, excised and 
homogenized (1:2, w/v) in 10mM-Tris-144mM-KCl 
buffer (pH 7.4) using a teflon pestle. The homogenate 
was centrifuged as described above for pigs' liver. The 
cytosol was filtered through a 0.22-^ m filter (Milli-
pore, Molsheim, France) and chromatographed on a 
Sephadex G-75 column (5 x 60 cm, Pharmacia) with 
lOmM-Tris-HCl (pH 7.4, 4°C). The metallothionein-
containing fractions were determined by the relative 
elution volume Ve/Vo = ± 2) and were applied to a 
Sephadex DEAE-A25 column (2.5 x 20 cm) and 
eluted with a linear gradient of 10-300 mM-Tris-HCl 
(pH 8.5, 4°C). The fractions that correspond to Mt-1 
and Mt-2 (as determined by the cadmium content of 
Table 1. Percentage composition of the diets 
Diet code 
Ingredient 
Casein 
Pigs' liver, untreated 
Pigs' liver, cadmium treated 
Wheat white flour 
Mineral mixture* 
Vitamin ADEK preparationf 
Vitamin B mixture! 
Lard 
Cadmium chloride 
Zinc chloride 
Control 
20.17 
3.14 
— 
54.12 
4.24 
0.36 
0.24 
17.73 
— 
0.0035 
CdCl2 
20.17 
3.14 
— 
54.12 
4.24 
0.36 
0.24 
17.73 
0.0049 
0.0035 
Cd-liver 
20.49 
— 
3.14 
53.80 
4.24 
0.36 
0.24 
17.73 
— 
— 
•The mineral mixture contained (per gram): 399 mg KH2P04, 
389 mg CaCO,, 142 mg NaCl, 58 mg MgS04 , 5.7 mg 
FeSO„.7H20, 0.9mg ZnCI2, 0.8mg CuS04 .5H20, 4.6mg 
MnS04 .2H20, 0.02 mg CoCl,.6H20, 0.007 mg KI, 0.08mg 
KCr(SO„)2.12H20. 
fThe ADEK vitamin preparation contained (per gram): 939 mg 
vitamin A concentrate (2250 IU/g), 30 mg vitamin D concentrate 
(750 IU/g), 1.0 mg vitamin E preparation (50%), 1.0 mg mena-
dione-Na-bisulphite (K3), 30 mg wheat starch. 
ÎThe vitamin B mixture contained (per gram): 3 mg thiamin. HCl, 
2.25mg riboflavin, 4.5mg pyridoxin.HCl, 15mg niacin, 6mg 
Ca-pantothenate, 0.075 mg biotin, 0.75 mg folic acid, 37.50 mg 
vitamin B,2 (0.1%), 931 mg choline chloride. 
the eluate as described below) were pooled, dialysed 
against water (Amicon YM membrane), and 
lyophilized. 
Diets. A semi-synthetic powdered basal diet was 
composed in such a way that it mimics a Western type 
of human diet (high in fat, low in fibre, without 
excessive amounts of minerals and vitamins). One 
diet consisted of the basal diet supplemented with the 
high-cadmium pig-liver homogenate described above, 
providing 30 mg cadmium/kg diet. A second diet 
contained the basal diet supplemented with cadmium 
chloride to a dietary level of 30 mg cadmium/kg and 
untreated liver from the control pigs, in an amount 
equal to the amount of liver eaten by the first group. 
The third diet contained the basal diet and the 
untreated liver sample without additional cadmium 
and was used as the control diet. The percentage 
compositions of the test diets are given in Table 1. 
The diets were analysed for moisture, crude protein, 
methionine, cystine, crude fat, calcium, phosphorus, 
zinc, copper, iron, magnesium and cadmium (Table 2). 
Animals and maintenance. Male, weanling, Wistar-
derived SPF-bred rats (Bor; WISW) were obtained 
from F. Winkelmann (Institute for the Breeding of 
Laboratory Animals GmbH & Co. KG, Borchen, 
FRG). At the beginning of the study the rats were 
about 4 wk old. We used young, growing animals to 
Table 2. Chemical analyses of the diets 
Constituent 
Moisture (%) 
Crude protein (%) 
Methionine (%) 
Cystine (%) 
Crude fat (%) 
Calcium (%) 
Phosphorus (%) 
Zinc (mg/kg) 
Copper (mg/kg) 
Iron (mg/kg) 
Magnesium (mg/kg) 
Cadmium (mg/kg) 
Control 
10.2 
27.0 
0.72 
0.28 
18.9 
0.66 
0.63 
48 
12 
56 
510 
0.1 
Diet code 
CdCl2 
10.5 
26.8 
0.71 
0.26 
18.9 
0.66 
0.61 
48 
11 
63 
510 
29.2 
Cd-liver 
9.3 
27.1 
0.71 
0.27 
18.9 
0.66 
0.63 
51 
11 
59 
518 
30.9 
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study the effects of cadmium on body-weight gain. 
The rats were housed under conventional conditions, 
in suspended stainless-steel cages fitted with a wire-
mesh floor and front. The room temperature was 
maintained at 22 ± 2°C and the relative humidity at 
40-70%. A 12-hr light/dark cycle was maintained 
and the number of air changes was about ten/hr. 
Before the experiment all rats were fed the basal diet 
without any further additions. Drinking-water was 
supplied in glass bottles which were cleaned once each 
week. Food and water were provided ad lib. 
Experimental design and treatment. The rats were 
acclimatized to the animal facilities for 8 days and 
were then allocated to three groups of ten animals 
using a computer-generated random-number table. A 
few rats were re-allocated in order to equalize the 
initial mean body weights of the various groups. Each 
treatment group (housed in groups of five) received 
one of the three test diets. Analysis of the test diets 
revealed that under the experimental conditions the 
levels of cadmium were between 98 and 103% of the 
intended level of 30 mg/kg diet. 
Observations. The rats were weighed at weekly 
intervals and were observed daily for condition and 
behaviour. Food and water intake were measured 
over weekly periods throughout the study. 
Haematology and clinical chemistry. Blood samples 
were collected from the tips of the tails of all animals 
on day 22 and were examined for haemoglobin 
concentration, packed cell volume, erythrocyte and 
total and differential leucocyte counts. At autopsy 
heparinized blood samples collected from the ab-
dominal aorta of all rats were centrifuged at 1250# 
for 15 min, using Sure-sep II dispensers (General 
Diagnostics). The plasma was then analysed for 
alkaline phosphatase, aspartate aminotransferase, 
alanine aminotransferase and urea. 
Urinalysis. On day 24 rats were deprived of water 
for 24 hr, and of food for 16 hr. Urine was collected 
from the individual animals during the last 16hr of 
the deprivation period and its volume (calibrated 
tubes), density (Bellingham and Stanly refractometer) 
and calcium content were determined. 
Pathology. On day 28 the animals were killed by 
exsanguination from the abdominal aorta whilst 
under light ether anaesthesia, and autopsied. Immedi-
ately after evisceration the pancreas, testes, kidneys, 
spleen, liver, lungs and small intestine were weighed 
and the organ:body-weight ratio was calculated. 
Samples of the weighed organs of all animals were 
fixed in 4% neutral phosphate buffered formaldehyde 
solution. The tissue samples were processed and 
embedded in paraffin wax, sectioned at 5 ^ m, stained 
with haematoxylin and eosin, and then examined 
microscopically. 
Metal analysis. Zinc, calcium and copper were 
determined by flame atomic absorption spectrometry. 
The samples were dry-ashed at 500°C and dissolved 
in hydrochloric acid. Cadmium was determined by 
flame atomic absorption spectrometry or graphite 
furnace atomic absorption spectrometry after a wet 
digestion of the sample by sulphuric acid. 
Statistical analysis. Data on body weights were 
evaluated by a one-way analysis of covariance, fol-
lowed by Dunnett's multiple-comparison tests. The 
laboratory determinations and organ weights were 
evaluated by a one-way analysis of variance, followed 
by Dunnett's multiple-comparison tests. Differential 
white blood cell counts were analysed by the Mann-
Whitney U-test. 
RESULTS 
Gel filtration of the liver cytosol from cadmium-
treated pigs revealed that more than 90% of the 
cadmium eluted with a relative elution coefficient 
(Ve/Vo) corresponding to a protein molecular mass 
of 10 kDa (Fig. 1). A reversed-phase HPLC system 
was used to characterize further the Cd-Mt from the 
porcine cytosol. The HPLC chromatogram (Fig. 2b) 
280nm 
1.0 
[Cd] 
9 
• 7 
i o 
Fig. I. Elution profile on a Superose 12 column (30 x 1 cm, Pharmacia) of 200/il liver cytosol from pigs 
treated intramuscularly with CdCl2 for 3 wk. Flow 0.3 ml/min. The cadmium content of fractions (0.35 ml) 
was determined by atomic absorption spectrometry. The arrow indicates a molecular mass of 10 kDa and 
corresponds to the cadmium-containing fractions. The molecular mass was estimated using four 
molecular-mass markers ranging from 78 to 12.4 kDa. 
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Fig. 2. Reversed-phase HPLC elution profile on a Hypersil ODS (200 x 3 mm i.d.) column. The separation 
was performed using lOmM-sodium phosphate (solvent-1) and lOmM-sodium phosphate buffer in 
acetonitrile (60:40, v/v; solvent-2) as eluting solvents. The injected sample was eluted with a linear gradient 
of 0-5% solvent-2 in 5 min and from 5 to 20% solvent-2 in 15 min with a flow-rate of 0.4 ml/min. The 
injection volume was 50 /il. a = purified rat liver metallothionein, b = heat-treated pig liver cytosol. The 
arrow indicates the domain of MT-1 used for the UV spectrum (A 190-280 nm) given in the figure below 
the chromatogram. 
exhibited two major isoforms. For comparison, a 
chromatogram depicting the separation of the 
metallothionein isoforms from rat liver is shown in 
Fig. 2a. The spectral analysis of porcine Mt-1 showed 
that the cadmium-binding protein in the pig liver had 
a U V spectrum similar to that of purified rat metallo-
thionein isoform 1 (Fig. 2: Amax at 199 nm, broad 
shoulder at 250 nm, Amin at 280 nm). Based on molec-
ular weight, cadmium-binding properties, heat-stabil-
ity and spectral analysis it was concluded that more 
than 90% of the cadmium bound to pig liver was 
associated with metallothionein. 
All rats appeared to be healthy throughout the 
4-wk study. However, growth and food intake were 
significantly decreased in both groups fed cadmium. 
Rats fed tissue-incorporated cadmium gained more 
weight than those fed CdCl2 especially during the last 
2 wk of the study (Table 3). Both cadmium-treated 
groups showed a lower water consumption than the 
control group but not significantly so (Table 3). 
Haemoglobin concentration and packed cell vol-
ume were considerably decreased in both cadmium-
treated groups (Table 4). These effects were most 
pronounced in the group fed CdCl2. The lowered 
haemoglobin concentration in the group treated with 
CdCl2 was accompanied by a significant decrease in 
the mean corpuscular volume, the mean corpuscular 
haemoglobin and the mean corpuscular haemoglobin 
concentration. These effects occurred to a lesser 
extent in the rats fed cadmium bound to metallothio-
nein (Table 4). The white blood cell variables were 
not affected by cadmium treatment (data not shown). 
An increase in the plasma aspartate aminotrans-
ferase and alanine aminotransferase activities was 
observed in both cadmium treated groups. This effect 
was most pronounced in the animals fed CdCl2 
(Table 5). There were no other treatment-related 
differences in clinical chemistry parameters between 
the groups. The volume, density and calcium content 
of the urine produced during 24 hr (see Materials and 
Methods) did not show treatment-related differences 
between the groups (data not shown). 
The group fed the diet supplemented with CdCl2 
showed a significant increase of the relative weight of 
Table 3. Mean values of body weight, food consumption and water consumption in rats fed 30 ppm cadmium in the diet 
Duration of 
(days) 
0 
7 
14 
21 
28 
Overall means 
Control 
67.6 ± 1.8 
113.9 + 2.4 
163.8 ±3.5 
208.0 + 4.1 
252.7 ±4.3 
161.4 
Body weight (g)f 
CdClj 
67.7 + 1.6 
108.0 + 2.0** 
151.3 + 2.6** 
193.7 + 3.3** 
230.1 +3.4** 
150.1 
Cd-liver§ 
67.6+1.5 
107.4 + 2.0** 
153.0 ±2.7** 
199.9 + 4.3 
239.6 + 5.3* 
153.6 
Food consumption (g/ 
Control 
74.1 
98.0 
109.4 
110.8 
98 
CdCl2 
68.5 
87.2 
100.3 
100.1 
89 
rat/week){ 
Cd-liver§ 
68.8 
90.2 
105.4 
107.2 
92.9 
Water consumption (ml 
Control 
113.7 
163.0 
165.3 
155.3 
149.4 
CdCl2 
102.2 
136.4 
152.7 
135.6 
131.7 
rat/week)} 
Cd-liver§ 
105.2 
144.2 
158.3 
148.9 
139.1 
tBody-weight values are means ± SEM for groups of ten animals. The values of the mean body weights marked with asterisks differ 
significantly (COVAR + Dunnett's test) from the control diet (*/> < 0.05; **F < 0.01). 
{The mean values for food/water consumption were recorded weekly for two cages each of five animals. The values for food/water 
consumption by the test animals did not differ significantly from the values for animals on the control diet (ANOVA + least square 
significant difference test). 
§Cadmium incorporated in liver was obtained by treating pigs with CdCI, and processing the livers as described in Materials and Methods. 
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Table 4. Mean haematological findings in male rats fed 30 ppm cadmium in the 
diet for 22 days 
Diet code 
Parameter 
Hb (mmol/l) 
RBC (10'/ml) 
PCV (1/1) 
MCV (fl) 
MCH (fmol) 
MCHC (mmol/l) 
Control 
8.6 ±0.1 
5.8 + 0.1 
0.402 ± 0.004 
69.8 + 1.1 
1.49 ±0.02 
21.3 + 0.4 
CdCI2 
6.2 + 0 . 1 " 
5.7 + 0.1 
0.319 + 0.006*» 
56.0 ± 0 .8" 
1.09 + 0.02" 
19.5 + 0.4«* 
Cd-liver 
7.9 ± 0 . 1 " 
5.7 ±0.1 
0.382 ± 0.007* 
66.7+ 1.6 
1.39 + 0 .02" 
20.8 + 0.2 
Hb = haemoglobin concentration RBC = red blood cell count 
PCV = packed-cell volume MCV = mean corpuscular volume 
MCH = mean corpuscular haemoglobin 
MCHC = mean corpuscular haemoglobin concentration 
Values are means ± SEM for groups of ten rats. Those values marked with 
asterisks differ significantly (ANOVA + Dunnett's test) from the correspond-
ing control value (*P <0.05; **P < 0.01; two-sided). 
the small intestine and a significant decrease of the 
relative weight of the liver (Table 6). The microscopic 
examination of the liver, kidneys, spleen, testes, pan-
creas, lungs and small intestine revealed substance-
related changes in the spleen only. The extra-
medullary haematopoiesis that was observed in the 
spleen of the controls was decreased in incidence and 
degree in the cadmium-treated groups. The decrease 
was most pronounced in the group fed CdCl2 where 
extramedullary haematopoiesis was absent. 
Feeding 30 mg CdCl2/kg for 28 days resulted in a 
mean cadmium concentration in the liver of 
6.71 mg/kg tissue, which is » lore than twice the 
amount found in animals fed a similar amount of 
liver-incorporated cadmium (Table 6). The copper 
level in the liver was slightly increased in the animals 
fed CdClj whereas the zinc concentration of the liver 
was increased in both cadmium-treated groups. 
In contrast to the liver, the kidneys show a much 
less marked difference in cadmium accumulation 
between the cadmium-treated groups; feeding cad-
mium incorporated in liver resulted in only a slightly 
lower cadmium concentration in the kidney than 
feeding CdCl2. In contrast to the liver the copper level 
in the kidneys was decreased in both cadmium-treated 
groups whereas the zinc concentration was signifi-
cantly increased only in the group fed cadmium 
incorporated in liver (Table 6). 
DISCUSSION 
In the present study several well known signs of 
cadmium toxicity occurred after repeated oral expo-
sure to CdCl2 or cadmium incorporated in pigs' liver. 
The cadmium compound in the pigs' liver was char-
acterized to help understand the difference in cad-
Table 5. Clinical chemistry of the plasma of rats fed 30 ppm 
cadmium in the diet for 28 days 
Parameters 
ALAT (units/1) 
ASAT (units/I) 
ALP (units/1) 
Urea (mmol/l) 
Control 
56.9+ 1.0 
22.5 + 0.8 
410.9 + 23.8 
7.39 + 0.47 
Diet code 
CdCl2 
75.2 ± 2 . 2 " 
50.0 + 2 .7" 
410.0 + 20.4 
6.7 + 0.34 
Cd-liver 
64.7 ± 1.5" 
32.5 + 1.6" 
380.0 + 22.0 
7.39 + 0.18 
ALAT = alanine aminotransferase 
ASAT = aspartate aminotransferase ALP = alkaline phosphatase 
Values are means for groups of ten rats. Those marked with asterisks 
differ significantly (ANOVA + Dunnett's test) from the corre-
sponding control value (*/> < 0.05; "P < 0.01). 
mium uptake from a diet containing CdCl2 or 
cadmium incorporated in tissue. Reversed-phase 
HPLC resolved two isoforms of metallothionein from 
porcine liver cytosol using purified rat metallo-
thionein as a Cd-Mt standard. These two isoforms 
together accounted for over 90% of the total cad-
mium present in the pigs' liver preparation. The 
existence of porcine metallothionein isoforms has 
been reported previously by other investigators 
(Mehra and Bremner, 1984; Richards and Steele, 
1987). 
The daily intake of cadmium in the present study 
was 0.29-0.45 mg/rat or 2-3 mg cadmium/kg body 
weight. Although the exposure level of the rats was 
similar for both cadmium compounds, the severity of 
the toxic effects observed was different: signs of 
anaemia, decreased weight gain, decreased extra-
medullary haematopoiesis and increased ALAT and 
ASAT activity were all more pronounced in the rats 
fed CdCl2. Moreover, the increase of ALAT/ASAT 
activity in the blood plasma of rats fed with CdCl2 
was accompanied by a significant decrease in relative 
liver weight. However, both cadmium-treated groups 
showed no treatment-related histopathological 
changes in the liver. This result is somewhat surpris-
ing since, for example, Andersen et al. (1988) found 
Table 6. Relative organ weights and metal concentrations in liver and 
kidneys of rats fed 30 ppm cadmium in the diet for 28 days 
Parameters Control 
Relative organ weight (g/kg body 
Pancreas 
Testes 
Spleen 
Lung 
Small intestine 
Liver 
Kidneys 
1.9 + 0.09 
10.92 + 0.24 
2.48 + 0.12 
6.27 ± 0.08 
26.70+ 1.1 
47.7 ± 0.6 
7.99 + 0.1 
Diet code 
CdCl; 
weight) 
2.26 + 0.13 
11.86 + 0.32 
2.54 ±0.13 
6.49 + 0.14 
33.0 + 0.8** 
45.1 +0.4** 
7.84 + 0.13 
Cd-liver 
1.97 + 0.08 
11.45 + 0.39 
2.48 + 0.13 
6.44 ± 0.09 
29.30 + 0.70 
46.2 ± 0.70 
7.95 + 0.12 
Metal concn in liver (mg/kg) 
Cadmium 0.08 ±0.02 6.71 ± 0 . 2 " 3.09 ±0.18** 
Zinc 30.5 ±0.4 32.5 ±0.3* 32.5 ±0.7* 
Copper 4.4±0.1 5.0 ±0.1** 4.1 ±0.1 
Metal concn in kidneys (mg/kg) 
Cadmium 0.07 ± 0.02 
Zinc 27.9 + 0.4 
Copper 16.3 ±1.1 
8.47 ± 0.4" 6.52 ± 0.35** 
28.4 ±0.9 32.1 ± 0 . 8 " 
10.5 ± 0 . 7 " 7.3 + 0 .3" 
Values are means ± SEM for ten rats; those marked with asterisks 
differ significantly (ANOVA + Dunnett's test) from the corre-
sponding control value (*/• <0.05; **/* <0.01). 
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histopathological changes in the livers of mice 10 
days after oral exposure to a single dose of CdCl2 
(30 mg/kg body weight), and Elinder (1986) reported, 
that for detecting the long-term effects of cadmium 
on the liver, liver morphology is a more sensitive 
parameter than the liver-enzyme activities in the 
blood. In contrast, Dudley et al. (1985) showed 
significantly increased plasma activities of aspartate 
aminotransferase and alanine aminotransferase 2 wk 
after sc exposure to CdCl2 whereas morphological 
signs of hepatic injury did not occur until 4 wk after 
exposure. 
The differences in the extent of signs of adverse 
effects between CdCl2 and incorporated cadmium are 
accompanied by differences in the cadmium concen-
trations in the liver and kidneys. The ratio between 
the cadmium concentration of the liver and the 
kidneys was 0.79 in the group fed CdCl2 and 0.47 
after feeding of liver-incorporated cadmium. Similar 
findings have been reported by Maitani et al. (1984) 
in mice after a single oral administration of CdCl2 or 
liver-incorporated cadmium. The observed difference 
is almost solely due to the difference in accumulation 
in the liver and not to any marked difference in the 
uptake by the kidneys. 
Crews et al. (1989) have found that the majority of 
cadmium in pig-kidney metallothionein-like protein 
survives in vitro gastro-intestinal digestion, which 
may indicate that at least part of the cadmium is able 
to recombine with the metallothionein-like protein at 
higher pH after passage through the stomach. It has 
been suggested that cadmium-metallothionein can 
pass through the intestinal mucosa partially intact 
because of the constantly high kidney/liver concen-
tration after oral exposure to Cd-Mt (Cherian 1979; 
Maitani et ai, 1984). If this theory is correct, Cd-Mt 
after entering the bloodstream would then accumu-
late preferentially in the kidneys and not in the liver. 
The suggestion that Cd-Mt can be taken up intact is 
further supported by the work of Cherian (1979) who 
found that a major portion of the ingested Cd-Mt was 
isolated intact from the intestinal mucosa 4 hr after 
oral exposure to Cd-Mt. However, no hard evidence 
exists that exogenous Cd-Mt can pass the intestinal 
barrier. 
There are two possible explanations of the differ-
ence in the extent of effects of CdCl2 and tissue-incor-
porated cadmium. First, there is a difference in the 
accumulation in the target organs, and secondly there 
may be a difference in the sensitivity of the target 
organs to the two compounds. 
There are no data available on the liver toxicity of 
Cd-Mt in vivo. However, from recent in vitro studies 
(Beattie et al., 1987; Bracken et al, 1989) it appears 
that CdCU is more toxic to primary hepatocyte 
cultures than Cd-Mt. The difference in the signs of 
liver toxicity between the group fed a diet containing 
CdCl2 and the diet with Cd-Mt in the present study is 
therefore probably not only caused by the difference 
in cadmium accumulation but also by a difference in 
the sensitivity of the liver cells to CdCl2 and Cd-Mt. 
It is not surprising that no renal toxicity was 
observed in the present study, since the cadmium 
concentrations were too low for acute toxicity and the 
exposure time too short for chronic toxicity (Friberg 
et al., 1974; Kjellström, 1986). After iv injection of 
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Cd-Mt or CdCl2 several research groups concluded 
that Cd-Mt was more nephrotoxic than the CdCl2 
(Cherian et al., 1976; Nordberg et al, 1975; Squibb 
et al, 1979). This can at least partly be ascribed to the 
higher accumulation of Cd-Mt in the kidneys ob-
served after parenteral exposure (Tanaka et al, 1975). 
However, from the experiment of Sendelbach and 
Klaassen (1988) it appears that Cd-Mt is more 
nephrotoxic than CdCl2 after iv administration de-
spite a similar degree of accumulation in the kidneys, 
which points to a difference in the mechanisms of 
action of the two compounds. If such a difference also 
applies to the oral route of exposure, then our results 
may be valuable for assessing the risks to humans 
from cadmium consumed in animal products. 
Exposure to Cd-Mt seems to lead to a lower 
hepatotoxicity than exposure to corresponding 
amounts of CdCl2. Since both compounds accumu-
late to a similar extent in the kidneys, nephrotoxicity 
may at least be equal in severity for both forms of 
cadmium. 
Anaemia is one of the well known signs of toxicity 
after peroral exposure to cadmium and is thought to 
be related to the effects of cadmium on the metab-
olism of iron or zinc (Elinder, 1986). For the time 
being we have no sound explanation for the difference 
in the degrees of anaemia caused by the two dietary 
forms of cadmium. It is surprising that the erythro-
poiesis in the spleen is reduced by the cadmium 
treatment. However, the incidence of extramedullary 
haematopoiesis in rats of this strain and age is quite 
variable. Therefore no significance is attached to the 
disappearance of extramedullary haematopoiesis in 
the CdCl2-treated group. More research is being 
undertaken to determine the kinetics of the Cd-Mt 
uptake after oral exposure, and the role of the small 
intestine in the uptake and distribution of tissue-
incorporated cadmium. 
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Chapter 3 
CADMIUM ACCUMULATION AND METALLOTHIONEIN 
CONCENTRATIONS AFTER 4-WEEK DIETARY EXPOSURE TO 
CADMIUM CHLORIDE OR CADMIUM-METALLOTHIONEIN IN RATS 
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to Cadmium Chloride or Cadmium-Metallothionein in Rats. GROTEN, J. P., SINKELDAM, E. J., 
LUTEN, J. B., AND VAN BLADEREN, P. J. (1991). Toxicol. Appl. Pharmacol. I l l , 504-513. The 
distribution of cadmium was examined in rats fed diets containing either cadmium-metallothionein 
(CdMt) or cadmium chloride (CdCl2) for 4 weeks. The test diets contained 3, 10, or 30 mg Cd/ 
kg diet (3, 10, or 30 ppm) as CdMt or 30 mg Cd/kg diet (30 ppm) as CdClj. A second study was 
performed to establish the Cd content in liver and kidneys after exposure to low doses of both 
CdMt and CdCI2 (1.5 and 8 ppm Cd). The feeding of CdMt resulted in a dose- and time-dependent 
increase of the Cd concentration in liver, kidneys, and intestinal mucosa. Rats fed 30 ppm CdMt 
consistently showed less Cd accumulation in liver and intestinal mucosa than did rats fed 30 ppm 
CdCl2. However, renal accumulation in rats fed 30 ppm was similar until Day 28 regardless of 
Cd form. At lower dietary Cd levels (1.5 and 8 ppm), relatively more Cd is deposited in the 
kidneys, although even at these doses the kidney/liver ratio of Cd is still higher with CdMt than 
with CdCl2. Tissue metallothionein (Mt) levels in the intestinal mucosa were relatively constant 
but always higher after CdCl2 exposure than after CdMt exposure. Mt levels in both liver and 
kidney increased after CdCl2 or CdMt exposure during the course of study. Although Mt levels 
in liver were higher after CdCI2 intake (30 ppm) than after CdMt intake (30 ppm), renal Mt 
concentrations were the same for both groups. In fact on Day 7, CdMt administration resulted 
in slightly higher Mt levels than CdCl2 administration, suggesting a direct accumulation of ex-
ogenous CdMt in the kidneys. In conclusion, after oral exposure to CdMt in the diet there is a 
relatively higher Cd accumulation in the kidneys. However, the indirect renal accumulation via 
redistribution of Cd from the liver might be lower than after CdCl2 exposure. Which of these two 
phenomena is decisive in the eventual level of renal toxicity of Cd after long-term oral intake 
could determine the toxicological risk of the chronic intake of biologically incorporated Cd. 
© 1991 Academic Press, Inc. 
The main source of environmental exposure tallothionein (Webb, 1986). A similar protein, 
to Cadmium (Cd) for nonsmokers is food phytochelatin, is the major Cd-binding protein 
(Foulkes 1986). Due to the small safety margin in plants (Wagner, 1984; Kägi and Kojima, 
between the actual level of dietary intake and 1987). 
the toxic level of Cd (Buchet et al, 1990), hu- Previous studies have shown that parenteral 
man dietary exposure to Cd has become a ma- administration of cadmium-metallothionein 
jor concern. In this regard, although most tox- (CdMt) leads to a more pronounced nephro-
icity studies have used inorganic salts of Cd, toxicity than parenteral administration of in-
this is clearly not the chemical form in which organic Cd salts (Nordberg et al, 1975; Che-
Cd occurs in the diet. In animals one of the rian et al, 1976; Squibb et al, 1979). This is 
main Cd-binding ligands is the protein me- due at least in part to a higher accumulation 
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of Cd in the kidneys from CdMt exposure 
(Tanaka et al, 1975). It is thought that CdMt 
is reabsorbed into the renal proximal cells after 
glomerular filtration. The exogenous CdMt is 
degraded in lysosomes and free Cd, released 
within the cell, will cause damage (Squibb et 
al, 1979; Kjellström, 1986). Cd-cytotoxicity 
is believed to be dependent on the amount of 
free ionic Cd present in the cell which is not 
sequestered by available endogenous metal-
lothionein or glutathione (Jin et al, 1987; Su-
zuki and Cherian, 1989). Alternatively, it is 
suggested that CdMt will damage the brush 
border during reabsorption of the CdMt com-
plex (Cherian, 1982) and, indeed, a higher 
sensitivity of the kidneys to Cd in the form of 
CdMt has also been observed (Sendelbach and 
Klaassen, 1988). 
Several studies have examined the distri-
bution of Cd salts and CdMt after oral expo-
sure. A few such studies used biologically in-
corporated Cd. For example, internal organs 
of Cd-exposed pigs (Uthe and Chou, 1974) or 
whole oysters (Sullivan et al, 1984) have been 
used as source material for exposure to bio-
logically incorporated Cd. The results of these 
studies are difficult to interpret since Cd-bind-
ing ligands were not characterized prior to use. 
Other researchers have studied the oral ab-
sorption of Cd after gavage of CdMt. For ex-
ample, Cherian (1979, 1983) used purified rat 
CdMt, while Maitani et al (1984) used CdMt 
added to rat liver homogenate. The gavage 
studies using CdMt as the only Cd-binding li-
gand have demonstrated that the liver to kid-
ney ratio of Cd concentrations was much lower 
after exposure to CdMt compared to CdCl2. 
This was mainly due to a selective deposition 
in the kidneys after CdMt exposure (Cherian 
1979, 1983; Maitani et al, 1984). However, 
in these studies, the animals were exposed by 
gavage and no kinetics of the Cd disposition 
were determined. Moreover, since rats exposed 
to very low doses of CdCl2 show selective renal 
Cd accumulation (Lehman and Klaassen, 
1986), the question remains whether the se-
lective renal accumulation after CdMt expo-
sure is dose-dependent. 
In a previous study we attempted to simu-
late normal dietary exposure of humans to 
CdMt through the food chain by incorporating 
CdMt into the diet instead of using gavage 
(Groten et al, 1990). In this way, possible ef-
fects of dietary factors were taken into account. 
It is known that dietary factors like minerals, 
vitamins, and proteins affect the intestinal Cd 
uptake or the Cd toxicity (Fox, 1979; Task-
group on Metal Interactions, 1978; Groten et 
al, 1991). It was shown that there is a clear 
difference in toxicity in rats fed either inor-
ganic (CdCl2) or pig liver-incorporated Cd in 
which Cd was mainly bound to porcine CdMt. 
Signs of Cd toxicity, such as decreased weight 
gain, anemia, and liver damage, were all more 
pronounced after exposure to CdCl2 than after 
feeding of CdMt (Groten et al, 1990). 
The present study was intended to establish 
the kinetics of the Cd uptake and the CdMt 
concentration in the kidneys, liver, and intes-
tinal mucosa during 4-week oral exposure to 
CdMt via the food and to study the dose-de-
pendent Cd disposition. Such a comparative 
study might provide more insight into the ob-
served differences in toxicity between inor-
ganic and Mt-bound Cd. 
MATERIALS AND METHODS 
Test Substance 
Cadmium chloride, with a purity of at least 99% as 
specified by the supplier was obtained from E. Merck (AG 
Darmstadt, FRG). 
Preparation of Cd Incorporated into Pig Liver 
Three male pigs, initially weighing 50 ± 4 kg, were 
housed separately in metabolism cages. The animals were 
injected in the thigh intramuscularly with CdCI2 dissolved 
in saline according to the following schedule: on Days 0, 
9, 12, 15, and 18 with 3 mg Cd/kg and on Days 3 and 6 
with 6 mg Cd/kg. 
Four weeks after the last injection the animals were killed 
and the livers were removed. The livers were pooled, ho-
mogenized, lyophilized, and stored at -30°C. Livers ob-
tained from two untreated pigs were handled in the same 
way. Cd analysis of freeze-dried liver samples (see below) 
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revealed that the Cd and Zn content was 950 and 700 mg/ 
kg tissue, respectively. In a previous study (Groten el ai, 
1990) the Cd-binding ligand in the pig liver that accounted 
for almost 90% of the total Cd present was characterized 
as CdMt. 
experimental conditions the actual levels of Cd were be-
tween 93 and 97% of the intended level. 
Observations and Analyses 
Diets 
A semisynthetic powdered basal diet was composed in 
such a way that it mimics a Western-type human diet: 
high in fat, low in fiber, without excessive amounts of 
minerals and vitamins (Sinkeldam et ai, 1990). Four diets 
consisted of the basal diet supplemented with the pig liver 
homogenates described above, providing dietary levejs of 
0, 3, 10, or 30 ppm Cd. A fifth diet contained the basal 
diet supplemented with CdCI2 to a dietary level of 30 
ppm Cd (for chemical composition of the diets see Groten 
et ai, 1990). Mineral analysis of the test diets revealed 
that the Zn content was 46.5 ± 1.5 ppm, the Fe content 
was 7 7 + 1 2 ppm, and the protein concentration was 
27.1 ± 1.1%. 
Animals and Maintenance 
Male, weanling, Wistar-derived SPF-bred rats (Bor; 
WISW) were obtained from F. Winkelmann (Institute for 
the Breeding of Laboratory Animals GmbH & Co. KG, 
Borchen, FRG). At the beginning of the study the rats 
were 4 to 5 weeks old. They were housed under conven-
tional conditions in suspended stainless-steel cages fitted 
with a wire-mesh floor and front. The room temperature 
was maintained at 22 ± 2°C and the relative humidity at 
40-70%. A 12-hr light/dark cycle was maintained and the 
number of air changes was about 10/hr. Prior to the ex-
periment all rats were fed the basal diet with no further 
additions. Drinking water was supplied in glass bottles 
which were cleaned weekly. Food and tap water were pro-
vided ad libitum. Diets were provided as a meal mash in 
stainless steel cans. The food was covered by a perforated 
stainless steel plate which effectively prevented spillage. 
Food intake was measured by weighing the feeders. On 
Days 4 and 7 and once weekly thereafter, the leftovers in 
the feeders were weighed and discarded prior to filling the 
feeders with fresh portions. 
Experimental Design and Treatment 
The rats were acclimatized to the animal facilities for 
8 days and were then allocated into five groups of 18 an-
imals using a computer-generated random number table. 
A few rats were reallocated in order to equalize the initial 
mean body weight in the various groups. Each treatment 
group (housed in groups of five) received one of the five 
test diets. Analysis of the test diets revealed that under the 
The rats were weighed at weekly intervals and were ob-
served daily for condition and behavior. Food and water 
intakes were measured over weekly periods throughout 
the study. 
Tissue preparation. On Days 2, 4, 7, 14, 21, and 28 
three animals of each group were killed by exsanguination 
from the abdominal aorta while under light ether anesthesia 
and necropsied. Immediately after evisceration the kidneys, 
liver, and small intestine were weighted and the medulla 
of the kidneys was removed using a pair of tweezers. After 
weighing, both the kidney cortex and the liver were im-
mediately frozen using liquid nitrogen and finally kept in 
an -80°C freezer prior to use. To remove all intestinal 
contents, a cannula which was connected to a reservoir 
with a 10-ml dispenser was inserted into the duodenum. 
Every intestine was rinsed thoroughly with 60 ml of phos-
phate-buffered saline (six strokes of a 10-ml dispenser). 
Finally the small intestine was sliced lengthwise at one 
side and was placed on an ice-cold petri dish (20 cm di-
ameter). The intestinal mucosa was scraped with an object 
glass at an angle of 40° to the surface. Mucosal scrapings 
were immediately frozen in liquid nitrogen and kept in a 
-80°C freezer. 
The tissues were thawed just prior to analysis and ho-
mogenized using a teflon pestle in a 10 mM Tris-HCl buffer 
(pH 7.4, 4°C). An aliquot of the homogenized tissue was 
used for the metal analysis. The rest of the homogenate 
was centrifuged at 9,000,1» for 20 min and the supernatant 
(S9 mixture) was used for CdMt analysis. 
Cd and CdMt analysis. Zn was determined by flame 
atomic absorption spectrometry (FAAS). The samples were 
dry-ashed at 500°C and dissolved in hydrochloric acid. 
Cd was determined by FAAS or graphite furnace atomic 
absorption spectrometry (GFAAS) after a wet digestion of 
the sample by sulfuric acid. The tissue level of CdMt was 
determined by the Cd-hemoglobin assay as developed by 
Onosaka and Cherian (1978) and modified by Eaton and 
Toal (1982). A 200-jd aliquot of heat-treated S9 homog-
enate of liver, intestine, or kidneys was saturated by in-
cubation with 200 1^ of 10 mM Tris-buffered CdCl2 (0.26 
mM Cd). After 10 min the incubation mixture was pro-
cessed through two sequential treatments with 2% bovine 
hemoglobin (Hb; Sigma, St. Louis) and heating (2 min, 
95°C). In both steps the denatured Hb protein was spun 
down (8,000,?, 10 min). After the second step, the super-
natant was decanted and the Cd content was determined 
by atomic absorption spectrometry. 
From the resulting mean values (duplicate/animal), the 
concentration of Mt in the original solution was calculated 
using a molar apo-Mt:Cd ratio of 1:7 (Winge and Miklossy, 
1982). The Mt concentration was determined in the con-
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trois and at the Cd dose levels of 30 ppm Cd on Days 2, 
7, 14, and 28. 
Second Experiment 
After the main experiment it was decided to perform a 
second experiment to establish the kidney/liver Cd ratio 
after 28 days of exposure to low levels of both CdMt and 
CdCl2. For that purpose five groups of rats (five animals/ 
group) were fed with a diet that contained 1.5, 8, or 30 
ppm Cd as CdCl2 and 1.5 and 8 ppm Cd as CdMt. On 
Day 28 all animals were killed. Experimental design, tissue 
preparation, and AAS analysis were performed as in the 
main study. 
Statistical Analysis 
Data on body weights were evaluated by a one-way 
analysis of covariance, followed by Dunnett's multiple 
comparison tests. The laboratory determinations and organ 
weights were evaluated by a one-way analysis of variance, 
followed by Dunnett's multiple comparison tests. The data 
on the ratio between the Cd content of kidney and liver 
were evaluated by a two-way analysis of variance for the 
overall effect and by a paired t test for the effect on the 
separate days. 
RESULTS 
General condition and behavior of the rats 
appeared to be normal throughout the 4-week 
study. Body weight gain and food consump-
tion were similar in all groups (Table 1 ). The 
daily intake of Cd in rats fed 3 ppm CdMt 
varies from 125 to 260 /ug/kg body wt. For rats 
fed 30 ppm Cd as CdCl2 or CdMt the daily 
intake varied from 1 to 2.5 mg/kg body wt. 
The variation in dose is due to the body weight 
gain. There were no consistent differences in 
organ weights or food consumption among the 
test groups. 
Feeding of pig CdMt produced a dose- and 
time-dependent increase of the Cd concentra-
tion in all organs (Fig. 1). However, at the dose 
level of 3 ppm Cd in the diet the time-depen-
dent increase was not statistically significant 
in the liver and kidneys. In contrast to the kid-
neys and the liver the intestinal mucosa al-
ready contained fairly high Cd levels after 2 
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FIG. 1. Cd concentrations in small intestine, liver, and kidneys after oral exposure to CdCI2 (30 mg Cd/ 
kg diet) or pig's CdMt (3, 10, or 30 mg Cd/kg diet) for 28 days. Every value is the mean ± SEM of three 
rats. All values marked with an asterisk differ significantly from the group fed 30 mg Cd/kg as CdMt (**p 
< 0.01 and *p < 0.005). Note the y-axis of the intestine is plotted from 0 to 15 mg/kg and the y-axis of the 
liver and kidneys is plotted from 0 to 10 mg/kg. 
days of exposure to either inorganic or bio-
logically incorporated Cd. 
After 28 days the Cd concentration in the 
intestinal mucosa is more than twice as high 
after the feeding of CdCl2 as after the feeding 
of CdMt (Fig. la). A similar pattern was found 
for the Cd accumulation in the liver; from Day 
2 onward the feeding of CdCl2 resulted in al-
most twice the amount of Cd in the liver com-
pared with the feeding of CdMt (Fig. lb). 
In sharp contrast no difference in the Cd 
concentration between CdCl2 and CdMt ex-
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FIG. 2. The ratio between kidney and liver Cd concen-
trations of rats fed 30 mg Cd/kg diet. Each value is the 
mean ± SEM of three rats. Values marked with an asterisk 
in the group fed CdCl2 differ significantly from the group 
fed 30 mg Cd/kg as pig's CdMt (**p < 0.01 and *p < 
0.005). 
posure in the kidneys was observed during the 
first 22 days of the study (Fig. lc). Only on 
Day 28 did the animals fed CdCl2 show a sig-
nificantly higher Cd accumulation in the kid-
neys than the animals fed CdMt, but the dif-
ference was much smaller than that observed 
for liver and small intestine. 
A plot of the kidney/liver ratio of Cd con-
centration versus time of exposure (Fig. 2) 
shows that oral exposure to CdMt leads to a 
significantly higher ratio than the feeding of 
inorganic Cd on Days 4, 22, and 28 and when 
regarding the whole experimental period. Ini-
tially, the Cd distribution from CdMt is very 
different from the distribution of Cd originat-
ing from CdCl2. However, the difference be-
comes less pronounced with time and from 
Day 15 onward the increase in the relative 
contribution of the Cd content of the kidneys 
is similar for both Cd forms, although CdMt 
gives a consistently higher Cd ratio between 
kidneys and liver. 
A comparison of the ratio between renal 
and hepatic Cd concentrations at low doses of 
CdCl2 and CdMt was performed in a separate 
study. Cd accumulation after feeding 30 ppm 
CdCl2 was determined in both studies: the 
kidney/liver Cd ratios were 1.4 and 1.3, re-
spectively, for the main and the second study. 
The ratio of kidney/liver Cd concentration is 
dose dependent as feeding of a low dose of 
CdMt or CdCl2 (1.5 ppm Cd) resulted in a 
relatively higher Cd disposition in the kidneys 
than the feeding of a high dose (30 ppm Cd). 
However, at all dose levels tested the kidney/ 
liver Cd ratio is still higher after feeding of 
CdMt than after feeding of CdCl2 (Table 2). 
From the organ weights it was calculated 
that the total Cd intake in liver and kidneys 
at the doses of 2, 8, and 30 ppm Cd was 3.5, 
39.2, and 105 /tg Cd, respectively, after feeding 
CdCl2 and 2.4, 9.6, and 39.3 jug, respectively, 
TABLE 2 
MEAN VALUES OF LIVER AND KIDNEY CONCENTRATIONS IN RATS FED CdCl2 OR CdMt 
FOR 28 DAYS AT THREE DIETARY Cd LEVELS 
Diets 
Cd concentration in mg/kg tissue 
Liver Kidney cortex Cd ratio kidney/liver 
1.5ppmCdCl2 
8 ppm CdCI2 
30 ppm CdCI2 
1.5 ppm CdMt 
8 ppm CdMt 
30 ppm CdMt" 
0.20 ± 0.05 (2.6) 
2.34 ±0.61 (32.45) 
7.64 ± 1.47(84.6) 
0.14 ±0.02 (1.72) 
0.54 ± 0.38 (6.37) 
2.93 ± 0.39 (28.0) 
0.43 ±0.2 (0.87) 
3.10 ±0.64 (6.78) 
9.98 ±2.0 (19.66) 
0.37 ± 0.04 (0.76) 
1.15 ±0.5 (2.23) 
6.26 ± 1.2 (11.26) 
2.41 ± 0.62 
1.34 ±0.16 
1.31 ±0.19 
2.75 ± 0.50 
2.50 ± 0.70 
2.10 ±0.20 
Note. Cd concentrations are means ± SD for groups of five animals. The value between brackets gives the mean 
total Cd intake in liver and kidneys, respectively, in ^g Cd. For details of the experiment see Materials and Methods. 
" Values of the 30 ppm CdMt dose are derived from the first experiment and are means ± SD of three animals. 
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after feeding CdMt. Thus, the total Cd intake 
in liver and kidneys for 30 ppm CdMt and 8 
ppm CdCl2 is approximately equal, although 
Table 2 shows that the renal Cd content is 
more than twice as high after feeding 8 ppm 
Cd as CdMt than after feeding 30 ppm Cd as 
CdCl2. 
The CdMt content of the various organs was 
also measured: After feeding of 30 ppm Cd as 
CdCl2 or as CdMt the Mt levels in liver and 
kidneys were significantly increased compared 
to the control (Figs. 3b and 3c). In contrast to 
the kidneys and the liver, the Mt concentration 
in the intestinal mucosa is already significantly 
raised after 2 days of exposure to either of the 
Cd forms, but the Mt concentration does not 
increase during the course of the study (Fig. 
3a). From Day 14 onward, a significant dif-
ference in the Mt content in liver and intestine 
based on the treatment form of Cd occurred 
(Figs. 3a and 3b), as CdCl2 leads to higher Mt 
levels than CdMt. However, renal Mt levels 
for both Cd forms were equal. In fact on Day 
7 the feeding of CdMt resulted in significantly 
higher Mt levels in the kidneys than did the 
feeding ofCdCl2 (Fig. 3c). 
small Intestine 
day 2 day 7 day 14 day 28 
kidney 
day 2 day 7 day 14 day 28 
FIG. 3. Mt concentrations in small intestine, liver, and 
kidneys after oral exposure to CdCl2 or pig's CdMt (30 
mg Cd/mg) for 28 days. Every value is the mean ± SD of 
three rats. Values marked with an asterisk in the control 
group and in the group fed CdCl2 differ significantly from 
the group fed CdMt (**p < 0.01 and *p < 0.005). 
DISCUSSION 
In the present investigation the disposition 
of biologically incorporated Cd, specifically Cd 
associated with Mt, was studied. In this regard, 
some evidence suggests that the sequence of 
events for intestinal uptake of CdMt is differ-
ent from that for CdCl2. The first potential 
difference between CdCl2 and CdMt can be 
found in the gastrointestinal stability of CdMt. 
Cherian (1979) and Ohta and Cherian (1991) 
found that a major portion of ingested CdMt 
could be isolated intact from the intestinal 
mucosa after oral exposure to CdMt. Crews et 
al. (1989) have shown that indeed at least part 
of a pig kidney or equine CdMt-like protein 
survives in vitro treatment with gastrointestinal 
proteolytic enzymes. Thus CdMt does in fact 
appear to reach the intestine. It is well known 
that CdMt after iv administration preferen-
tially accumulates in the kidneys, unlike in-
organic salts of Cd that accumulate in the liver 
(Nordberg et al, 1975; Tanaka et al, 1975; 
Squibb et al, 1979; Sendelbach and Klaassen, 
1988; Maitani et al, 1988). Furthermore, it 
has been suggested that CdMt can pass the 
intestinal mucosa at least partially intact be-
cause of the high kidney/liver ratio found after 
single bolus oral exposure to CdMt (Cherian, 
1979; Maitani et al, 1984; Ohta and Cherian, 
1991). Thus the results of the present study 
showing a high kidney/liver ratio of Cd con-
centration also indicate that CdMt incorpo-
rated into the diet is at least partially absorbed 
intact. 
The general theory for CdCl2 disposition is 
that after absorption of very low amounts of 
ionic Cd through the intestine the Cd ions are 
initially bound to available endogenous Mt 
and transported preferentially to the kidneys 
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(Lehman and Klaassen, 1986). However, after 
a higher dose (100 ng Cd/kg body wt or 
higher), the available endogenous circulating 
Mt pool is overloaded and Cd will bind to 
higher molecular weight plasma proteins such 
as albumin and then be deposited in the liver 
(Lehman and Klaassen, 1986). To what extent 
CdCl2 or other inorganic salts are accumulated 
by the kidneys after oral administration thus 
depends on the dose. This hypothesis is 
strengthened by the present results which show 
that the selective renal disposition of Cd from 
CdCl2 is dose-dependent after subchronic ad-
ministration. A level of 1.5 ppm Cd as CdCl2 
in the diet resulted in a higher proportion of 
the total dose depositing in the kidneys after 
4 weeks of exposure than did a dose level of 
30 ppm Cd as CdCl2. Moreover at the 30 ppm 
level the Cd accumulation in the kidneys after 
feeding of CdCl2 increases with time. Initially 
the ratio of the kidney/liver Cd concentration 
is low and comparable to the ratio observed 
after a single similar dose in the study of Leh-
man and Klaassen (1986), but after 28 days 
of exposure the Cd concentration in the kid-
neys is higher than in the liver. However, after 
exposure to dietary CdMt the kidney/liver ra-
tio of Cd is always higher than after CdCl2 
intake, irrespective of dose. In the first week 
of exposure to 30 ppm Cd in the diet the Mt 
concentration in the kidneys was even higher 
after administration of CdMt than after ex-
posure to CdCl2. This, in conjunction with 
the fact that similar renal Cd concentrations 
were observed until Day 7, might support the 
theory (Cherian, 1979; Maitani et al, 1984; 
Ohta and Cherian, 1991) that exogenous 
CdMt indeed passes the intestinal barrier and 
reaches the kidneys intact. The differential 
disposition of CdCl2 and CdMt between liver 
and kidney is less pronounced at lower doses 
of Cd, but still large enough to indicate met-
abolic differences. 
In contrast to the liver and kidneys the Mt 
and Cd levels of the intestine are rather con-
stant, which might be explained by the con-
tinuous renewal of the intestinal epithelium 
and desquamation of the "old" mucosa. Cd, 
which is retained in the intestinal wall, is thus 
released back into the lumen due to this epi-
thelial sloughing and is available for reabsorp-
tion by lower parts of the intestine (Valberg 
et al, 1976; Foulkes, 1986). An equilibrium 
between uptake and desquamation would re-
sult in constant Mt and Cd levels of the intes-
tine in chronically exposed animals. The fact 
that the Cd content in fact slightly increased 
might indicate that relatively more Cd is 
bound to the same amount of CdMt in the 
course of the study as proposed by Goyer et 
al. ( 1990) for kidney and liver Mt after par-
enteral administration of CdCl2. On the other 
hand, it might also indicate that other Cd-
binding ligands are involved in the intestinal 
retention of Cd or CdMt rather than intest-
inal Mt. 
The ratio of kidney to liver concentrations 
increased during the third and fourth weeks 
of exposure after both CdCl2 and CdMt ad-
ministration. This could be attributed to the 
frequent observation that after chronic Cd ex-
posure kidney Cd levels increase due to a 
gradual redistribution from the liver (Nordberg 
et al, 1985). At all doses tested, CdCl2 leads 
to a higher Cd content of the liver than CdMt. 
After toxic insult or as a consequence of the 
age-related degeneration of the liver (Dudley 
et al, 1985; Nordberg et al, 1985), more Cd 
is thus available for redistribution from the 
liver to the kidneys after exposure to an in-
organic Cd salt than after exposure to CdMt. 
This raises the question of what the impact of 
the Cd redistribution from the liver to the kid-
neys will be during long-term oral intake in 
the final level of renal intoxication. 
In conclusion, after oral exposure to CdMt 
in the diet there is a relatively higher accu-
mulation of Cd in the kidneys. However, the 
indirect renal accumulation via redistribution 
of Cd from the liver might be lower than after 
CdCl2 exposure. Which of these two phenom-
ena is decisive in the eventual level of renal 
toxicity of Cd after long-term oral intake could 
determine the toxicological risk of the chronic 
intake of biologically incorporated Cd. 
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Abstract—The protective role of metallothionein (Mt) in the toxicity of Cadmium (Cd) is controversial, 
since Cd bound to Mt is more nephrotoxic than ionic Cd after parenteral exposure and less hepatotoxic 
than ionic Cd after oral exposure. This study compared the uptake and toxicity in vitro of CdClj and two 
isoforms of rat cadmium metallothionein (CdMt-1 and CdMt-2) using primary rat kidney cortex cells 
primary rat hëpatocytes, liver hepatoma cell line H-35, kidney epithelial cell line NRK52-E and intestinal 
epithelial cell line IEC-18. The molar ratio of Cd was 2.1 and 1.4 mol Cd/mol Mt for CdMt-l and CdMt-2, 
respectively. Monolayer cultures were incubated for 22 hr with CdCI,, CdMt-1 or CdMt-2 and Cd-
accumulation was examined at Cd levels of 0.25-10 jiM-Cd. Cells exposed to CdCl? accumulated more 
Cd in 22 hr than cells exposed to an equimolar amount of CdMt. For CdCl2 the Cd accumulation is 
directly related to the Cd concentration in the medium; however, for CdMt an increase in Cd 
concentration in the medium above 2/iM had no effect on the Cd accumulation in the cells. At Cd 
concentrations above 2/<M, therefore, the difference in Cd accumulation between CdCl2 and CdMt was 
greater (5-6 times) than at concentrations below 2 ^ M (1-2 times). Cytotoxicity was examined in the 
Cd-concentration range from 0.2S to 100/J M by determining the lactate dehydrogenase (LDH) release in 
the medium and the neutral red uptake in the cells. Under these culture conditions CdCI, was at least 
100 times more toxic than CdMt-1 or CdMt-2 in all cell types tested. Primary hepatocyte cultures were 
ten times more sensitive (50% LDH release at l-2^M) to CdCI3 intoxication than primary cultures of 
renal cortical cells or the intestinal cell line (50% LDH release at 10-20 ^IM). Hepatic and renal cell lines 
were less sensitive (50% LDH release at 20-35 /iM) than the corresponding primary cultures. No difference 
in sensitivity towards CdMt-1 or CdMt-2 was found for the various cell types tested. To investigate the 
influence of the molar Cd ratio of CdMt on cytotoxicity, the Cd content of CdMt-1 (2.1 mol Cd/mol Mt) 
was artificially raised in vitro to 5 mol/mol Mt. Compared with native CdMt, CdMt with a high molar 
Cd ratio in primary renal cultures showed a 15% increase in LDH release at a Cd concentration of 
l500pM in the medium. In conclusion, exogenous CdMt is far less toxic than CdCI, to cell cultures in 
a serum-free medium. Whereas CdCI, in all cases showed dose-dependent Cd accumulation. Cd 
accumulation due to CdMt exposure in all cell types tested reached a plateau at medium Cd concentrations 
of 2 fiM. The low cellular Cd uptake of CdMt and the corresponding low cytotoxicity supports previously 
reported results in vivo, showing that the difference in toxicity between CdMt and CdCl2 is associated with 
a difference in Cd distribution. 
INTRODUCTION Robards and Worsfold, 1991). In food a major 
portion of the Cd is bound to metal-binding proteins 
Occasionally humans are exposed to inorganic
 s u c h a s p h y t o c h e l a t i n s a n d meiallothioneins. Metal-
cadmium (Cd), but the general population is mainly , o t h i o n e i n ( M t ) i s k n o w n t 0 h a v e a k e y r o l e i n t h e 
exposed to cadm.um through food (Foulkes, 1986;
 d e t o x i f i c a t i o n o f h e a v y m e t a l s i n a n i m a l s (Waalkes, 
1990; Webb, 1986). There is some evidence that rats 
exposed to cadmium-metailothionein (CdMt) by way 
Abbreviations: AAS = atomic absorption spectrometry;
 o f ( h e f o o d s h o w Cd-accumulation preferentially in 
Cd = cadmium; CdMt = cadmium-metailothionein; , , . , , _ , . , , „ , . „ . . , , ' . 
EDTA = ethylenediaminetetraacetic acid; FAAS = t h e k , d n e v s ( G r o t e n e' aL> 1 9 9> = M a i t a n ' et al< 1 9 8 4 ! 
flame atomic absorption spectrometry: GFAAS = Ohta and Chenan, 1991). On the other hand, after 
graphite furnace atomic absorption spectrometry; oral exposure to inorganic Cd, Cd accumulates also 
H-35 = hepatoma cell line; IEC-18 = intestinal epi- to a considerable extent in the liver. It is thought that 
theiial cell line; LDH = lactate dehydrogenase; Mt = « . . , , , . ., . . .. , , 
metallothionein; NRK-52E = normal rat kidney Cd ions, once absorbed in the intestine, are bound 
(epithelial like) cell line; PBS = phosphate buffered 'o high molecular weight plasma proteins such as 
saline. albumin and to Mt. The Cd-albumin complex is 
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taken up in the liver, where after degradation of the 
Cd-albumin, Cd is bound again to hepatic Mt. Cd 
bound to intestinal or hepatic Mt is taken up in the 
kidneys, and after degradation of this Cd-complex, 
Cd is bound to renal Mt (Lehman and Klaassert, 
1986; Ohta and Cherian, 1991; Webb, 1986). The 
binding to proteins such as albumin and Mt thus 
serves as a protective mechanism to scavenge Cd 
from the blood. However, the protective role of Mt 
is rather controversial since it has been shown that 
CdMt after iv injection is even more nephrotoxic 
than ionic Cd. This can largely be ascribed to the 
higher renal accumulation of CdMt after parenteral 
exposure (Cherian et al., 1976; Nordberg et al., 1975; 
Squibb et al., 1979; Tanaka et al., 1975). In contrast 
to the acute nephrotoxicity of parenteral CdMt, it has 
been shown that signs of subacute toxicity such as 
anaemia and hepatotoxicity are less pronounced after 
dietary exposure to CdMt than after exposure to 
CdClj (Groten et al., 1990). The lower toxicity of 
CdMt in this case correlates well with the fact that the 
intestinal and hepatic uptake of Cd after CdMt 
exposure is lower than after exposure to CdCl2 
(Groten et al., 1991; Maitani et al., 1984). Indeed, 
studies in vitro using primary hepatocytes have 
confirmed that exogenous CdMt is less toxic to 
primary hepatocytes than CdCl2 and this is due, at 
least in part, to a difference in Cd-uptake (Beattie 
et al., 1987; Sendelbach et al., 1989). However, 
isolated renal epithelial cells are apparently more 
sensitive to CdMt in vitro, in spite of a low Cd uptake 
(Cherian 1982, 1985). In addition, renal accumu-
lation of Cd in vivo was almost similar for both 
CdMt or CdCl2 when given orally (Groten et al., 
1991). 
A reliable comparison of the data from different 
cytotoxicity studies using cells of different tissue 
origin has been difficult to date, because for example, 
the method of preparation of CdMt (e.g. species, 
molar Cd ratio) and the culture conditions (e.g. use 
of serum) have not always been identical. For this 
reason the study reported here was undertaken to 
compare the accumulation and toxicity of CdMt and 
CdCl2 in primary cultures and cell lines grown under 
the same conditions and using one identical batch 
of native CdMt. This comparative study provides 
more insight into the difference in toxicity between 
exogenous CdMt and CdCI2, and the difference in 
sensitivity between hepatic, renal and intestinal cells 
in vitro. The results may eventually shed light on 
similar differences in vivo. 
MATERIALS AND METHODS 
Cell culture 
Primary cells. Rat hepatocytes were isolated 
using the two-step collagenase perfusion technique 
described by Seglen (1976) and modified by Paine 
et al. (1979). 
The cells were plated in 10-cm tissue culture 
dishes (Costar, Cambridge, MA, USA) or 6-well 
tissue culture plates (Costar) at a density of 8 x 10' 
cells/dish in 10 ml medium or 1 x 106 cells/well, 
respectively. Cell viability, as determined by trypan 
blue exclusion, ranged from 80 to 95%. The culture 
medium was Williams medium E, supplemented with 
3% (v/v) newborn calf serum, 1 /iM-insulin, 10/IM-
hydrocortisone and 50 mg gentamicin/litre. The Cd 
exposure took place 24 hr after isolation of the 
hepatocytes. 
Rat primary kidney cells were isolated according to 
the method of Jones et al. (1979) as modified by 
Bruggeman et al. (1989). The cells were plated on 
6-cm tissue culture dishes in 5 ml medium or 6-well 
tissue culture plates in 2 ml medium at a density of 
2-3 x 106 cells/dish or 0.4 x 10' cells/well, respect-
ively. Cell viability, as determined by trypan blue 
exclusion, ranged from 70 to 90%. The cells became 
confluent between 3 and 5 days after plating. The 
culture medium was Williams E, supplemented with 
10% foetal calf serum (FCS), penicillin-streptomycin 
(100 U, mg/litre). The Cd exposure took place 24 hr 
after confluency. 
Cell lines. NRK-52E epithelial kidney cells (pas-
sage 17-20) and IEC-18 intestinal epithelial cells 
(passage 19-25) were cultured in HEPES-buffered 
Dulbecco's modified Eagle's medium. H-35 liver hep-
atoma cells were cultured in Ham's F12. All cell lines 
were obtained from ATCC (Rockville, MD, USA). 
All media were supplemented with 2 mM-glutamine, 
5% FCS and 5000 units penicillin-streptomycin/l. 
Cells were seeded on 10-cm dishes in 10 ml culture 
medium or 6-well tissue culture plates in 2.5 ml 
culture medium at a density of 2 x 10' cells/dish or 
0.3 x 106 cells/well, respectively, and became conflu-
ent between 2 and 3 days after plating. Cd exposure 
took place 24 hr after confluency. 
Preparation of CdMt 
Rat Mt was purified from livers of male Wistar 
[Crl:WI(WU)Br] rats that, previously had been 
injected sc with CdCI2 dissolved in saline according 
to the following schedule: on day 0 and 12 with 
3 mg/kg and on day 4, 6, 8 and 10 with 1.2mg/kg 
body weight. Two days after the last injection the 
livers were perfused with 0.9% NaCl, excised and 
homogenized (1:2, w/v) in 10mM-Tris/144mM-KCl 
buffer (pH 7.4) using a teflon pestle. The homogenate 
was centrifuged at 10,000 g for 15 min, decanted 
and again centrifuged at 100,000 £ for 70 min. The 
cytosol was filtered through a 0.22-/* M filter (Milli-
pore GS, Molsheim, France) and chromatographed 
on a Sephadex G-75 column (5 x 60 cm, Pharmacia, 
Uppsala, Sweden) with 10 mM-Tris-HCl. The Mt 
containing fractions were determined by the relative 
elution volume (VJV„= ±2) and were applied to a 
Sephadex DEAE-A25 column (2.5 x 20 cm) and 
eluted with a linear gradient of 10-300 mM-Tris-HCl 
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(pH 8.5, 4°C). The fractions that corresponded to 
CdMt-1 and CdMt-2 (as determined by the cadmium 
content of the eluate) were pooled, dialysed against 
water (Amicon YM membrane, Danvers, Ireland) 
and lyophilized. HPLC analysis on hypersil ODS 
HPLC steel columns (UV absorption wavelengths 
ranging from 190 to 280 nm, as described by Groten 
et al, 1990) revealed one single peak for every 
isoform with less than 8% impurities in the prep-
aration. Finally, the lyophilized material of several 
isolations was pooled to obtain 29 mg lyophilized 
Mt-1 and 38 mg Mt-2 from 80 ml liver cytosol. Both 
isoforms contained Zn and Cu in addition to Cd. It 
should be emphasized that, in vivo, Cd-induced Mt is 
almost always found in a mixed-metal form consist-
ing of Cd, Zn and small amounts of Cu (Holt et al, 
1985; Otvos et al, 1987; Webb, 1986). The molar 
ratios of Cd/Zn/Cu in Mt-1 and Mt-2 were 1:1.2:0.04 
and 1:1.4:0.06, respectively. Based on a purity of 
90% (as determined by the Cd-haemoglobin assay of 
Onosaka et al, 1978 and modified by Eaton and 
Toal, 1982) Mt-1 and Mt-2 contained 2.1 mol Cd/mol 
Mt and 1:4 mol Cd/mol Mt, respectively. 
Preparation of Cd-containing media 
A filter-sterilized stock solution of CdCU in dem-
ineralized water was pipetted into the serum-free 
culture medium. CdMt was weighed, dissolved in a 
small volume of serum-free culture medium and 
sterilized through a 0.22-/1 M filter (Millipore GV, 
Low Protein Binding). All Cd-containing media were 
prepared freshly before each experiment. The Cd 
concentration of the medium was checked by atomic 
absorption spectrometry (AAS) as described below 
and was always between 80 and 110% of the intended 
Cd level. 
Cd accumulation 
To examine the Cd accumulation, primary cultures 
and cell lines in monolayer culture were incubated for 
22 hr in serum-free culture medium with a final Cd 
concentration of 0.25, 0.5, 1, 2, 5 and 10 JJM, as 
CdClj, CdMt-1 or CdMt-2. The Cd-accumulation 
studies were performed in triplicate in 10-cm tissue 
culture dishes. After treatment, the Cd-containing 
medium was removed and the dishes were rinsed 
twice with 0.02% ethylenediaminetetraacetic acid 
(EDTA) in phosphate buffered saline (PBS) to 
remove adherent Cd, followed by rinsing the dishes 
twice with PBS to remove EDTA. Cells were 
detached with a teflon cell scraper (Costar, Cam-
bridge, MA, USA), collected in 3 ml PBS and cooled 
to 4°C. The cells (except primary kidney cells) were 
spun down gently at 50 # for 10 min, the supernatant 
was removed and the cells were resuspended in 
0.8 ml Tris-HCl (10 mM, pH 7.4); this was done to 
concentrate the cell suspension after being detached 
in PBS buffer. In this way, more than 90% of the 
accumulated Cd was recovered in the pellet consisting 
of intact cells and less than 10% was lost in the 
supernatant derived from damaged cells. For kidney 
cells the Cd recovery in the cell pellet was much 
lower, owing to the fact that many cells were dam-
aged while being detached; primary kidney cells were 
therefore collected directly after being detached in 
1 ml PBS followed by sonification. The cell yield after 
the primary kidney cells were detached was there-
fore 8-15% lower than for other cell types. All cell 
suspensions were sonicated on ice for 20 sec with a 
sonifier (Soniprep 150, MSE, UK). The cell hom-
ogenate was then centrifuged at 9000 £ for 20 min 
(4°C). Finally, the supernatant (S-9-mixture) was 
decanted and stored at — 20°C before analysis. 
The samples were dry-ashed at 500°C and dissolved 
in hydrochloric acid. Cd in the cells was determined 
by flame AAS (FAAS) or graphite furnace AAS 
(GFAAS) after wet digestion of the sample by sul-
phuric acid. The Cu and Zn concentration of the 
CdMt was analysed by GFAAS and FAAS respect-
ively. The total protein content in the S-9 mixture 
was determined according to the method of Lowry 
et al (1951) using a centrifugal analyser (Cobas-
Bio). Cell accumulation is always expressed as fig 
Cd/mg cellular protein. 
Cd toxicity 
Toxicity was examined at Cd concentrations rang-
ing from 0.5 to 100/JM. Two toxicity tests were used: 
(1) LDH release (membrane permeability); (2) NR 
uptake (pinocytic uptake). For all cell types, mor-
phology and cell attachment were examined using 
phase-contrast light microscopy. For determination 
of LDH release, cells were seeded on 6-well plates as 
described previously. After 22 hr exposure to one of 
the Cd compounds in a serum-free medium, this 
medium was removed and kept at 4°C. Cells were 
detached as described previously and sonicated in 
PBS in a volume equivalent to the medium. LDH 
enzyme activity was measured in the medium and in 
the cells. The increase in the. percentage LDH release 
was determined as the LDH activity in the medium 
divided by the total LDH activity present in cells and 
medium. The 50% LDH release was determined by 
extrapolation as the concentration at which 50% of 
the LDH activity was present in the medium. For the 
NR uptake the cells were seeded on a 96-well tissue 
culture plate (Costar) and exposed for 22 hr to the 
Cd-containing media. NR uptake was determined 
using a slight modification of the method of Babich 
and Borenfreund (1990). The 50% inhibition of NR 
uptake was the concentration at which the NR 
uptake was reduced by 50% compared with untreated 
cells. 
To compare the cytotoxicity of native CdMt and 
CdMt with a high molar ratio of Cd, CdMt-1 in vitro 
was saturated with Cd. For that purpose, 6.5 mg 
CdMt-1 was dissolved in 1 ml Tris-HCl buffer 
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(10 mM, pH 7.4) containing 5.5 M-Cd as CdCl2 and 
incubated for 15 min at room temperature. To 
separate Cd bound to CdMt from free ionic Cd, the 
Mt sample was applied to a Sephadex G-75 column 
(2.5 x 70 cm, Pharmacia, Uppsala, Sweden) and 
chromatographed with a volatile 25 mM-ammonium 
acetate buffer (pH 7). Fractions of 2 ml were col-
lected and the Cd content was determined. The gel 
filtration revealed two Cd-containing peaks: the first 
peak with a relative elution volume (Ke/K„) of ± 2 
contained the Mt fractions and the second peak 
contained free ionic Cd not bound to Mt, which 
elutes later on the Sephadex column (VtIV,= 
2.9-3.4). As determined by AAS analysis, the 
saturated CdMt-1 contained 5 mol Cd/mol Mt. 
The toxicity of the two metallothioneins with 
different molar Cd ratios (2 mol Cd/mol Mt and 
5 mol Cd/moi Mt, respectively) was tested using 
proximal renal cultures only. Owing to the limited 
amount of material the experiment was performed in 
a 24-well plate (Costar) with 200/il medium/well. 
Toxicity was determined at actual Cd concentrations 
ranging from 10 to 1500/JM, depending on the cell 
type used, and LDH release into the medium was 
measured 22 hr after exposure. 
Statistical analysis 
The data relating to Cd content in the individ-
ual cell types were evaluated by a one-way analysis 
of variance, followed by pairwise /-tests. A Bon-
ferroni correction was applied to the significance 
level to adjust the false-positive error rate for multiple 
comparisons (Dixon, 1988). 
RESULTS 
Cd accumulation 
At non-toxic CdCl2 levels (0.25-2 /m) the cellular 
Cd concentration was directly related to the concen-
tration of CdCl2 in the medium. At higher CdCl2 
concentration (5-10/iM-Cd) the accumulation'data 
are unreliable because some cell types (such as hep-
atocytes, IEC-18) showed decreased cell viability at 
1.8 r- (C) 
1 2 3 4 5 6 7 8 9 
[Cd] in medium (UM) 
10 2 3 4 5 6 7 8 9 
[Cd] In medium (UM) 
1 2 3 4 5 6 7 8 9 1 0 
[Cd] in medium (UM) 
8 9 10 
[Cd] In medium (UM) [Cd] in medium (UM) 
Fig. 1. Intracellular cadmium (Cd) concentrations in relation to Cd exposure-concentration in five types 
of cells: (a) IEC-18 intestinal cell line; (b) primary hepatocytes; (c) H-35 hepatoma cell line; (d) primary 
renal cortical cells; (e) NRK-52E kidney cell line. Cells were exposed for 22 hr to CdCl2 ( O ), 
cadmium-metallothionein (CdMt)-1 —O—, or CdMt-2 (—V—). Every value is the mean of results from 
three tissue culture dishes. Vertical bars indicate standard deviation (SD). When no bars are present, the 
SD was smaller than the size of the plotted data point. Values marked with an asterisk in the group treated 
with CdCI, differ significantly Trom the groups exposed to CdMt-1 and -2 (**P < 0.05; *P < 0.1). Values 
marked with a dagger in the group treated with CdMt-1 differ significantly from the groups exposed to 
CdMt-2 ( t t^ < 0.05, t f < 0.1). 
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Table 1. Cellular toxicity of CdCl, in five types of cell culture 
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Fig. 2. Concentration-dependent toxicity of Cd as 
measured by lactate dehydrogenase (LDH) release into 
the medium. Cells were treated with CdCl, (upper line(s)) 
(O). CdMt-1 or CdMl-2 for 22 hr. CdMt-l and CdMt-2 
are shown together as one (bottom) line (V). Vertical 
bars indicate standard deviations. The LDH release of 
H-35 and NRK-52E cells after CdMt treatment is not 
depicted as LDH release gives the same results as with 
primary hepatocytes and primary renal cortical cells. 
Data points are means ± SD from three replicate tissue 
culture dishes. When no bars are present, the SD was 
smaller than the size of the plotted data point, (a) 1EC-I8 
( ); (b) hepatocytes ( ) and H-35 cell line ( ); 
(c) renal cortical cells ( ) and NRK-52E kidney cell 
line ( ). 
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Primary hepatocytes 
Primary renal cortical cells 
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•LDH» - the concentration at which 50% of the lactate dehydro-
genase (LDH) activity is present in the medium. 
INR,, = the concentration at which the neutral red (NR) uptake is 
reduced by 50% compared with untreated cells. Every parameter 
was measured at least in two separate sets of experiments. Every 
experiment consisted of three replicate dishes (LDH assay) or 
eight replicate wells (NR assay). For details of incubation see 
Methods. 
these levels (see Figs 2a,b). The intracellular Cd 
concentration at a dose of 1 fiti-Cd in the medium 
(which is not toxic for most cell types) varied between 
0.08 and 0.2/xg/mg protein. In general, the cellular 
Cd concentration after CdCl2 exposure in primary 
cultures and cell lines of liver was higher than in the 
renal cultures (Fig. lb-d). Cells exposed to CdMt-1 
or CdMt-2 showed a dose-related cellular Cd con-
centration up to 2|iM-Cd in the medium. However, 
above 2/J.M the Cd accumulation of both CdMt 
isoforms did not increase further with increasing Cd 
concentrations in the medium. Therefore, at high Cd 
concentration in the medium all cell types exposed to 
CdMt accumulated much less Cd than cells exposed 
to the same concentration of CdCl2. After exposure 
to CdMt-1, Cd accumulation was slightly, but con-
sistently, higher than after exposure to CdMt-2. The 
difference in accumulation between CdMt-1 and 
CdMt-2 became statistically significant at several Cd 
concentrations in the liver cell line (Fig. 1c). 
Cd toxicity 
The toxicity of CdCl2, CdMt-1 or CdMt-2 to 
primary cells of liver and kidney, as measured by 
LDH release into the medium, is depicted in 
Fig. 2(b,c). For comparison the toxicity of CdCl2 to 
cell lines of liver and kidney is shown as a dotted 
line in the same figures. The NR uptake is not 
depicted since the results were very similar to the 
LDH release data. It appears that the differences in 
accumulation between CdCl2 and CdMt (Fig. I) are 
accompanied by a marked difference in cytotoxicity 
(Fig. 2). LDH release into the medium of cells 
without any Cd treatment varied according to cell 
type, but was always between 3 and 8% for the cell 
lines. LDH release in control incubations from pri-
mary cultures was higher. In untreated hepatocytes 
and proximal renal cells, respectively, 10 and 16% of 
the LDH activity was present in the medium after 
22 hr of culture. After 22 hr treatment with CdCl2, 
primary hepatocytes are the most sensitive to CdCI2 
intoxication, since increased LDH release was seen 
at Cd levels of 0.5 ^M and higher (Fig. 2b). It seems 
that both primary hepatocytes and the hepatoma cell 
line were more sensitive to CdCl2 than were the 
kidney primary cultures and cell line. 
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1500 
[Cd] in medium (UM) 
Fig. 3. Concentration-dependent toxicity of Cd as measured by LDH release into the medium. Cells 
were treated with CdCl, (0), CdMt-1 with 2 mol Cd/mol Mt (Cd2Mt, • ) or CdMt-1 with 5 mol 
Cd/mol Mt (Cd5Mt, 63) for 22 hr. Data points are means ± SD from three replicate tissue culture wells 
on a 24-well tissue culture plate. When no bars are present, the SD was smaller than the size of the 
plotted data point. 
Table I shows the calculated Cd concentration 
for CdCl2 at which 50% of the LDH is released 
into the medium or the Cd concentration at which 
NR uptake in the cell was reduced by 50%. In 
primary hepatocyte cultures the 50% LDH release 
or 50% reduced NR uptake is reached at a value 10 
times lower (1-2/iM-Cd) than in primary renal cor-
tical cultures (10-20/m). The intestinal epithelial 
cell culture IEC-18 seems to be more sensitive to 
CdCl2 than the other cell lines (Fig. 2a) and the 
50% LDH release or NR uptake was reached at a 
Cd concentration of ±\0fiM (Table I). As shown 
in Table 1, the Cd level at which 50% LDH 
release was reached, was almost similar to the 
Cd concentration at which 50% reduction of the 
NR uptake was obtained. The two indicators of 
cytotoxicity used in this investigation correspond 
well to the morphological differences in ceil 
attachment observed. 
CdCI2 is consistently much more toxic to primary 
cultures and cell lines than CdMt-1 or CdMt-2. No 
increase in LDH release, no reduced NR uptake and 
no morphological changes were observed in cells 
exposed to equimolar Cd concentrations in the form 
of CdMt. 
To investigate whether CdMt becomes toxic at 
higher Cd concentrations than those tested in the 
main experiment (0-100 fiM-Cd), a separate cytotox-
icity study was performed • in primary renal cells 
with Cd concentrations up to 1.5mM-Cd (Fig. 3). 
Although toxicity starts for CdCl2 at 10/iM-Cd, no 
signs of toxicity could be observed for native CdMt-1 
(2.1 mol Cd/mol Mt) up to 1.5 mM-Cd. For CdMt-1 
in which the Cd content had been raised artifi-
cially to 5 mol Cd/mol Mt, LDH release was slightly 
(although not statistically significantly) increased. 
DISCUSSION 
CdMt is one of the main forms in which Cd is 
present in the diet (Chmielnicka and Cherian, 1986; 
Foulkes, 1986). Compared with CdCl2, both the 
intestinal and hepatic uptake of CdMt in vivo are low 
(Groten et al., 1991; Maitani et al.). In agreement 
with this, the present results in vitro also indicate a 
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low cellular uptake of CdMt by the intestinal and 
hepatic cells. Moreover, both in vivo (Groten et al., 
1990) and in vitro, the difference in Cd accumulation 
between inorganic Cd and CdMt is accompanied by 
a considerable difference in hepatotoxicity. However, 
the difference in Cd accumulation between CdCl2 and 
CdMt cannot be put forward as the only reason for 
the difference in hepatotoxicity: for instance, primary 
hepatocyte cultures show signs of toxicity due to 
CdCl2 treatment between 0.5 and 2 ftMi-Cd, but not by 
an equimolar Cd concentration in the form of CdMt, 
although at these exposure levels there are no distinct 
differences in cellular Cd concentrations between 
hepatocytes exposed to CdCI2 or CdMt. 
The exact mechanism by which cadmium induces 
cytotoxicity still remains to be elucidated. In general, 
Cd cytotoxicity is believed to be dependent on the 
amount of free ionic Cd present in the cell that has 
not been sequestered by available endogenous Mt or 
other thiols (Glennas and Rugstad, 1984; Jin et al., 
1987; Sendelbach et al., 1989; Stacey, 1986). The 
cytotoxicity of CdMt has been investigated in the 
kidneys in particular, but the mechanism involved is 
still not understood. CdMt is thought to be taken up 
by endocytosis (Cherian, 1979) and cytotoxicity may 
be a consequence of intracellular Cd release after 
degradation of the protein (Cain and Holt, 1983; 
Maitani et al., 1988; Squibb et al., 1979). It has been 
suggested that hepatic or intestinal uptake of CdMt 
will also take place by way of endocytosis (Beattie 
et al., 1987; Ohta and Cherian, 1990). However, the 
fact that in this study both CdMt-1 and CdMt-2 are 
less hepatotoxic than CdCl2, in spite of a similar Cd 
concentration in the hepatocytes, seems to argue 
against an acute release of Cd from exogenous CdMt 
after this metalloprotein has been taken up by the 
cell. 
Alternatively, it has been suggested that CdMt 
damages the brush-border or cell membrane during 
reabsorption of the CdMt, because toxicity of CdMt 
to renal cells has been observed (Cherian, 1982) in 
spite of a lower cellular uptake for CdMt than for 
ionic Cd. In contrast to this, it has been shown in vivo 
that CdMt, both after parenteral and oral exposure, 
is taken up more easily in the kidneys than ionic Cd 
(Cherian et al., 1976; Groten et al., 1991; Kjellström, 
1986; Maitani et al., 1984 and 1988; Tanaka et al., 
1975). This selective renal uptake of CdMt in vivo 
is probably due to direct and efficient glomerular 
filtration and reabsorption of CdMt in the proximal 
cells; thus, the difference in accumulation between 
CdMt and CdCU in proximal cells in vivo is attribu-
table to a difference in glomerular filtration, which 
determines the availability of the Cd-compound for 
the proximal tubule cells in the pro-urine. This can-
not be simulated in vitro when proximal tubule cells 
are exposed directly, without the interference of 
glomeruli, to equimolar-Cd amounts of both Cd 
forms. On the other hand, the study in vitro reported 
here does show that proximal renal cells, like hepatic 
and intestinal cells, are not very sensitive to CdMt 
under these culture conditions. Thus, previous results 
indicating that renal epithelial cells are specifically 
sensitive to CdMt in vitro (Cherian, 1982) could not 
be confirmed. It should be emphasized that the 
difference in sensitivity might be due to the difference 
in experimental conditions, with regard to cell iso-
lation, Mt purification and/or culture conditions. 
Most of the cells in the primary renal culture of the 
present experiment have previously been identified as 
proximal tubular cells, since the histochemical detec-
tion of y-glutamyltranspeptidase showed bright red 
areas demonstrating the presence of the proximal 
tubular brush-border enzyme (Bruggeman et al., 
1989). In our study, all cells were cultivated under 
what were, according to the literature, optimal con-
ditions including FCS; only during exposure were the 
cells cultivated overnight in a serum-free medium. 
This was done to compare this study with the work 
of Beattie et al. (1987) and Sendelbach et al. (1989), 
using only small amounts of serum or even serum-
free medium during the exposure period. Further-
more, it is known that serum proteins can markedly 
decrease the availability of Cd as CdCU in the 
medium and the transport into the cell (Corrigan and 
Huang, 1983; Klug et al., 1988). Possibly for that 
reason, the cytotoxicity of CdCl2 in the present study 
was 20 times higher (50% LDH release at 10-20 ^M-
Cd) than in the study of Cherian (1982 and 1985), 
who observed cytotoxicity on CdCl2 treatment at a 
concentration of 200-400 p M-Cd. 
Electron microscopy in the present study (data not 
presented) revealed that the intestinal cells and the 
renal proximal cells possessed numerous, thin mi-
crovilli covering the surface membrane, which would 
greatly enhance the efficiency of the cell in its absorp-
tive function. It has been suggested that the absorp-
tion of Cd ions takes place by endocytosis, but to date 
there is no evidence to prove this assumption. Fur-
thermore, it has been shown for ionic Cd that intern-
alization of the surface-bound Cd fraction occurs in 
erythrocytes and in membrane vesicles prepared from 
the intestinal brush border, ruling out the role of 
ATP-dependent pinocytosis (Bevan and Foulkes, 
1989; Foulkes, 1988). Nevertheless, Cd accumulation 
in intestinal brush borders from CdCI2 is higher than 
from CdMt (Sugawara et al., 1988). 
The uptake of CdMt was suggested to take place 
by way of receptor-mediated endocytosis (Cherian, 
1982; Foulkes, 1986). This might be supported by the 
finding that the rat intestinal epithelial cell line (IEC) 
and primary cells of intestine and kidneys of the rat 
are, indeed, capable of protein endocytosis from the 
culture medium (Adams, 1984; Heyman et ai, 1989; 
Maunsbach, 1966; Wall and Maack, 1985). If such 
an uptake route exists, it could certainly account 
for the slow rate of accumulation of CdMt in the 
present study. In this experiment, however, we did 
not study the form in which Cd crossed the cell 
membrane. 
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The study reported here has shown that the cellu-
lar Cd concentration as a result of Cd uptake from 
CdMt reaches a plateau at a concentration of about 
2/iM. CdMt-1, which has a higher degree of Cd 
saturation than CdMt-2, leads to slightly, but consist-
ently, higher Cd accumulation in several cell types 
tested, indicating that there is a transport mechanism 
involved in the uptake of the protein, irrespective of 
the Cd content. In agreement with this, it has been 
shown in vivo by Suzuki et al. (1979) and Holt et al. 
(1985) that the uptake of Cd in the kidneys after 
exposure to CdMt is higher when the Cd:Zn ratio in 
the injected Mt is raised. However, it has also been 
shown that an increase in the Cd content of the Mt 
molecule does not dramatically affect the toxicity in 
the kidneys (Suzuki et al., 1979). This was also seen 
in the present study in vitro, when primary renal cell 
cultures exposed to CdMt with an artificially raised 
Cd content showed a slight toxic response only at 
very high Cd concentrations. Severe cell damage 
after CdMt exposure in the range 40 to 80 UM, as 
shown by others (Cherian, 1982 and 1985), cannot be 
explained by assuming a higher molar Cd ratio within 
CdMt. 
In summary, the cytotoxicity of CdMt is lower 
than the toxicity of inorganic Cd for all cell types 
tested, even when the Cd content of CdMt is artifi-
cially raised. In general, the difference in cytotoxicity 
between CdMt and CdCl2 corresponds well to a 
difference in cellular uptake of Cd, and no cell type 
tested was specifically sensitive to CdMt, at least not 
under the culture conditions, described. This is in 
agreement with results in vivo (Groten et al., 1990 
and 1991) showing a difference in toxicity between 
CdMt and CdCU attributable to a difference in organ 
distribution of Cd. 
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Abstract—The toxicity of Cd was examined in rats fed diets containing 30 mg Cd/kg as CdCl2 for 8 wk. 
The Cd-containing diets were supplemented with various combinations of the minerals Ca, P, Mg, Mn, 
Cu, Fe, Zn and Se in order to investigate the protective effect of these mineral combinations on Cd 
accumulation and toxicity. The mineral combinations were chosen such that the effect of the individual 
components could be analysed. At the end of the 8-wk feeding period, the Cd concentrations in the liver 
and renal cortex were 13.9 and 19.5mg/kg body weight, respectively. The feeding of 30 mg Cd/kg diet 
alone resulted in well known Cd effects, such as growth retardation, slight anaemia, increased plasma 
transaminase activities and alteration of Fe accumulation. Only supplements that contained extra Fe 
resulted in a significant protection against Cd accumulation and toxicity. The most pronounced effect was 
obtained using a supplement of Ca/P, Fe and Zn, which resulted in a 70-80% reduction in Cd 
accumulation in the liver and kidneys, as well as a reduction in Cd toxicity. The protective effect of the 
mineral combinations was mainly due to the presence of Fe2+, but in combinations with Ca/P and Zn 
the effect of Fe was most pronounced. Compared with Fe2+ the protective effect of Fe3+ was significantly 
lower. Addition of ascorbic acid to Fe in both forms improved the Fe uptake, but consequently did not 
decrease Cd accumulation. Thus, the mineral status of the diet may have a considerable impact on the 
accumulation and toxicity of Cd, fed as CdCl2 in laboratory animals. For the risk assessment of Cd intake, 
special consideration should be given to an adequate intake of Fe. 
INTRODUCTION 
Outside of the industrial environment, most of the 
body burden of Cd is derived from the diet. Several 
studies over the past 15 years have demonstrated 
that dietary nutrients like Zn, Fe, Mn, Cu, Se, Ca, 
ascorbic acid and vitamin D alter the intestinal 
uptake and/or the oral toxicity of Cd in animals 
and humans (Chmielnicka and Cherian, 1986; Fox, 
1979; Nordberg et ai, 1985; Task Group on Metal 
Interactions, 1978). 
There is some evidence that several metals can 
inhibit Cd absorption in the intestine in vitro 
(Sahagian et al, 1967) and in vivo (Foulkes, 1985). 
However, the mechanisms of both Cd absorption and 
the way in which trace elements interfere with this 
process are still not clear (Foulkes, 1986). Most 
investigations have focused on a single metal-metal 
interaction, and few attempts have been made to 
compare the actual mineral status of other trace 
elements in the same study. Because of the complexity 
of trace-element interactions more extensive studies 
are required in which the effect of several minerals 
can be considered simultaneously. The authors are 
aware of only a few studies that have examined 
the effect of a dietary supplement of a combination 
of minerals (Banis et al., 1969; Jacobs et ai, 1977, 
1978b and 1983). Therefore, in order to gather more 
*To whom all correspondence should be addressed. 
Abbreviations: AAS = atomic absorption spectrometry. 
information on the protective effect of nutrient sup-
plements in excess of nutritional requirements, a 
more extensive study was undertaken in the present 
paper. Eight minerals were studied, which, according 
to the literature, are thought to be effective in lower-
ing Cd accumulation in the body (Task Group on 
Metal Interactions, 1978). All other trace elements 
were kept constant, at a level meeting the nutrient 
requirements of the laboratory rat (National 
Research Council, 1978). 
In preliminary experiments, the sensitivity of the 
strain of rats used was examined and a dietary level 
of 30 mg Cd/kg diet was established as suitable for 
use in subsequent studies (Groten et al, 1990). 
The study comprised two experiments. The first 
was designed to compare the effect on Cd toxicity 
of diets supplemented with seven combinations of 
minerals, such that the effect of a single component 
could be analysed. In the second experiment, further 
studies were undertaken on those individual trace 
elements that were found, in experiment 1, to be the 
most effective in reducing Cd toxicity. 
MATERIALS AND METHODS 
Chemicals. CdCl2 with a purity of at least 99%, 
was obtained from E. Merck AG (Darmstadt, 
Germany). The compounds used in the mineral 
supplements were MgCl2-6H20, CaHP04-2H20, 
KH 2P0 4 , FeS04 7H 20, CuS04 5H20, ZnCl2, 
Na 2SeCy5H 20 and MnS04 H 2 0 . All were obtained 
from E. Merck (analytical grade). 
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Table 1. Percentage composition of basal diet of rats 
fed diets containing 30 mg Cd/kg and supplements of 
various combinations of minerals 
Ingredient 
Casein 
White wheat-flour 
Mineral mixture* 
Vitamin ADEK preparation! 
Vitamin B mixtureî 
Lard 
% Composition 
22.53 
54.72 
4.24 
0.36 
0.24 
17.91 
•In l g mineral mixture: 399 mg KH2P04 , 389 mg 
CaCOj, 142 mg NaCl, 58 mg MgS04, 5.7 mg 
FeSCy7H20, 0.9mg ZnCl2, 0.8mg CuSO. 5H20, 
4.6 mg MnS04 H 2 0, 0.02 mg CoCl2 6H20, 
0.007 mg KI and 0.08 mg KCr(S04)212H20. 
tin 1 g vitamin mixture: 2113 IU vitamin A concentrate, 
704 IU vitamin D concentrate; 30 mg vitamin E 
preparation (50%), 1 mg menadione-Na-bisulphite 
(Kj) and 30 mg wheat-starch. 
{In 1 g vitamin B mixture: 3 mg thiamine - HCl, 2.25 mg 
riboflavin, 4.5 mg pyridoxine • HCl, 15 mg niacin, 
6mg Ca-pantothenate, 0.075 mg biotin, 0.75 mg 
folic acid, 37.50 mg vitamin Bl2 (0.1%) and 931 mg 
choline chloride. 
Animals and maintenance. Weanling, Wistar-
derived specific-pathogen-free rats (Bor; WISW) were 
obtained from F. Winkelmann (Institute for the 
Breeding of Laboratory Animals GmbH & Co. KG, 
Borchen, Germany). At the beginning of the study 
the rats were about 5 wk old. They were housed under 
conventional conditions, in suspended stainless-steel 
cages fitted with a wire-mesh floor and front. The 
room temperature was kept at 22 ± 2°C, and the 
relative humidity at 40-70%. A 12-hr light/dark cycle 
was maintained, and the number of air changes was 
about 10/hr. Prior to the experiment, all rats were 
fed the basal diet without any further additions. 
Drinking-water was supplied in glass bottles, which 
were cleaned once a week. Food and water were 
provided ad lib. 
Experiment 1 
Diets. A semi-synthetic, powdered basal diet 
(Table 1) was composed to resemble a western type 
of human diet (high in fat, low in fibre, without 
excessive amounts of minerals and vitamins). The 
mineral content of the basal diet was based on the 
nutrient requirements of the rat according to the 
National Research Council (1978). The experiment 
consisted of 11 test groups (diet codes A-K). Ca and 
P were always added as one combination, because 
they interactively affect the other's bioavailability 
(Spencer, 1984; Zemel and Linkswiler, 1981). There-
fore, the ratio between Ca and P in the diet should 
be kept constant upon addition. To obtain 30 mg 
Cd/kg diet, 0.049% CdCl2 (w/w) was added to the 
basal diet. Mineral analysis of the 11 diets (see Table 
2) revealed that, under the experimental conditions, 
the actual levels of Cd were between 87 and 105% of 
the intended level of 30mg/kg. Control groups A 
and C contained 170 and 190 ng Cd/kg diet, respect-
ively. All minerals were distributed homogeneously 
throughout the diet, considering the low variation 
between individual sample data (data not shown). 
One batch of each of the diets was stored in a freezer 
at c. — 20°C until use. Twice a week the diets in the 
feeders were refreshed with a portion of the test diets 
(thawed immediately before use). 
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Experimental design and treatment. The rats were 
acclimatized to the animal facilities for 1 wk, and 
were then allocated to 11 groups of 10 animals using 
a computer-generated random number table. A few 
rats were reallocated in order to equalize the initial 
mean body weight in the various groups. Each treat-
ment group (housed in groups of 5) received one of 
the test diets. On day 28, 3 rats were autopsied and 
on day 56 autopsy was conducted on 7 rats. 
Observations and analyses. The rats were weighed 
at weekly intervals and were observed daily for 
condition and behaviour. Food and water intake 
were measured over weekly periods throughout the 
study. 
Haematology and clinical chemistry. Blood samples 
were collected from the tip of the tail of all animals 
on days 24 and 51, and were examined for haemo-
globin concentration, packed cell volume, erythrocyte 
and total leucocyte counts. At autopsy (days 28 and 
56), heparinized blood samples collected from the 
abdominal aorta of all rats were centrifuged at 1250 g 
for 15 min, using Sure-sep II serum-plasma separ-
ators (Organon Teknika, Durham, NC, USA). The 
plasma was then analysed for aspartate aminotrans-
ferase and alanine aminotransferase. 
Mineral content of liver and kidneys. At autopsy, on 
days 28 and 56, the Cu, Zn and Cd levels were 
determined in both liver and kidney cortex (see 
Analysis of minerals). 
Experiment 2 
Diets. The purpose of experiment 2 was to deter-
mine whether the effect of the mixture Ca/P, Zn and 
Fe could be attributed to the presence of Ca/P, Zn or 
Fe (2+ or 3+) alone. The experiment consisted of two 
sets of separate bioassays. In both sets, two control 
groups were taken into account: one control group 
was fed the Cd-supplemented diet without any min-
eral supplement. A second control group was fed the 
Cd diet supplemented with a total mineral mixture of 
Ca/P, Zn and Fe2+. The test groups in the first set 
consisted of diets with a supplement of the single 
compounds Ca/P, Zn or Fe2+ in order to check the 
contribution of each single trace element that, ac-
cording to experiment 1, was effective in reducing Cd 
toxicity. Two other test groups in the first set con-
sisted of a Cd diet supplemented with Fe3+ or 
Fe3+ + 0.25% ascorbic acid. This allowed the com-
parison of possible effects of Fe2+ and Fe3+. In the 
second set, the control groups were similar to those 
in the first set. The test groups in the second set 
consisted of Cd diets supplemented with Fe2+, 
Fe2+ + 0.25% ascorbic acid or 0.25% ascorbic acid 
alone, to check the effect of ascorbate on the effect of 
Fe2+. Twice a week the diets in the feeders were 
refreshed with a portion of the tests diets (thawed 
immediately before use). This procedure proved to be 
essential for the outcome of the study. In an initial 
experiment where the diet was not refreshed and was 
kept at room temperature, the protective effect of Fe 
was much less pronounced. 
Experimental design. The rats were acclimatized 
to the animal facilities for 1 wk and were then re-
allocated to 7 groups in the first set and to 5 groups 
in the second set. Each group consisted of 5 animals, 
obtained using a computer-generated random number 
Table 2. Mineral analyses of diets containing 30 mg Cd/kg and supplements of various combinations of minerals, which were fed to rats 
Minerals (% or mg/kg diet) 
Ingredients 
Experiment 1 
A: Basal diet 
B: + Cd 
C: + TMM 
D: + Cd + TMM 
E: + Cd + Ca/P, Mg, Cu 
F: + Cd + Ca/P, Fe2+, Zn 
G: + Cd + Ca/P, Se, Mn 
H: + Cd + Mg, Fe2+, Se 
I: + Cd + Mg, Zn, Mn 
J: + Cd + Fe2+, Cu, Se 
K: + Cd + Cu, Zn, Se 
Experiment 2 
Set 1 
A: Basal diet + Cd 
B: + Cd + Ca/P, Zn, Fe2+ 
C: + Cd + Fe2+ 
D: + Cd + Fe3+ 
E: + Cd + Fe ï + + VC 
F: + Cd + Ca/P 
G: + Cd + Zn 
Sel 2 
A: Basal diet + Cd 
B: + Cd + Ca/P, Zn, Fe2+ 
C: + Cd + Fe2+ 
D: + Cd + Fe2+ + VC 
E: + Cd + VC 
Ca 
(%) 
0.67 
0.66 
1.28 
1.28 
1.3 
1.29 
1.28 
0.64 
0.66 
0.66 
0.66 
0.67 
1.3 
0.67 
0.67 
0.67 
1.2 
0.66 
0.68 
1.3 
0.68 
0.68 
0.68 
P 
(%) 
0.61 
0.63 
1.32 
1.34 
1.33 
1.35 
1.3 
0.59 
0.6 
0.6 
0.6 
0.60 
1.27 
0.61 
0.60 
0.61 
1.31 
0.59 
0.61 
1.29 
0.60 
0.61 
0.61 
Zn 
(mg/kg) 
28 
27 
140 
140 
29 
125 
29 
28 
125 
29 
140 
27 
140 
27 
29 
27 
28 
140 
28 
135 
28 
28 
28 
Cu 
(mg/kg) 
11 
10 
51 
51 
46 
7 
11 
10 
8 
51 
70 
— 
— 
— 
— 
— 
— 
— 
— 
— 
— 
— 
— 
Fe 
(mg/kg) 
46 
39 
195 
185 
35 
215 
42 
245 
46 
215 
40 
70 
270 
290 
270 
250 
65 
65 
80 
265 
285 
290 
80 
Mg 
(%) 
0.046 
0.046 
0.25 
0.25 
0.24 
0.046 
0.046 
0.26 
0.26 
0.047 
0.046 
— 
— 
— 
— 
— 
— 
— 
— 
— 
— 
— 
— 
Mn 
(mg/kg) 
56 
54 
235 
235 
45 
48 
250 
60 
270 
260 
54 
— 
— 
— 
— 
— 
— 
— 
— 
— 
— 
— 
— 
Se 
(mg/kg) 
0.11 
0.10 
0.85 
0.78 
0.11 
0.09 
0.88 
0.84 
0.1 
0.09 
0.62 
— 
— 
— 
— 
— 
— 
— 
— 
— 
— 
— 
— 
Cd 
(mg/kg) 
0.17 
30.5 
0.19 
28 
29.5 
28 
26 
30 
29.5 
31.5 
30 
30 
27 
32 
29 
29 
30 
28 
28 
26 
28 
27 
29 
TMM = total mineral mixture of Ca, P, Mg, Mn, Cu, Fe2+, Zn and Se VC = vitamin C 
table (see experiment 1). Each treatment group 
(housed in groups of 5) received one of the test diets 
for 28 days. 
Observations and analyses. The rats were weighed 
at weekly intervals and were observed daily for 
condition and behaviour. Food and water intakes 
were measured over weekly periods throughout the 
study. 
Mineral content of liver and kidneys. At autopsy, on 
day 28, the liver and kidneys were removed and 
weighed. Part of the liver and kidney cortex were 
prepared for atomic absorption spectrometry (AAS) 
analysis (see Analysis of minerals). The Fe, Zn and 
Cd content was determined in both the liver and 
kidney cortex. 
Analysis of minerals 
Samples taken from each of the test diets were 
analysed to check the content of Cd and minerals in 
the diet. For the determination of Ca, Mg, Mn, Zn 
and Fe, samples of 5 g of each diet were dry-ashed at 
500°C. The residues were dissolved in hydrochloric 
acid. The mineral content was determined by flame 
AAS. Se was determined by fluorimetry. Samples of 
1 g were digested with perchloric acid/nitric acid. 
After reduction with hydrochloric acid Se was 
coupled to 2,3-diaminonaphthalene and extracted 
into cyclohexane. The samples for P determination 
were ashed and dissolved in nitric acid. The P content 
was determined gravimetrically after precipitation 
with a sulphate-molybdate solution. For the determi-
nation of Zn and Fe in the liver and kidneys, samples 
(1-2 g) were wet-digested with sulphuric acid and 
nitric acid, and analysis was performed by flame AAS 
or gas-flame AAS. The measurement of Cd in diets 
and organs was determined by flame AAS or gas-
flame AAS after wet-digestion of the samples (1-2 g) 
with sulphuric acid and nitric acid (Muys, 1984). 
Statistical analysis 
Experiment I. Data on body weights, laboratory 
determinations and organ weights were evaluated 
using a one-way analysis of covariance, followed by 
Dunnett's multiple comparison tests. Differential 
white blood cell counts were analysed using the 
Mann-Whitney U-test. The data for animals killed 
on day 28 were analysed separately from those killed 
on day 56. The measurements in experiment 1, as 
shown in Tables 3 and 4 and Figs 2, 3 and 4, were 
subjected to the aforementioned individual statistical 
analysis. However, there are no two groups in exper-
iment 1 that differ in the addition of just one mineral. 
Therefore, all data from experiment 1 were also 
subjected to multiple analysis of variance; one analy-
sis for experimental groups A-D and one for groups 
D-K. This method of analysis, as shown in Fig. 6, 
uses all eight experimental groups, and the compari-
sons drawn will be more accurate than comparisons 
with two groups. For groups A-D a two-way 
ANOVA was used to assess the effects of Cd ad-
dition, addition of a total mineral mixture, and the 
possible enhancement or inhibition of the effect of Cd 
by the total mineral mixture. In the analysis of groups 
D-K, the influence of seven minerals was studied on 
only eight experimental groups. A complete design 
with all possible combinations of minerals would take 
27 experimental groups, so the present experiment 
was one-sixteenth of a 27 design. This design is 
exemplified by Box et al. (1978). 
Experiment 2. Both bioassays in experiment 2 were 
analysed using a one-way ANOVA, followed by 
Student's r-test to evaluate differences of interest. In 
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Table 3. Mean haematological findings on days 24 and 51 (experiment 1) from rats fed diets containing 30 mg Cd/kg and supplements of 
various combinations of minerals 
RBC 
(109/ml) 
Hb 
(mmol/litre) 
PCV 
(litre/litre) 
MCV 
(A) 
MCH 
(fmol) 
MCHC 
(mmol/litre) WBC 
A: Basal Diet 
B: + Cd 
C: + TMM 
D: + Cd + TMM 
E: + Cd + Ca/P, Mg, Cu 
F: + Cd + Ca/P, Fe2+, Zn 
G: + Cd + Ca/P, Se, Mn 
H: + Cd + Mg, Fe2+, Se 
I: + Cd + Mg, Zn, Mn 
J: + Cd + Fe2 + , Cu, Se 
K: + Cd + Cu, Zn, Se 
6.1 +0.1 
7.3 + 0.11 
5.9 + 0.1 
7.9 + 0.2 
5.8 + 0.2 
7.0 + 0.2 
5.8 + 0.2 
7.2 + 0.2 
5.6 + 0.1 
7.9 + 0.2 
5.9 + 0.1 
7.1 +0.1 
6.1 +0.4 
7.9 + 0.3 
6.4 + 0.1 
7.2 + 0.1 
6.2 + 0.2 
8.4 + 0.2*» 
6.1 +0.1 
7.3 + 0.1 
5.9 + 0.1 
8.0 + 0.2*« 
8.2 + 0.1 
9.2 + 0.2 
5.7 + 0.3** 
5.9 + 0.2** 
8.4 + 0.1 
9.3 ± 0.2 
8.1 +0.1 
9.1 +0.1 
5.3 + 0.1** 
5.5 ±0.2** 
8.2 + 0.2 
9.2 + 0.2 
5.8 ±0.2** 
6.4 + 0.3** 
8.4 + 0.1 
9.3 ±0.1 
6.3 + 0.3** 
7.6 ±0.2 
8.3 + 0.1 
9.4 + 0.1 
5.9 + 0.2** 
6.9 + 0.5** 
0.406 ± 0.05 
0.46 ± 0.007 
0.297 + 0.01« 
0.34 ±0.01** 
0.42 + 0.004 
0.464 ±0.01 
0.4 + 0.003 
0.45 + 0.004 
0.29 ±0.01** 
0.32 ±0.012 
0.39 + 0.007 
0.45 + 0.005 
0.29 ±0.01** 
0.35 + 0.02** 
0.415 + 0.01 
0.47 ± 0.01 
0.326 + 0.02** 
0.406 ±0.01** 
0.4 + 0.003 
0.476 + 0.01 
0.31 +0.01** 
0.38 ± 0.02** 
66.6 ±1.35 
62.7 + 1.4 
50.3+ 1.5** 
42.6 ±0.8** 
71.7+ 1.6 
66.0+ 1.8 
69.0+1.5 
64.9+ 1.6 
51.1 ± 1.1** 
40.7 + 1.0** 
67.7 + 0.9 
64.1 +0.5 
48.5 + 2.9** 
44.6+ 1.7** 
64.9 + 2.1 
65.2 + 0.4 
52.6 + 2.7** 
48.5 + 2 . 1 " 
65.6 + 1.2 
65.4 + 1.3 
52.2 + 1.5 
47.1 + 2.5** 
1.35 + 0.03 
1.26 + 0.03 
0.97 + 0.03** 
0.75 + 0.02** 
1.44 + 0.04 
1.32 + 0.03 
1.4 + 0.02 
1.31 +0.03 
0.94 + 0.02** 
0.7 + 0.02** 
1.4 ±0.02 
1.3 + 0.02 
0.96 + 0.06** 
0.81+0.2** 
1.31 +0.03 
1.29 + 0.01 
1.02 + 0.05** 
0.91 +0.04** 
1.36 + 0.02 
1.29 + 0.02 
1.0 + 0.03** 
0.85 + 0.05** 
20.3 + 0.4 
20.1+0.2 
19.2 + 0.4 
17.7 + 0.2** 
20.2 + 0.2 
20 + 0.1 
20.3 + 0.3 
20.1+0.3 
18.5 + 0.6** 
17.2 + 0.1** 
20.6 + 0.3 
20.3 + 0.3 
19.8 + 0.3 
18.1 +0.2** 
20.2 + 0.3 
19.8 + 0.1 
19.4 + 0.5 
18.7 + 0.1** 
20.7 + 0.3 
19.7 + 0.2 
19.2 + 0.2 
18.1+0.3** 
13.4+ 1.2 
14.8+1.3 
18.2+1.0* 
20 + 0.7** 
18.1 + 1.6" 
13.2 + 1.5 
16.4 + 1.0 
16.0 + 0.7 
20.1 + 1.8" 
19.8 + 0.7** 
14.7 + 1.4 
15.9 + 0.9 
16.6 + 0.7 
17.5 + 1 .1" 
16.1 +0.6 
15.9 + 0.86 
17.2+ 1.4 
16.4 + 0.9 
16.8 + 0.6 
16.5+ 1.00 
17.5 + 0.6 
17.5+ 1.0 
Hb = haemoglobin concentration MCH = mean corpuscular haemoglobin MCHC = mean corpuscular haemoglobin concentration 
MCV = mean corpuscular volume PCV = packed cell volume RBC = red blood cell count 
TMM = total mineral mixture of Ca, P, Mg, Mn, Cu, Fe2+, Zn and Se WBC = white blood cell count 
The top value is the mean ± SEM of groups of 5 rats on day 24. The bottom value is the mean ± SEM of groups of 7 rats on day 51. Those 
marked with asterisks differ significantly (ANOVA + Dunnett's test) from the corresponding control value (diet A) (*P < 0.05; 
" P < 0 . 0 1 ; two-sided). 
the first bioassay, groups with Fe2+, Fe3+, Ca/P and 
Zn, and the group containing Ca/P, Fe2+ and Zn, 
were compared with the group to which no extra 
mineral was added. In this way the individual effects 
of each mineral could be assessed. A separate com-
parison was carried out, in both bioassays, of the 
groups containing Fe3+ and Fe3+ 4- ascorbic acid, 
and the groups containing Fe2+ and Fe2+ + ascorbic 
acid, to determine the effect of ascorbic acid. 
RESULTS 
All rats in the experiments appeared to be healthy 
throughout the 4- and 8-wk studies and none of the 
rats died. 
Experiment 1 
During the study, body weight increased steadily in 
all groups (Fig. 1). From day 7 to day 56 the mean 
gain in body weight was significantly decreased, 
compared with control group A, in rats that were fed 
diets without mineral supplements (group B) or diets 
with mineral supplements that did not contain Fe2+ 
(groups E, G, I and K). In these groups, the food 
intake was reduced by about 10% in the first month 
(data not shown). Body weights of rats that were all 
fed Cd-enriched diets with a mineral supplement 
containing Fe (groups D, F, H and J) were generally 
comparable with the controls (groups A and C), and 
there were no noticeable and consistent differences in 
food intake. 
On days 24 and 51, animals fed the Cd-enriched 
diet without mineral supplements showed a decrease 
in the haemoglobin concentration and packed cell 
volume, and subsequently in the mean corpuscular 
volume, and the mean corpuscular haemoglobin con-
centration. The white blood cell counts were signifi-
cantly increased (Table 3). Supplementation of the 
74 
Table 4. Mean clinical findings in the plasma on days 28 and 56 (experiment 1) of rats fed diets 
containing 30 mg Cd/kg and supplements of various combinations of minerals 
ALAT (units/litre) ASAT (units/litre) 
Diet Day 28 Day 56 Day 28 Day 56 
A: Basal diet 30.5 ± 2.6 28.2 + 4.1 57.8 ± 2.5 61.7 ±4.2 
B: + Cd 66.1 ±7.5** 63.1 ±4.7** 85 ± 6.5** 89.1 ±4.4** 
C + TMM 27.8 ±1.5 27.7 ±2.1 57.0 ±1.6 52.4 ± 2.4 
D: + Cd + TMM 45.2 ± 7.6 36.4 ± 1.4 64.9 ± 3.7 52.4 ± 2.4 
E: + Cd + Ca/P, Mg, Cu 60.2 ± 7 . 6 " 67.7 + 3 . 5 " 82.8 ± 6.9* 91.5 ±3.3** 
F: + Cd + Ca/P, Fe2+ , Zn 35.7 ± 0.8 35.2 ±2.3 59.1 ±5.9 54.8 ± 2.2 
G: + Cd + Ca/P, Se, Mn 63.2 ± 4.3** 65.9 ±5.3** 84.3 ± 6 . 3 " 94.6 ±5.9** 
H: + Cd + Mg, Fe2+, Se 41.9 + 3.4 37.4 ±2.4 65.4 ±4.5 57.7 ±2.2 
I: + Cd + Mg, Zn, Mn 60.5 ± 7.6** 54.5 ± 3 . 4 " 84.8 ± 1.6** 68.7 ± 3.1 
J: + Cd + Fe2+ , Cu, Mn 44.6 ±5.5 34.6 ±1.7 65.9 ± 7.4 57.9 ±2.0 
K: + Cd + Cu, Zn, Se 65.0 ± 5 . 3 " 58.3 ± 3.0 84.6 ± 5.6** 74.4 ±4.4 
ALAT = alanine aminotransferase ASAT = aspartate aminotransferase 
TMM = total mineral mixture of Ca, P, Mg, Mn, Cu, Fe2+ , Zn and Se 
Values are means ± SEM for groups of 3 rats on day 28 and groups of 7 rats on day 56. Those 
marked with asterisks differ significantly (ANOVA + Dunnett's test) from the corresponding 
control value (diet A) (*P <0.05; " / > <0.01). 
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Fig. 1. Mean body weights (g) of rats in experiment 1 fed diets containing 30 mg Cd/kg and supplements 
of various combinations of minerals, for groups of 10 animals. The values of the mean body weight in 
animals fed with diets b, e, i, g and k differ significantly from the control diet a from day 14 to day 56 
(analysis of covariance + Dunnett's test). Codes a-k stand for diet codes A-K. The mineral supplement 
of all diet codes (A-K) is given in Table 2. 
Cd diet with mineral mixtures that did not contain Fe 
showed similar haematological findings. However, 
animals fed the Cd diet supplemented with a mineral 
mixture that contained Fe (groups D, F, H and J) 
showed no changes in the haematological parameters 
(Table 3 and Fig. 6). The data on white blood cell 
counts in Table 3 are not fully conclusive since group 
C, which is a control group, also showed an increase 
in the white blood cell count. However, the statistical 
analysis in Fig. 6 shows that rats receiving mineral 
supplements with Fe have significantly less white 
blood cells compared with supplements without Fe. 
An increase in the plasma aspartate aminotransferase 
and alanine aminotransferase activities was observed 
in all rats treated with 30 mg Cd/kg diet that did not 
receive supplements. Rats fed the Cd diet sup-
plemented with mineral mixtures that contained Fe 
(groups D, F, H and J) did not show a significant 
increase in the aminotransferase activities (Table 4 
and Fig. 6). 
All Cd-treated groups showed Cd accumulation in 
the liver and kidneys (Fig. 2). No Cd accumulation 
was noticeable in either control group. There was an 
almost linear increase in the Cd concentration from 
day 28 (Fig. 2a) to day 56 (Fig. 2b) in the rats fed Cd 
without additional Fe in the supplement (groups B, 
E, G, I and K). However, in the animals fed Cd with 
the total mineral supplement (group D) or the ani-
mals fed Cd with a mineral supplement that con-
tained Fe2+ (groups F, H and J) the Cd accumulation 
in the liver and kidneys was much lower compared 
with animals fed Cd without a Fe supplement. The 
protection against Cd accumulation was highest in 
the groups fed Cd with a mineral mixture that 
contained Ca/P, Zn and Fe (Fig. 2). In these groups 
there was hardly any increase in the Cd content of the 
liver from day 28 to day 56. 
Figure 6 shows the overall difference in the Cd 
accumulation of all groups combined fed Cd with Fe, 
compared with all groups combined fed Cd without 
Fe. Groups fed Cd supplemented with Fe showed, 
overall, significantly less Cd accumulation than the 
groups fed Cd without Fe (Fig. 6). On day 56, all Cd-
treated groups showed a slightly lower Zn content in 
the liver. This effect was most pronounced in animals 
with a high Cd accumulation (Zn data not shown). 
Cd treatment resulted in a significant decrease in 
the Fe content of the liver (Figs 3a and b). After 
75 
1 Liver 
5 O 
•o 
O 
Fig. 2. Cd concentration in the liver and kidneys of rats in experiment 1 fed diets containing 30 mg Cd/kg 
and supplements of various combinations of minerals. All values are means ± SD of 3 rats on day 28 
(Fig. 2a) and of 7 rats on day 56 (Fig. 2b). Those marked with asterisks differ significantly 
(ANOVA + Dunnett's test) from diet D (P < 0.05; **P < 0.01). The mineral supplement of all diet codes 
(A-K) is given in Table 2. 
150 
Fig. 3. Fe concentration in the liver and kidneys of rats in experiment 1 fed diets containing 30 mg 
Cd/kg and supplements of various combinations of minerals. All values are means ± SD of 3 rats on 
day 28 (Fig. 3a) and of 7 rats on day 56 (Fig. 3b). Those marked with asterisks differ significantly 
(ANOVA + Dunnett's test) from diet D (*P < 0.05; **P < 0.01). See Table 2 for the mineral supplement 
of each diet code. 
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Fig. 4. Cd (Fig. 4a) and Fe (Fig. 4b) concentrations in the 
liver and kidneys of rats in the first set of experiment 2 fed 
diets containing 30 mg Cd/kg and supplements of various 
combinations of minerals, after 28 days of exposure. All 
values are means ± SD of 5 animals. Those marked with 
asterisks differ significantly (ANOVA + Dunnett's test) 
from diet A (•ƒ> < 0.05; **P < 0.01). See Table 2 for mineral 
supplements of each diet code. 
supplementation of the Cd-enriched diet with extra 
Fe in the mineral mixture, the Fe level of the liver was 
normal (compared with control group A). The Fe 
content in the kidneys showed very high variations 
between animals. There was still a significant decrease 
in the Fe content of animals fed a diet without any 
additional Fe in the mineral supplement (for the 
overall effect, see Fig. 6; the individual effects of the 
groups B, E, G and K are shown in Fig. 3). 
There were no noticeable differences in the relative 
liver and kidney weights among the groups on any of 
the dissection days (data not shown). 
Experiment 2 
The mineral mixture Ca/P, Zn and Fe showed a 
similar protection against Cd accumulation as in 
experiment 1 : the Cd accumulation in both liver and 
renal cortex was reduced by up to 80%. When 
animals were fed a Cd diet supplemented with either 
Fe2+, Zn or Ca/P, only the Fe group showed a 
significant decrease in the Cd content in the liver and 
kidneys (Fig. 4). However, the Cd decrease after the 
Fe2+ supplement was significantly less than with 
the mineral mixture that also contained Ca/P and 
Zn. The protection against Cd accumulation after 
addition of Fe3+ was significant, although less pro-
nounced than after addition of Fe2+. Addition of 
ascorbic acid to the Fe3+ supplement did not signifi-
cantly improve the Cd reduction. However, addition 
o 
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Fig. 5. Cd (Fig. 5a) and Fe (Fig. 5b) concentrations in the 
liver and kidneys of rats in the second set of experiment 2 fed 
diets containing 30 mg Cd/kg and supplements of various 
combinations of minerals, after 28 days of exposure. 
All values are means ± SD of 5 animals. Those marked 
with asterisks differ significantly (ANOVA + Dunnett's test) 
from diet A (•ƒ» < 0.05; **P < 0.01). See Table 2 for mineral 
supplements of each diet code. 
of ascorbic acid to a Cd diet slightly reduced 
Cd accumulation in the liver and kidneys without 
addition of extra Fe (Fig. 5). 
DISCUSSION 
To study the competition between orally adminis-
tered Cd and other minerals during subchronic 
exposure, eight different minerals were added in 
different combinations to the diet of rats. Seven diets 
supplemented with three-to-four minerals were used 
in order to obtain a restricted number of diets, which 
still could provide clear information on the effect of 
the individual trace elements on Cd toxicity. After 
consuming a diet containing 30 mg Cd/kg for 8 wk, 
male rats showed a number of well known Cd effects, 
such as growth retardation, anaemia, decreased Ca 
concentration of the femur, increased plasma trans-
aminase activities and alteration of Fe metabolism. 
Based on the food intake, it was calculated that the 
daily intake of Cd was 0.17-0.36 mg Cd/rat, which is 
equal to 1.5-2.5 mg Cd/kg body weight. 
The exposure of the rats to Cd was similar in all 
Cd diets. However, the addition of certain mineral 
mixtures diminished the toxic effects of Cd. The 
differences in toxicity between unsupplemented Cd 
diets and some of the Cd diets supplemented with 
minerals were accompanied by differences in the Cd 
content of the liver and kidneys. The results clearly 
demonstrate that the protective effect of a total 
mineral mixture against Cd toxicity was due to the 
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Fig. 6. Effects of Ca/P, Zn, Fe, Cu and total mineral mixture in the presence of Cd on selected variables 
in rats fed diets containing 30 mg Cd/kg and supplements of various combinations of minerals. Only effects 
significantly differing from 0 are shown (0.01 <*P < 0.05; 0.001 < **P < 0.01; ***P < 0.001). Effects are 
means of the groups with the relevant mineral minus the means of the groups without the mineral. Results 
of total mineral mixture relate to groups A-D, results of Ca/P, Zn, Cu and Fe are from groups D-K. 
LogCd/Fe Liv/Kid = logarithm of Cd/Fe content (mg/kg) in the liver and kidneys; log (b.w.) = logarithm 
of body weight (g). All other abbreviations are explained in Tables 3 and 4. Whenever two parameters 
are shown in one Fig. (log Cd/Fe LIV and KID or ASAT and ALAT), a dashed bar relates to the first 
parameter in the list (log Cd/Fe LIV or ASAT) and an open bar relates to the second parameter (log Cd/Fe 
KID or ALAT). 
presence of extra Ca/P, Zn and Fe. The protective 
effect of Fe was more pronounced than the effect of 
Ca/P and Zn. On the other hand, a combined sup-
plement of these three minerals was more effective in 
preventing Cd accumulation than a single supplement 
of one of the minerals. 
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Previous studies have indicated a correlation be-
tween the Fe and Cd content in the diet and the 
Cd and Fe absorption in animals. For Fe-deficient 
animals it was thought that the uptake of Cd in 
the intestinal mucosa and its transport from the 
intestine to other compartments of the body is 
increased (Flanagan et al, 1978; Fox, 1979; Hamilton 
and Valberg, 1974; Valberg et al., 1976). In Fe-
supplemented diets in which Fe2+ was added to the 
diet, the uptake and transport of Cd seemed to be 
lowered in quails (Fox et al., 1971 and 1980). More-
over, the addition of Fe2+ was effective in preventing 
signs of Cd toxicity in rats and pigs (Pond and 
Walker, 1972 and 1973). From the studies of Fox 
et al. (1971 and 1980) and from the present results it 
appears that the protective effect of Fe in birds and 
rodents is probably due to decreased Cd uptake 
through the gastro-intestinal tract. 
Since we showed that Fe was the most effective 
mineral in rats for preventing Cd accumulation, the 
next question to answer was whether Fe2+ and Fe3+ 
were equally effective. Fox et al. (1971) showed that 
feeding of Fe2+ is more effective in preventing 
anaemia in birds caused by Cd than the feeding of 
Fe3+ . The present study shows similar findings for 
rats, since the protective effect of feeding Fe2+ is more 
pronounced than with Fe3+. 
The enhancement of Fe absorption by ascorbic 
acid has been repeatedly reported for man (Bothwell 
et al., 1982; Bowering et al, 1976; Hallberg and 
Rossander, 1982). Several authors have shown re-
duced Cd toxicity by combined administration of 
ascorbic acid and Fe, owing to the improved Fe 
absorption (Fox et al, 1980; Maji and Yoshida, 
1974). In the present study, the dose level of ascorbic 
acid chosen does not significantly affect the Cd 
accumulation of the Fe3+-fortified diet. However, 
when ascorbic acid is given alone, the Fe absorption 
is not improved, whereas the Cd accumulation is 
significantly lowered. Therefore, the improvement in 
Fe absorption seems to be not the only effect of 
ascorbic acid on the gastro-intestinal uptake of Cd. 
The present investigation has shown that Cd ac-
cumulation in rats is mainly influenced by Fe and not 
by other minerals. This finding raises the question 
whether the intestinal transport of Cd in rats is 
specifically mediated by the Fe transfer system, since 
interaction between Cd and the Fe transport system 
has already been shown previously (Hamilton and 
Valberg, 1974; Leon and Johnson, 1985; Schäfer and 
Forth, 1984). However, the mechanism behind the 
competition of Fe and Cd is still not understood. 
Schäfer and Forth (1984) postulated that Cd com-
petes with the Fe transfer system mainly by binding 
to mucosal transferrin. Mucosal transferrin appears 
to be an important determinant in Fe uptake in the 
intestine (Huebers et al, 1983). A second explanation 
for the interaction of Fe with Cd accumulation is 
based on the work of Petro and Hill (1987), who 
showed that ip injection of Fe greatly increased 
hepatic metallothionein production in rats. The 
studies of Cousins et al (1977), Valberg et al. (1976) 
and Eaton and Toal (1982) have shown that Cd is 
associated with metallothionein-like proteins in the 
intestine. Changes in the metallothionein level in the 
intestine by Fe may result in an alteration of Cd 
retention. However, it is unknown whether Fe can 
change metallothionein production in the gastro-
intestinal tract. A third protein that might contribute 
to the competition between Cd and Fe is ferritin. 
Although the level of Cd binding to ferritin is low 
compared with the binding of Fe, the possibility 
exists that the uptake of small amounts of Cd may 
involve binding to intestinal ferritin (Fox et al, 1980; 
Joshi and Zimmerman, 1988). 
In quails, Jacobs et al (1978b) found that doubling 
of the Zn content (60 ppm) in the diet reduced the 
Cd uptake of the liver. The beneficial effect of a 
combined supplement of Zn together with Cu and 
Mn has been reported by Jacobs et al. (1977 and 
1978a,b). They showed, by studying the individual 
trace elements, that only Zn caused the protective 
effect against Cd accumulation (Jacobs et al, 1983). 
This observation seems to be in agreement with our 
findings. Moreover, Banis et al (1969) found that a 
combined administration of Zn and Fe had a protec-
tive effect against Cd accumulation in rats. From our 
study it appeared that a supplement of Fe together 
with Zn and Ca/P (groups F and D in experiment 1) 
was the most effective diet against the retention of 
Cd. Thus, the results of Banis and those from our 
studies indicate a protective effect of dietary Zn, 
especially when combined with extra Fe. 
The role of Ca is not clear. Several studies have 
shown that diets with a low Ca content can increase 
body retention of Cd (Hamilton and Smith, 1978; 
Norberg et al, 1985). Moreover, Foulkes (1980) has 
shown that, after in situ perfusion of the intestine, a 
high Ca dose can inhibit Cd absorption. From the 
present study it appeared that a Ca/P supplement 
slightly reduced Cd accumulation and improved the 
protective effect of Fe in both experiments. However, 
the Ca and P supplement introduced signs of toxicity 
such as elevated levels of liver enzymes in the plasma 
and decreased packed cell volume and haemoglobin 
concentration in the blood as indicated in Fig. 6. 
Thus, although Ca/P influences Cd accumulation, it 
appears that Ca/P protects against Cd toxicity only 
in the presence of Fe in the mineral supplement. 
Considering the other minerals, from the results 
obtained in this comparative study it appears that 
high levels of the elements Mg, Mn, Se or Cu did not 
affect the uptake of Cd and did not protect against 
Cd toxicity in rats. 
In conclusion, in a direct comparison of eight 
potentially effective minerals in the diet, the amount 
of which was accurately defined, only combinations 
with Fe were found to protect significantly against the 
toxicity of CdCl2; the protective effect appeared to be 
based on lowering Cd accumulation. For man, the 
present results indicate that special consideration 
should be given to an adequate Fe intake when 
assessing the health risks of Cd intake. 
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It has been shown that addition of extra calcium/phosphorus (Ca/P), zinc (Zn) and iron (Fe 2 +) to the diet results in a 
significant protection against cadmium (Cd) accumulation and toxicity in rats fed inorganic Cd salt. However, it is not clear 
whether the presence of these mineral supplements in the diet also protects against the Cd uptake from cadmium-metal-
lothionein. The present study examines the influence of Ca /P , Zn and Fe 2 + on the Cd disposition in rats fed diets containing 
either 1.5 and 8 mg Cd/kg diet as cadmium-metallothionein (CdMt) or as cadmium chloride (CdCI2) for 4 weeks. The feeding of 
Cd resulted in a dose-dependent increase of Cd in intestine, liver and kidneys. The total Cd uptake in liver and kidneys after 
exposure to CdMt was lower than after exposure to CdCI2. At thé low dietary Cd level and after addition of the mineral 
supplement, the kidney/liver concentration ratio increased. However, this ratio was always higher with CdMt than with CdCl2, 
suggesting a selective renal disposition of dietary CdMt. The uptake of Cd from CdCI2 as well as from CdMt was significantly 
decreased by the presence of a combined mineral supplement of Ca/P , Zn and Fe2 + . The protection which could be achieved 
was 72 and 75% for CdMt and 85 and 92% for CdCI2 after doses of 1.5 mg/kg and 8 mg/kg respectively. In a following 
experiment it was shown that the protective effect of the mineral mixture against CdMt was mainly due to the presence of Fe2 + . 
It seems clear that Cd speciation and the mineral status of the diet have a considerable impact on the extent of Cd uptake in 
rats. 
Cd2 +; Cadmium chloride; Cadmium-metallothionein; Accumulation; (Rat) 
1. Introduction 
Outside of the industrial environment, most of the 
body's burden of cadmium orginates from the diet 
(Foulkes, 1986; Robards, 1991). Due to the small safety 
margin between the actual level of the dietary intake 
and the toxic level of Cd (Buchet et al., 1990), human 
dietary exposure to Cd is at present a major concern. 
In food of animal and vegetable origin, Cd is mainly 
associated with the protein metallothionein (Wagner, 
1984; Webb, 1986; Kagi, 1987). In spite of numerous 
studies performed with CdCI2, a clear lack of informa-
tion on the toxicological risk of CdMt exists. Recently, 
it has been shown that signs of toxicity (e.g., anemia, 
hepatotoxicity) in subacute studies are less pronounced 
in rats exposed to CdMt than in rats exposed to inor-
ganic Cd-salt (Groten et al., 1990). This correlates well 
with the fact that the intestinal and hepatic uptake of 
Cd after CdMt exposure is lower than after exposure 
Correspondence to: J.P. Groten, TNO-ITV, P.O. Box 360, 3700 AJ 
Zeist, Netherlands. Tel. 31-3404.44144; Fax 31-3404.57224. 
to CdCi2 (Maitani et al., 1984; Groten et al., 1991b). 
However, in spite of the lower total Cd uptake in 
experiments with CdMt, the renal Cd accumulation 
from CdMt is relatively higher than from CdCl2 
(Maitani et al., 1984; Groten et al., 1991b; Ohta and 
Cherian, 1991). The most acceptable hypothesis ex-
plaining this finding is that CdMt is, at least partially, 
absorbed intact and is then immediately deposited in 
the kidneys (Groten et al., 1991b; Ohta and Cherian, 
1991). 
Several dietary factors including vitamins, proteins, 
and minerals are known to affect the intestinal Cd 
uptake of inorganic Cd-salts (Fox, 1979; Nordberg, 
1985; Chmielnicka and Cherian, 1986). Recently it has 
been shown that a combined mineral supplement of 
Ca/P, Zn and Fe was very effective in preventing Cd 
toxicity and resulted in an 80% decrease of the Cd 
accumulation after feeding of inorganic Cd (Groten et 
al., 1991a). However, the impact of these minerals on 
the absorption of biologically incorporated Cd has not 
been investigated. 
The present study describes the influence of mineral 
supplements on the uptake of Cd after exposure to 
CdMt in two successive 4-week feeding studies in rats. 
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2. Materials and methods 
2.1. Chemicals 
Cadmium chloride with a purity, as specified by the 
supplier, of at least 99% was obtained from E. Merck, 
Darmstadt, Germany. Compounds used in the mineral 
mixtures were CaHPO,, 2H20, KH 2 P0 4 , Fe(2 + )S04 
7H 2 0, ZnCI2, all obtained from E. Merck, Darmstadt, 
Germany (analytical grade). 
2.2. Animals and experimental design 
Albino male rats, Wistar outbred (Hsd/Cpb : WU) 
were obtained from a colony maintained under SPF 
conditions at Harlan/CPB, Austerlitz, Netherlands. At 
the beginning of the study the rats were 5-6 weeks old. 
They were housed under conventional conditions, in 
suspended stainless steel cages fitted with a wire-mesh 
floor and front. The room temperature was maintained 
at 22 + 2°C and the relative humidity at 40-70%. A 12 
h light/dark cycle was maintained and the number of 
air changes was about ten/h. Prior to the experiment 
all rats were fed a basal diet without any further 
additions. Drinking water was supplied in glass bottles 
which were cleaned once weekly. Food and water were 
provided ad libitum. 
The rats were acclimatized to the animal facilities 
for 1 week and were then allocated to test groups of 
five animals using a computer generated random num-
ber table. A few rats were reallocated in order to 
equalize the initial mean body weight in the various 
groups. Each treatment group (housed in groups of 
five) received one of the test diets. On day 28 all rats 
were autopsied. 
2.3. Preparation of cadmium incorporated in pig liver 
Seven young male pigs, initially weighing 57 ± 5 kg, 
were housed separately in metabolism cages. The ani-
mals were injected intravenously (vena jugularis) with 
cadmium chloride dissolved in saline according to the 
following schedule: on days 0, 2, 5 and 7 with 0.6 mg 
Cd/kg body weight, on days 9 and 12 with 0.9 mg 
Cd/kg body weight and on days 14, 16, 19, 21 and 23 
with 1.15 mg Cd/kg body weight. 3 days after the last 
injection the animals were killed and the livers were 
removed. The livers were pooled, homogenized, 
lyophilized and stored at -20°C. Livers obtained from 
two untreated pigs were handled in the same way and 
served as control material. Analysis of freeze-dried 
liver samples revealed that the Cd, Zn and Fe content 
was 950, 530 and 460 mg/kg tissue, respectively. In a 
previous study (Groten et al., 1990) the Cd-binding 
ligand in the pig liver that accounted for almost 90% of 
the total Cd present was characterized as metallothio-
nein. 
2.4. Diets 
The study comprised two experiments; the first one 
was designed to compare the effect on Cd accumula-
tion of diets supplemented with one mineral mixture 
known to protect efficiently against CdCI2. A second 
TABLE 1 
Mineral analyses of the diets. 
Diets 
Experiment I 
8ppmCdCI 2 -M in u 
2 ppm CdCI2 - M i n 
8ppmCdCI2 + Min 
2 ppm CdCI2 + Min 
8 ppm CdMt-Min 
2 ppm CdMt-Min 
8 ppm CdMt + Min 
2 ppm CdMt + Min 
Experiment 2 
10 ppm CdCI2 
10 ppm CdCI2 + Min 
IOppmCdCI2+Fe2 + 
10 ppm CdMt 
10 ppm CdMt + Min 
10ppmCdMt + Ca/P 
10 ppm CdMt+ Zn 
IOppmCdMt + Fe2+ 
Minerals 
Calcium 
(%) 
Phosphorus 
(mg/kg) 
Zinc 
(mg/kg) 
Copper 
(mg/kg) 
Iron 
(mg/kg) 
Cadmium 
(mg/kg) 
Nitrogen 
(%) 
0.65 
0.64 
1.42 
1.42 
0.65 
0.64 
1.44 
1.44 
0.67 
1.44 
0.66 
0.68 
1.43 
1.46 
0.67 
0.66 
0.63 
0.63 
1.38 
1.39 
0.63 
0.63 
1.22 
1.23 
61 
1.5 
0.64 
0.61 
1.4 
1.5 
0.63 
0.62 
49 
47 
138 
135 
49 
47 
139 
138 
35 
145 
34 
35 
140 
34 
145 
34 
2.2 
2.6 
2.2 
2.0 
2.9 
2.6 
3.2 
2.4 
-
-
-
-
-
-
-
-
79 
77 
273 
295 
79 
71 
288 
283 
70 
280 
260 
65 
270 
75 
65 
260 
7.5 
1.6 
7.5 
1.4 
8.5 
1.6 
8.5 
1.6 
9.7 
8.4 
9.8 
9.3 
8.4 
8.4 
9.9 
9.6 
4.38 
4.37 
4.19 
4.24 
4.52 
4.45 
4.37 
4.32 
4.38 
4.17 
4.3 
4.4 
4.1 
4.26 
4.38 
4.33 
1
 Min = Total mineral mixture ot Ca/P, Zn, Fe 
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experiment was undertaken to determine the effect of 
the individual elements used in the mixture of the first 
experiment. 
2.4.1. Experiment 1 
A semi-synthetic powdered basal diet was composed 
to resemble a Western type of human diet (see Groten 
et al., 1990). The mineral content of the basal diet was 
based on the nutrient requirements of the rat accord-
ing to the National Research Council (1978). Four 
diets consisted of the basal diet supplemented with 
lyophiiized pig liver from Cd-treated pigs providing a 
dietary level of 1.5 and 8 mg Cd/kg diet. Two of these 
diets were supplemented with a mineral mixture of 
Ca/P, Zn and Fe2 + which according to previous obser-
vations (Groten et al., 1991a) was the most effective 
against Cd accumulation. Four other diets consisted of 
the basal diet supplemented with CdCI2 and lyophiiized 
liver homogenate of control pigs which were not treated 
with Cd, provided dietary levels of 1.5 and 8 mg Cd/kg 
diet. The mineral analysis of the eight diets (see table 
1) revealed that, under the experimental conditions, 
the actual levels of Cd were 94% and 106% of the 
intended level for CdCI2 and CdMt respectively. 
One batch of each of the diets was stored in a 
freezer at — 20°C until use. Twice a week the diets in 
the feeders were refreshed with a portion of the test 
diets (thawed immediately before use). 
2.4.2. Experiment 2 
The purpose of experiment 2 was to determine 
whether the effect of the mixture Ca/P, Zn and Fe2 + 
could be attributed to the presence of Ca/P, Zn or 
Fe2 + alone. The control group was fed a Cd diet (10 
mg/kg diet) either as CdCl2 or CdMt supplemented 
with a combined mineral mixture consisting of Ca/P, 
Zn and Fe2 + . A third diet contained CdCI2 supple-
mented with Fe 2 + alone. Three diets contained CdMt 
(10 mg/kg diet) together with a supplement of the 
single compounds Ca/P , Zn or Fe2 + . The mineral 
analysis of the diets (see table 1) revealed that, under 
the experimental conditions, the actual levels of Cd 
were between 84 and 99% of the intended level for 
both CdCl2 and CdMt. 
2.5. Observation and analyses 
The rats were weighed at weekly intervals and were 
observed daily for condition and behaviour. Food and 
water intake were measured over weekly periods 
throughout the study. At autopsy on day 28 liver and 
kidneys were removed and weighed. In experiment 1 
the small intestinal mucosa was also removed and 
treated as described elsewhere (Groten et al., 1991b). 
Part of the liver, intestine or the kidney cortex was 
prepared for AAS analysis of the Fe, Zn and Cd 
content (Muys et al., 1984; Groten et al., 1990). 
2.6. Statistical analysis 
Data on body weights were evaluated by a one-way 
analysis of covariance, followed by Dunnett's multiple 
comparison tests. The laboratory determinations and 
organ weights were evaluated by a one-way analysis of 
variance, followed by Dunnett's multiple comparison 
tests. 
3. Results 
The general condition and behavior of the rats fed 
CdCI2 or CdMt appeared to be normal throughout the 
4-week study. Body weight gain and food consumption 
were similar in all groups and there were no consistent 
differences in organ weights between the control ani-
mals and the animals fed Cd (data not shown). 
3.1. Experiment 1 
Feeding of CdMt and CdCl2 produced a dose-de-
pendent Cd accumulation in liver, kidneys, as well as 
intestine (fig. 1). The Cd concentration achieved after 
28 days of dietary Cd exposure was highest in the 
intestinal mucosa and lowest in the liver. At a dose of 8 
mg/kg the Cd concentration in all three tissues was 
significantly higher after feeding of CdCl2 than after 
I Kidneys 
mg Cd/kg tissue 
8 1.5 
-Mln 
8 1.5 
-Mln •Mln 
mg Cd/kg diet 
Fig. 1. Cadmium concentration in liver, kidneys and small intestine 
in experiment 1. Rats were fed for 28 days a diet containing CdCI2 
or CdMt with and without a mineral mixture of Ca/P, Zn and Fe2 + 
( + Min / — Min). All values are means of five rats. Those CdMt 
groups marked with an 'o' differ significantly (ANOVA + Dunnett's 
test) from the CdCI2 group of a corresponding dose (° P < 0.05, 
°° P < 0.01). Those + Min groups marked with an asterisk differ 
significantly from the corresponding —Min group (ANOVA + 
Dunnett's test: * * P < 0.01). 
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CdMt. From the organ weights it was calculated that 
the total Cd uptake in liver and kidneys together at the 
dose levels of 1.5 and 8 mg/kg was 3.5 and 39.2 pg 
respectively after feeding of CdC!2, and 2.5 and 8.6 ^g 
respectively after feeding of CdMt (fig. 2). The differ-
ence in tissue Cd concentrations between CdMt and 
CdCl2 became less pronounced at a dose of 1.5 mg/kg 
(fig. 1). However as the calculation in fig. 2 shows, the 
total Cd amount in liver and kidneys together at the 
low CdCl2 dose was still higher than for CdMt. Supple-
mentation of the Cd diet with the mineral mixture 
lowered the Cd accumulation considerably: the protec-
tion which could be achieved was 72 and 75% when 
CdMt was given and 85 and 92% when CdCI2 was 
given at 1.5 and 8 mg/kg respectively. A plot of the 
ratio between Cd concentration in kidneys and liver 
(fig. 2) versus dose shows that oral exposure to 8 
mg/kg CdMt led to a higher Cd concentration ratio 
than the feeding of 8 mg/kg CdCl2. The difference 
became less pronounced at a dose of 1.5 mg/kg. Addi-
tion of the mineral mixture resulted in an increase in 
the kidney/liver ratio for both Cd forms. The increase 
in the Cd ratio after addition of extra minerals was 
mg C d / k g t i ssue 
[Cd) ratio kidney/liver 
+ Min 
2.2 0.6 
CdMt 
• CdCI _ 
mg Cd/kg diet 
Fig. 2. Ratio between kidney and liver Cd concentration of rats fed 
1.5 and 8 m g / k g Cd as CdCI 2 or CdMt . Each value is the mean of 
five individual calculated k idney/ l iver ratios of five rats. Values 
marked with an asterisk in the group fed 8 m g / k g CdCI 2 + Min 
differ significantly from the group fed 8 m g / k g CdMt + M in (* P < 
0.005). The value above/next to each bar gives the mean total Cd 
uptake in liver and kidneys together (in /ig Cd). For details of the 
experiment see Materials and methods section. M i n = Mineral mix-
ture of C a / P , Zn and F e 2 + . 
Liver B H Kidneys 
CdMt 
•Min *Fe •Min 'Ca/P «Zn »Fe 
Diets 
Fig. 3. Cadmium concentration in liver and kidneys in rats of 
experiment 2 after 28 days of exposure to 10 m g / k g Cd. A l l values 
are means of five animals. Those groups marked wi th an asterisk 
differ significantly from the corresponding group fed Cd without 
additional minerals ( A N O V A + Dunnett's test): * P < 0.05, * * P < 
0.01. + M in = diet supplemented with total mineral mixture of C a / P , 
Zn and F e 2 + , + Fe = Fe supplement, + C a / P = C a / P supplement, 
+ Zn = Zn supplement. 
more pronounced with CdMt than with CdCl2: the 
kidney/liver [Cd] ratio in animals fed 1.5 mg Cd/kg 
without extra minerals for CdCl2 and CdMt was 2.4 
and 2.8 respectively, whereas after addition of the 
mineral mixture the ratio increased to 3.1 and 4.2 
respectively (fig. 2). 
3.2. Experiment 2 
In the second experiment the effect on CdMt up-
take of the individual elements used in the combined 
mineral supplement of experiment 1 was studied. The 
mineral mixture Ca/P, Zn and Fe2 + showed a slightly 
lower protection in experiment 2 than at the 8 mg/kg 
Cd level in experiment 1: the Cd accumulation in the 
second experiment was reduced up to 59% and 71% 
for CdMt and CdCI2 respectively. When animals were 
fed a CdMt diet supplemented with either Fe2 + , Zn or 
Ca/P, only the Fe2 + group showed a significant de-
crease in the Cd content in the liver and kidneys (fig. 
3). For both CdMt and CdCI2 the decrease in Cd 
uptake after the Fe2 + supplement was almost similar 
to the decrease resulting from the mineral mixture that 
also contained Ca /P and Zn. 
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4. Discussion 
After addition of a mineral supplement consisting of 
Ca/P, Zn and Fe2 + to a diet with CdMt there are two 
striking differences compared with the effect of these 
minerals on CdCI2. Firstly, the total protection of the 
mineral mixture against Cd uptake from CdMt is lower 
than for inorganic Cd, and secondly relatively more Cd 
is deposited in the kidneys with CdMt than with CdCI2. 
The fact that the mineral supplement also protects 
against CdMt - albeit less pronounced than against 
CdCl 2 - might be explained by the partial degradation 
of CdMt in the gastrointestinal tract (Klein et al., 
1986). Once degraded, Cd from CdMt will show the 
same metabolic behavior as inorganic Cd-salt and the 
uptake in liver and kidneys will be decreased by min-
eral suppletion. On the other hand, rats fed CdMt 
supplemented with extra minerals showed a strong 
increase in the ratio of the kidney/liver Cd concentra-
tion. An explanation for the high kidney/liver Cd ratio 
after feeding of CdMt has been given previously 
(Maitani et al., 1984; Groten et al., 1991b) and orginates 
from the fact that a portion of ingested CdMt is not 
degraded (Klein et al., 1986, Crews et al., 1989), but 
does in fact appear to reach the intestine intact 
(Cherian, 1979; Ohta and Cherian, 1991). Since the 
selective renal disposition of CdMt is higher with extra 
minerals in the diet, it seems that the mineral supple-
ment does not affect the absorption of the intact ex-
ogenous CdMt, which will then reach the kidneys un-
hampered. 
In previous studies we have shown that a combined 
mineral supplement of Ca/P, Zn and Fe2 + resulted in 
a 70-80% reduction of Cd accumulation in liver and 
kidney as well as a reduction of Cd toxicity in rats fed 
30 ppm Cd as CdCI2. The present study shows that the 
protection against Cd uptake is even 10-20% higher at 
a CdClj intake of 1.5 mg/kg. However, at low dietary 
Cd levels or after addition of a combined mineral 
supplement, relatively more Cd is accumulated in the 
kidneys than in the liver. This selective renal disposi-
tion might be explained by the theory that low amounts 
of ionic Cd, once absorbed through the intestine, are 
initially bound to available endogenous metallothio-
nein, which will be transported preferentially to the 
kidneys (Lehman and Klaassen, 1986; Scheuhammer, 
1988). However, at higher Cd doses the available en-
dogenous circulating metallothionein pool is over-
loaded and Cd will also be bound to plasma proteins 
such as albumin and then be deposited in the liver 
(Lehman and Klaassen, 1986). Since addition of the 
mineral supplement decreases the Cd absorption, it 
will prevent to some extent the overload of the intesti-
nal metallothionein pool and as a consequence the 
kidney/ liver ratio will increase. 
Ca /P and Zn given alone only slightly reduce the 
Cd intake of CdMt. A similar effect of these minerals 
was observed after feeding of CdCl2 (Groten et al., 
1991a). The protective effect of the mineral mixture is 
thus almost solely due to the presence of Fe2 + and this 
finding supports the theory that the intestinal transport 
of Cd in rats is mediated by the Fe transfer system 
(Hamilton and Valberg, 1974; Leon and Johnson, 1982; 
Schäfer and Forth, 1984). The decrease in Cd uptake 
by Fe2 + will certainly result in a clear protection 
against Cd toxicity since in previous studies it was 
shown that a decrease of Cd accumulation in rats fed 
Cd is followed .by the disappearance of signs of Cd 
toxicity (Groten et al., 1990, 1991a). 
Thus, Fe2 + suppletion of the diet is a very effective 
way to prevent Cd accumulation and Cd toxicity from 
feeding of both inorganic Cd and biologically incorpo-
rated Cd. The results indicate that Cd speciation and 
the mineral status of the diet have a considerable 
impact on the ultimate uptake of Cd in rats. 
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Cd-METALLOTHIONEIN AFTER ORAL AND INTRAVENOUS 
ADMINISTRATION IN RATS 
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Abstract-In the present study an HPLC-based method is used to distinguish between endogenous 
and exogenous metallothioneins, and to study their metabolic fate simultaneously. For that 
purpose, Cd-metallothionein isoforms were purified from liver (LMt), kidneys (KMt) and 
intestine (IMt) of rats. Ion exchange chromatography revealed two isoforms in all rat tissues 
(Mt-1 and Mt-2) and both isoforms eluted as single discrete peaks on the HPLC system, except 
for the kidney in which case both isoforms eluted together as one single peak. Purified hepatic 
Mt isoform-1 (LMt-1) was radiolabeled with 109Cd and administered orally or intravenously at a 
low, non-toxic dose to rats. 109CdLMt-l administered i.v. preferentially distributed to the 
kidneys (approximately 45% of the dose). The Cd concentration in the kidneys increased rapidly 
between 5 and 30 min after administration and then remained constant for at least 48 hours. In 
contrast, in the liver only 6-9% of the dose was retained. HPLC analysis showed that 5 min 
after administration of LMt-1, Cd in the kidneys is no longer bound to intact LMt-1, but to 
heat-resistant degradation products of Mt of comparable molecular weight. Within 24 hours 
almost 40% of the Cd in the kidney was bound to KMt. 
After oral administration of 109CdLMt the Cd retention in the intestinal mucosa reached its 
maximum 5 hours after exposure, i.e. 1.5 % of the dose. Within 24 h. most of the administered 
Cd was again excreted by the faeces. At all time points, the majority of the Cd in the intestine 
was bound to heat-resistant proteins with a molecular mass similar to Mt. However, HPLC 
analysis showed that Cd was no longer bound to intact LMt-1; 35% of the Cd was transferred to 
IMt and the remainder of the Cd was bound to Mt-derived products. These Mt-like products 
originate from LMM, but also from IMt because they can also be found after oral exposure to 
inorganic Cd. After oral administration of LMt-1, Cd was equally distributed to kidneys and 
liver, but the retention was very low and isoform identification proved to be impossible. In in 
vitro experiments with renal and intestinal homogenates, the Cd was rapidly exchanged between 
the exogenous (LMt-1) and endogenous Mt-isoforms (KMt or IMt). The extent of Cd exchange 
was dependent on the concentration ratio between exogenous and endogenous Mt isoforms. 
Thus, after oral exposure to low doses of exogenous CdMt, the Cd ions will be bound to 
endogenous CdMt due to the rapid exchange and due to gradual degradation of exogenous 
CdMt. The rapid liberation of Cd-ions at low CdMt levels implies that at low oral doses 
exogenous CdMt will show the same metabolic behaviour as inorganic Cd. 
INTRODUCTION circulation and then be deposited in the kidneys 
(Min et al. , 1991). However, after a higher oral 
Intestinal absorption of low doses of Cd will dose, the available endogenous Mt pool is 
mainly lead to renal cadmium (Cd) accumu- overloaded and Cd will also bind to e.g. plasma 
lation, whereas after high doses of Cd, the Cd is proteins and then be deposited in the liver 
predominantly stored in the liver (Engstrom and (Suzuki, 1984; Lehman and Klaassen, 1986). In 
Nordberg, 1979, Lehman and Klaassen, 1986; the liver Cd will be associated to hepatic Mt, 
Scheuhammer, 1988). It has been proposed that which is probably released from the liver in the 
a low amount of ionic Cd will mainly be bound systemic circulation due to normal turnover of 
to endogenous metallothionein (Mt) of the hepatocytes or due to increased cell death 
intestine, which will be released in the systemic (Dudley et al., 1985; Webb, 1986) and is only 
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then transported to the kidneys. 
Cd in the diet is in part present as Cd-Mt. This 
dietary Mt can to some extent survive the 
treatment with gastro-intestinal proteolytic 
enzymes (Klein et al., 1986; Crews et al. '89) 
and can be taken up in the intestinal mucosa 
(Cherian et al., 1979; Ohta and Cherian, 1991). 
If released from the intestinal mucosa into the 
systemic circulation, exogenous CdMt shows, 
similar to endogenous CdMt, a selective renal 
disposition (Maitani et al., 1984; Ohta and 
Cherian 1991; Groten et al., 1991). However the 
degradation of dietary Mt, absorbed in the 
intestine, has so far not been studied in detail. 
CdMt which has been absorbed in the kidneys is 
presumably degraded within hours whereas the 
renal Cd concentration remains almost constant 
for days (Cain and Holt, 1983; Squib et al., 
1984). Studies on Cd-speciation in kidneys and 
intestine have thus far been performed with 
bolus amounts of CdMt and employ gel-filtration 
techniques to estimate the molecular size of the 
Cd-binding proteins. Under these conditions it 
remains uncertain whether Cd is exchanged 
between endogenous Mt in the tissue and exoge-
nous Mt taken up by the tissue. The fate of low 
doses of exogenous CdMt is not known in detail, 
although it has been suggested that before 
degradation of the CdMt in the tissue the Cd2+ is 
already liberated and will displace zinc in the 
renal endogenous Mt, that is already present 
(Webb and Etienne, 1977). 
In the last few years reversed phase-high 
performance liquid chromatography (RP-HPLC) 
has been applied to characterize different Mt 
isoforms expressed by different organs (Klauser 
et al., 1983; Richards and Steele, 1987; Waalkes 
et al., 1988; Groten et al., 1990). The advantage 
of HPLC over other Mt-detection techniques like 
RIA, mRNA-assays or metal saturation assays is 
that it can, in one step, provide information 
concerning the isoforms present in the tissue. 
The HPLC technique was applied in the present 
study to investigate simultaneously the Cd 
binding to endogenous and exogenous Mt, 
making use of the fact that different rat Mt-
isoforms show different elution profiles on RP-
HPLC (Groten et al., 1992). For that purpose 
purified CdMT was administered orally or 
intravenously to rats at low Cd-concentrations 
and the fate of radiolabeled Cd was studied. 
MATERIALS AND METHODS 
Chemicals. l09CdCl2 was obtained from Amers-
ham International (Bucks., U.K.) as stock soluti-
ons of lmCi and 100/tCi/ml in 0.1 N HCl (spec, 
activity 41.1 and 47.7 MBq//*g Cd). Acetonitrile 
(HPLC grade) was purchased from Westburg 
(Leusden, NL). All other chemicals (analytical 
grade) were obtained from E. Merck AG 
(Darmstadt, FRG). 
Animals and Maintenance. Albino male rats, 
Wistar outbred (Crl:WI(WU)Br) were obtained 
from a colony maintained under SPF-conditions 
at Charles River Wiga, Sulzfeld FRG. At the 
beginning of the study the rats were 10-12 weeks 
old, weighing 250-300g. During the experimen-
tal part they were housed in macrolon cages. 
The room temperature was maintained at 22 ± 2 
°C. and the relative humidity at 40-70 %. A 12 
hr-light/dark cycle was maintained. Drinking 
water was supplied in glass bottles which were 
cleaned twice a week. Food (pelletized cereal-
based stock diet) and water were provided ad 
libitum. The rats were acclimatized to the animal 
facilities for at least 3 days and were then alloca-
ted to test groups. 
Purification of CdMt. Rat Mt-isoforms were 
purified from liver, kidney and intestinal mucosa 
from rats which were treated with CdCl2 as 
described elsewhere (Groten et al., 1990). Brief-
ly, the tissue homogenates (cytosol) were filtered 
through a 0.22 jtm filter and chromatographed 
on a Sephadex G-75 column (5 x 60 cm, Phar-
macia, Sweden) with 10 mM Tris.HCl (pH 7.4, 
4°C). The CdMT-containing fractions (Ve/Vo = 
2 ± 0.2) were applied to a Sephadex DEAE-
A25 column (2.5 x 20 cm) and eluted with a 
linear gradient of 10-300 mM Tris.HCl (pH 8.5, 
4°C). The fractions which corresponded to Mt-1 
and Mt-2 were dialyzed against water (Amicon 
YM membrane, the Netherlands) and lyophi-
lized. The lyophilized Mt powder was dissolved 
in deionized water and further analyzed on RP-
HPLC (see below). Rat liver isoform-1 (LMt-1) 
was pooled from several isolations and used as 
test material for the in vivo and in vitro studies. 
The molar ratio of Cd:Zn:Cu in LMt-1 was 
1:1:0.04 respectively. Based on a purity of 90% 
(as determined by the Cd-Haem assay of Eaton 
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and Toal, 1982) LMT-1 contained 2.8 mol 
Cd/mol Mt. 
HPLC analysis. Purified Mt and heat treated 
organ homogenates were applied to an RP-
HPLC system using a stainless steel Hypersil 5 
ODS (250 x 4.6 mm) column (Chrompack, NL) 
eluted with a 10 mM sodium phosphate buffer 
(pH 7.2) (solvent-1) and 10 mM sodium phosp-
hate buffer in acetonitrile (40:60) (solvent-2) as 
eluting solvents. Samples were eluted with a 
linear gradient of 0-5% solvent-2 in 5 min and 
from 5 to 20% solvent-2 in 15 min with a flow 
rate of 1 ml/min. After UV detection at 220 nm 
fractions of 0.25 ml eluens were collected and 
counted for l09Cd in a gamma counter (LKB 
Rackgamma, Sweden). 109Cd-recovery on HPLC 
varied between 80-95%. 
Renal Cd speciation after parenteral exposure to 
mCdLMt-l. LMt-1 (1.5 mg) was incubated with 
109
 CdCl2 (40 /xCi) for 15 minutes in 2 ml deioni-
zed water. After incubation the l09CdLMT was 
diluted with a sterile solution of concentrated 
NaCl to obtain a final solution of 0.9 % NaCl 
containing 200 /ig LMtl/ml (5.1 /tCi/ml). Prior 
to injection purity of radiolabeled LMt-1 was 
checked on HPLC. The 109CdLMt-l solution was 
injected into the tail vein of rats (0.5 ml/300 gr 
body weight) and on 5 min., 30 min, 4 h and 
24 hours after injection two animals/group were 
sacrificed and liver and kidneys were removed 
and immediately emerged in liquid nitrogen. All 
tissues were homogenized in 2 volumes of 10 
mM Tris-144 mM KCl buffer (pH 7.4, on ice) 
and S9-mixture was prepared by centrifugation 
at 10.000g for 20 min (4°C). The renal homoge-
nates were applied to Sephadex gel-filtration 
columns (60x1.5 cm, 35 ml/h, 2 ml/fraction) 
and after heat treatment (1 min, 100°C) to the 
RP-HPLC system. Gel-filtration profiles were 
divided in three major areas: High molecular 
weight (HMW) proteins larger than lOkD, Mt-
like proteins between 3 and lOkD and 
compounds smaller than 3 kD. 
Intestinal Cd-speciation after oral exposure to 
,09CdLMt-l . LMt-1 (4 mg) was incubated with 
109CdCl2 (100 /iCi) for 15 minutes in 2 ml 10 
mM Tris.HCl and finally diluted to a concentra-
tion of 500 /ig Mt/ml. 
The animals, fasted overnight, were orally expo-
sed by gavage to the 109CdLMt-l (1 ml/200gr 
body weight) and after 5 min., 4 h and 24 hours 
two animals/group were sacrificed and intestine, 
liver and kidneys were removed. The intestinal 
mucosa was scraped off as described previously 
(Groten et al., 1991) and the mucosal scrapings 
as well as the liver and the kidneys were imme-
diately immersed in liquid nitrogen. All tissues 
were homogenized in 2 volumes of 10 mM Tris-
144 mM KCl buffer (pH 7.4) on ice and were 
prepared in the same way as described for renal 
homogenates after parenteral exposure. 
Renal and intestinal Cd-speciation after in vitro 
exposure to mCdCl2 or mCdLMt-l. To obtain a 
radiolabeled Mt, 500 fig LMt-1 was dissolved in 
lml (10 mM) Tris.HCl buffer (pH 8.0) and 
incubated for 10 minutes with 109CdCl2 (1-5 
/iCi). After the radiolabeling 109CdLMt-l was 
kept on ice prior to use. In preliminary experi-
ments it was established that 98 % of the 109Cd 
remained bound to LMt-1 after extensive dialysis 
through an amicon ultramembrane. The purity of 
the radiolabeled LMt-1 was established by 
HPLC which revealed one single peak of l09Cd-
labeled LMt-isoform 1 (see fig 1.). An equi-
molar Cd amount as CdCl2 was prepared by dis-
solving 32/tg CdCl2 in lml 10 mM TrisHCl 
buffer together with 109CdCl2 (1-5/tCi). Aliquots 
of the 109CdLMT-l or 109CdCl2 solution (20-
100/il) were added to 500 /il renal or intestinal 
homogenates of untreated rats. The total amount 
of radioactivity added to the homogenates was 
always between 50.000 and 100.000 dpm/100/il. 
Mt-concentration in the kidneys and intestine of 
untreated rats was 65 and 28 /ig /g tissue respec-
tively and the renal Mt concentration in kidneys 
of Cd-treated rats was 250/ig/g tissue (determi-
ned according to the method of Eaton and Toal, 
1982). The amount of 109CdLMt-l which was 
added to the renal and intestinal homogenates 
was chosen in such a way that the molar ratio 
between endogenous Mt (KMt or IMt) and ex-
ogenous Mt (LMt-1) was 5:1, 1:1 and 1:3 res-
pectively. After vigorously mixing, the homoge-
nates were incubated for 15 seconds at 37°C and 
subsequently heat-treated for 1.5 minutes at 
100°C. Lastly, the heat-treated tissue homogena-
tes were spun down at 10,000g for 5 minutes in 
an eppendorf centrifuge and the supernatant was 
decanted and kept on ice prior to HPLC analy-
sis. Stability of the CdMt-complexes in renal 
tissue was tested by incubating LMt-1 for 24 
hours in renal homogenates at 4°C and at 37 °C, 
followed by the work up procedure described 
above. 
93 
Stability of "»CdLMt-l in blood. Blood of 
untreated rats was collected in a heparinized 
culture tube and diluted 1:1 with 10 mM Tris-
HC1 buffer. Ten /il of the 109CdLMt-l solution 
was added to 600 /d blood to obtain a 
concentration of 9 /ig LMt-l/ml, which is 
comparable to the Mt concentration in the blood 
in the in vivo experiment after iv administration 
of CdMt. The blood was heat treated and 
centrifuged as described above. Finally the 
supernatant was applied to the RP-HPLC. 
RESULTS 
In order to fully characterize the HPLC sepa-
ration of rat Mt, tissue cytosol was fractionated 
using conventional chromatography techniques. 
Ion exchange chromatography of pooled gel-
filtration samples revealed that in all tissues of 
the rat, Mt was present in two main isoforms 
(Fig. la). In the intestine the majority of the Cd 
was however bound to isoform 2, whereas in the 
liver and kidney the Cd was equally divided 
among both isoforms. Mts which had undergone 
previous purification (i.e. low-
pressure gel-permeation and anion-exchange 
chromatography) were lyophilized and subjected 
to RP-HPLC which revealed that purified Mt 
isoform 1 and 2 from liver and intestine eluted 
as single discrete peaks with retention times of 
12.9 (±0.3) and 14.8 min (± 0.3) respectively. 
Thus, liver Mt isoforms (LMt) and intestinal Mt 
isoforms (IMt) showed an identical chromato-
graphic behaviour on HPLC (lb). In contrast, 
both kidney isoforms eluted together on HPLC 
Cd (ug/ml) UV (215 nm) 
20 3 0 4 0 
fraction number 
% radioactivity 
1c 
r* "———y^. . _ . » , • • / 
Kidney 
M t - 1 + M t - 2 
^ ~ K_ 
1d 
0 10 15 20 30 0 10 
time (min) 
Fig. 1 
la. Anion exchange chromatography (gradient of 10-300 mM Tris.HCl pH8.5) of rat Cd-Mt isolated by preparative gel-
filtration from liver/kidney/intestine cytosol. After purification and lyophilization the Cd-Mt isoforms were further analysed on 
reversed phase HPLC: IB: HPLC profile of rat Mt-1 and 2 from liver and intestine, lc: HPLC elution profile of Mtl and 2 
from kidney. Rats were treated with CdCl2 as described in method section. Id HPLC elution profile of LMt-1 after 
radiolabeling with '°°Cd. Mll/Mt2 = Metallolhionein isoform 1/2. 
94 
as a one single peak on 13 min, almost similar was labeled with l09Cd. Purity of these 
to the retention time of isoform-2 of liver and l09CdLMt-l probes was checked on HPLC. 
intestine (Fig. lc) . Thus, ion-exchange HPLC analysis showed that all radioactivity 
chromatography was superior to RP-HPLC in eluted as one single peak at 12.9 min, which 
resolving Mt-1 and -2 from rat kidney. corresponded to the UV signal of the purified 
In all in vitro and in vivo experiments LMt-1 LMt-1 (Fig. Id). 
Table 1. Cd disposition (as percentage of radioactive dose) in intestine, liver and kidneys after oral and 
intravenous administration of ""CdLMt in rats. Two animals were killed per time interval (every 
experiment was performed twice). 
Oral 
administration 
2 h . 
5 h . 
24 h. 
Intravenous 
administration 
5 min 
30 min 
4 h. 
24 h. 
Cd in Faeces 
(%) 
-
-
84,2+1 
-
-
-
-
Cd in intestinal 
mucosa (%) 
0.5+0.3 
1.6±0.4 
1.0 
-
-
-
-
Cd in liver 
(%) 
0.04±0.1 
0.05+0.03 
0.07 + 0.02 
6±1 
7 + 1 
8±2 
9±2 
Cd in Kidney 
(%) 
0.04 
0.05±0.01 
0.06+0.02 
26+2 
38±2 
45±3 
43 ±3 
% radioaclivity 
jililLmulll Ik 
Gel-filtration 
% radioactivity 
-•^ffHtrfli 
10 12 14 16 18 20 22 24 26 28 
time (min) 
RP-HPLC 
% radioactivity % radioactivity 
2d 24 h 
KMt 
. . „J 
1 [ 
l kl 
111 UIL inmtnniJL-n.-. 
2 4 6 8 10 12 14 16 18 20 22 24 26 28 30 
time (min) 
FIG. 2: Left side: Gel-filtration profiles of kidney S9 homogenate from rats which were i.v. dosed with ""CdLMt-1 2a=5 
min, 2b=24 h. Vo=42 ml. Right side: RP-HPLC elution profiles of heat treated renal homogenate. 2c=5min, 2d=24h. See 
for experimental details Materials and Methods 
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Table 1 shows the distribution of Cd with time 
after the i.v. administration of 109CdLMt. Cd 
administered as CdMt preferentially distributed 
to the kidneys (approximately 45% of the dose). 
Cd concentration in the kidneys increased 
rapidly between 5 and 30 min after admini-
stration and then remained constant for at least 
24 hours. The Cd-accumulation from CdMt in 
the kidneys appeared to be 5-8 times as high 
than in the liver. Fig 2. illustrates the gel-
filtration and HPLC elution profiles of the renal 
cytosol at 5 min and 24 hours after i.v. 
admininistration of 109CdLMt-l. It appeared that 
already 5 min after administration of CdLMt-1 
Cd is not bound anymore to this LMt. Instead, a 
small proportion of the Cd eluted at 13 min, a 
retention time which corresponds with that of 
purified KMt. The rest of the radioactivity eluted 
in the area between 15 and 20 min. and at 25 
min during the wash program of the column. 
These Cd ligands have not been further identi-
fied, but on the gel-filtration column they behave 
like Mt-proteins; the majority of the 109Cd in the 
kidneys was bound to proteins in the area 
between 3-10 kD (Ve/Vo = 2±0.2). One day 
after iv injection of LMt-1 the amount of Cd 
bound to KMt was substantially increased; 37% 
of the radioactivity elutes in the peak at 13 min 
and the amount of Cd eluting in the area 
between 15 and 20 min. was reduced. Gel-
filtration profiles of the 
kidney homogenate, (see also Fig.2) showed that 
a small percentage was bound to high molecular 
weight proteins (Ve/Vo= 1+0.2). The Cd 
binding to HMW proteins decreased with time; 5 
minutes after administration of LMt, 20% of the 
radioactivity in the kidney was bound to high 
molecular weight proteins whereas 24 hours 
after injection this proportion was only 6%. It 
should be emphasized that gel-filtration profiles 
show the total radioactivity present in the renal 
homogenate, whereas HPLC profiles only show 
% radioactivity % radioactivity 
Gel-filtration RP-HPLC 
% radioactivity % radioactivity 
3d CdLMt-1 
IMt-2 
Fig. 3. Left side: Geißtration profiles of intestinal mucosal S9-homogenate in rats 5 hours after oral exposure to CdCl2 (3a) 
or CdLMt-1 (3b). Right side: RP-HPLC elution profile of heat treated mucosal homogenate in same rats. 3c = CdCl2, 
3d=CdLMt-l. 
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heat-resistant Cd-binding ligands. The Cd 
recovery of heat treated renal homogenate was 
75 and 85% after 5 min and 24 hours 
respectively. The main part of the radioactivity 
which is lost in the pellet will presumably be 
bound to high molecular weight proteins, which 
seems to be in agreement with the gel-filtration 
profiles. 
Table 1 also shows the distribution of Cd with 
time after the oral administration of CdLMt-1. 
The Cd retention in the intestinal mucosa after 
oral exposure to LMt-1 reached its maximum 5 
hours after oral gavage. At that time a large pro-
portion of the radioactivity could be retrieved in 
the coecum (data not shown), but within 24 
hours almost 85% of the original dose was 
excreted by the faeces. HPLC analysis of the 
intestinal mucosa 5 hours after exposure to LMt-
1 showed that Cd was hardly bound to intact 
LMt-1 (Fig. 3d); only 10% of the Cd eluted at 
14 min. 20 % of the Cd is bound to IMt-2 and 
the rest of the radioactivity is found in a broad 
area with a retention time between 15 and 22 
min. For comparison, rats exposed for 5 hours 
to CdCl2 (Fig. 3c) showed a similar HPLC 
pattern, although relatively more Cd is bound to 
IMt-2 and IMt-1 (45%). The rest of the Cd 
mainly elutes from the column in the area 
between 15 and 20 min and during column 
rinsing at 25 min. Due to the low Cd disposition 
in the kidneys, no HPLC studies could be 
performed on the renal homogenates. Gel-
filtration profiles of the intestinal mucosa (Fig 
3a) show that 5 hours after CdCl2 administration 
20% of the Cd is bound to HMW proteins, 
whereas after exposure to CdLMt-1 (Fig. 3b) 
only 6% was bound to HMW proteins. The 
109Cd recovery in the supernatant of heat treated 
mucosa tissue was 81% and 94% for 
respectively CdCl2 and CdLMt. This implies that 
19 and 6% of the Cd binding proteins was not 
heat-resistant, which is in agreement with the 
percentage of Cd bound to high molecular 
weight proteins after gel-filtration. Thus, the 
majority of the Cd in rats exposed to low doses 
of CdMt or CdCl2 is bound to heat-resistant 
proteins. These proteins have a molecular weight 
in the range of Mt, but on HPLC these Cd-
ligands do not behave like purified Mt and eluted 
in a broad area between 15 and 20 min. 
After addition of l09CdCl2 to renal homogenates 
in vitro, a large fraction of the radioactivity 
elutes at 13 min, which corresponds with the 
retention time of purified renal metallothionein 
(fig 4a). The rest of the radioactivity, which is 
not bound to KMt elutes from the column at 25 
min., which is during the wash program with 
100% buffer B. When 109CdCl2 is added to renal 
homogenates of rats, which are pre-treated with 
CdCl2 the KMt becomes the main binding 
protein and there is hardly any radioactivity at 
25 min. (data not shown). After addition of 
109CdLMt-l to the renal homogenates in a 
concentration which is five times as high as the 
total endogenous (KMt) concentration (fig4b), 
the main part of the radioactivity elutes at 14.8 
min, corresponding with the retention time of 
purified 109CdLMt. This indicates that the Cd 
remained bound to CdLMt-1. However, when 
the LMt-1 concentration was lowered, the 
radioactivity of l09Cd redistributed from LMt 
towards endogenous renal Mt (fig 4c and 4d). 
Thus the ratio between KMt/LMt concentration 
determines the final Cd distribution in the renal 
tissue. 
Figure 5 shows the fate of l09CdLMt-l in renal 
homogenates during a 24 hours incubation period 
at 4 °C and at 37 °C. LMt was added at a 
concentration equal to the endogenous KMt 
concentrations. Immediately after incubation of 
CdLMt-1 at 37°C the 109Cd is distributed over 
KMt and LMt-1. After 4 hours of incubation the 
LMt-1 has disappeared while Cd is still bound to 
KMt. The rest of the radioactivity eluted at 25 
min during the wash program. After 24 hours 
neither LMt or KMt was visible anymore and 
the ,09Cd elutes in a broad area between 15 and 
20 min and again during the wash program of 
the column. In contrast, when CdLMt-1 is 
incubated with the renal homogenate at 4°C, the 
redistribution from LMt-1 towards KMt takes 
place very slowly and 24 hours after incubation, 
there is still some of the LMt-1 present in the 
homogenate. Nevertheless, the fact that Cd also 
redistributes at 4°C, indicates that to obtain a 
meaningful result, it is of crucial importance that 
tissue preparation in the in vivo experiments will 
be performed as quickly as possible and under 
ice-cold storage conditions. The 109Cd recovery 
in the heat-treated renal homogenate after 15 
sec., 4 h., and 24.h of incubation was 
respectively 80, 50 and 20 % at 37°C and 80, 75 
and 60 % at 4°C. This shows that at 37 °C after 
degradation of LMt-1, Cd became bound to 
proteins which are not heat-resistant. 
After incubation of intestinal homogenates with 
I09CdCl2 in vitro the Cd ions are mainly bound to 
IMt-2 and not to IMt-1 (Fig. 6a). This is in 
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X radioactivity 
Fig. 4. HPLC elution profiles of renal homogenates after 15 sec. incubation with CdCl2 (4A), or LMT-1 in a 
concentration ratio LMt:KMt of 5:1 (4B), 1:1 (4C) and 1:3 (4D). The area drawn black, co-elutes with LMt-1. 
LMt-1, 4°C, 4 h. LMt-1, 4 °C, 24h 
LMt-1 37°C, 16 n e . 
X radioactivity 
LMt-1, 37-C, 4h LMt-1. 37-C. 24h 
Sd 
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Fig. 5. HPLC elution profiles showing degradation of LMT and KMt in renal homogenates after in vitro 
incubation with LMt-1 (ratio LMt:KMt=l:l) for 15 sec. (5a,d), 4h. (5b,e) and 24 h. (5cJ) at 4°C and 
3TC respectively. The area drawn black, co-elutes with purified LMt-1. For details, see method section. 
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agreement with the fact that IMt-2 is the main 
metallothionein isoform in untreated rats (Fig 1). 
However, the total amount of Cd which was 
bound to endogenous Mt in the intestine (14%) 
is lower than observed for the kidneys (Fig 4a). 
The difference can be explained by the fact that 
the intestinal Mt concentration is twice as as low 
as the renal Mt concentration (see Materials and 
Methods). After addition of 109CdLMt to the 
intestinal homogenate in a LMt/IMt ratio of 5 to 
1 (i.e. LMt concentration 5 times as high as the 
endogenous IMt concentration) the majority of 
the l09Cd remained bound to LMt (Fig 6b). At a 
lower Mt concentration ratio between LMt and 
IMt the ,09Cd is distributed over LMt-1 and IMt-
2 (fig 6c and d). 
Lastly, LMt-1 was incubated with whole blood 
for 30 min. The LMt concentration was equal to 
that in the in vivo experiment after i.v. injection. 
HPLC analysis of the heat-treated blood sample 
revealed one single peak at 12.9 min, which 
indicates that Cd is firmly bound to the LMt in 
the systemic circulation. 
DISCUSSION 
Although ion-exchange chromatography showed 
two main Mt-isoforms in both liver and kidneys 
of rats the renal and hepatic Mt do not behave 
similarly on RP-HPLC; renal Mt-1 and Mt-2 
could not be separated whereas hepatic Mt 
isoforms were complete distinguishable. 
However, the fact that renal Mt isoforms elutes 
on HPLC as one peak at 13 min, allows a 
distinction from hepatic Mt isoform-1 (with a 
retention time of 14.8 min). This advantage also 
applies for the intestine since IMt-2, eluting at 
12.9 min is the main Cd-binding ligand in muco-
sal scrapings and is completely distinguishable 
from LMt-1. The main research objective of the 
present study was to investigate, in one step, the 
metabolic fate of both endogenous and exo-
genous CdMt in intestinal and renal tissue of rats 
which were exposed to low oral or iv doses of 
CdLMt-1. The detection limit of the HPLC 
system for purified Mt-samples is approximately 
0.5 ng Mt based on the UV sig-nal at 215nm. 
However, in samples of whole tissue homogena-
tes the detection limit is decreased to 
approximately 3-4 /tg/injection. Therefore RP-
HPLC in this study was conducted with 
phosphate buffer at neutral pH to be sure that 
metal-thiolate clusters of Mt remain intact 
(Richards and Steele, 1987). Under these 
conditions the sensitivity of the system was 
highly increased by studying the 109Cd elution 
profile in addition to the UV-chromatogram at 
215nm. This approach, to study the difference in 
chromatographic be-haviour by means of the Cd 
elution profile, has been reported to be 
succesfull in distin-guishing species-specific (i.e. 
pig and rat) metallothionein isoforms (Groten et 
al., 1992). Renal Cd accumulation after oral 
chronic exposure to cadmium is due to the 
release of CdMt from intestine and liver into the 
systemic circulation (Dudley et al., 1985; Min et 
al., 1991). After i.v. administration of a low, 
non-toxic dose to rats, CdMt was taken up 
predominantly by the kidneys and the maximum 
concentration was reached within 30 min after 
adminsitration. These results are in agreement 
with studies reported by Nordberg et al. (1975), 
Tanaka et al. (1975), and Dorian et al. (1992). 
After injection of LMt, 80% of the Cd is bound 
to Mt-like proteins, and this percentage 
increased with time. Already 5 min after i.v. 
injection of LMt-1, Cd in the kidneys was no 
longer bound to intact LMt-1 and, within 24 
hours a substantial amount of the Cd in the 
kidneys, released from LMt-1 was bound to 
endogenous renal Mt (KMt). A considerable 
proportion of the Cd was bound to other heat-
resistant compounds which had a retention time 
between 15 min and 20 min on the HPLC 
system, but on a gel-filtration column behaved 
like proteins with a molecular size in the Mt-
range. It seems likely that these Cd binding 
ligands are slightly modified or degraded 
products of endogenous and exogenous 
metallothioneins. This is in line with the fact that 
in vitro a similar concentration of exogenous 
CdMt was degraded in renal tissue homogenates 
within a few hours (Fig 5). The rapid 
degradation of CdMt in vitro seems to be in 
agreement with the results of Webb and Etienne 
(1977) and Min et al. (1992). However the Cd 
exchange between endogenous and exogenous 
Mt is not solely due to degradation of LMt-1 
because Cd was rapidly, i.e. within 15 sec. 
exchanged between LMt-1 and KMt in vitro, 
without the detection of Mt-degradation products 
on the HPLC. The Cd exchange was dependent 
on the ratio between the exogenous Mt ( = LMt) 
and the endogenous Mt (KMt) concentration in 
the tissue. The Cd release from exogenous me-
tallothionein in the present study appears to be a 
faster proces than the Cd release from rat CdMt 
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Fig 6. HPLC elution profile of heat-treated intestinal mucosa after 15 sec. in vitro incubation 
with CdCl2 (6a) or CdLMt-1 with ratio LMt.KMt of 5:1 (6b), 1:1 (6c), 1:3 (6d). 
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as used by Cain and Holt (1983) and Squibb et 
al.(1984). This difference can be explained by 
the fact that the CdMt concentration used was 
much higher than in the present study. Thus, a 
larger proportion of the Cd remains bound, at 
least initially, to the exogenous Mt and in this 
situation the Cd release is determined by the 
gradual degradation of exogenous CdMt (Cain 
and Holt, 1983; Squibb et al., 1984). It 
appeared that the in vitro degradation of exoge-
nous LMt-1 in the present study occurred faster 
(4 hours) than the degradation of the endogenous 
KMt (24 hours). Similar findings have been 
shown by Feldman et al. (1978) and Min et al 
(1986) and it has been suggested that the 
lysosomal degradation of endogenous and 
exogenous CdMt mainly takes place via cystein 
protease (Min et al., 1992). 
At a high oral dose, a proportion of the dietary 
CdMt can pass the intestinal wall and will reach 
the kidneys intact (Cherian, 1979). 
Consequently, the Cd concentration ratio 
between kidney and liver is higher after 
exposure to CdMt than after exposure to 
inorganic Cd salts (Maitani et al., 1984; Groten 
et al., 1991). In the second part of the study the 
intestinal Cd speciation was studied at low oral 
doses of CdMt. For comparison, the Cd disposi-
tion after a similar Cd dose in the form of 
organic Cd-salts was also examined. The intes-
tinal and hepatic uptake of CdCl2 was higher 
than for CdMt, which seems to be in agreement 
with the results of Ohta and Cherian (1991). 
However, the total renal Cd disposition after 24 
hours was similar for both Cd compounds (data 
of CdCl2 not shown). HPLC analysis of the 
intestinal mucosa revealed that a large fraction 
of the Cd from CdMt and CdCl2 elutes in an 
broad area between 15 and 20 min. Rats 
exposed to CdMt showed always more of these 
compounds than rats exposed to CdCl2. Whether 
these Mt derived Cd-ligands can reach the 
bloodstream remains unsolved. These Cd ligands 
have not been identified, but the in vitro 
incubation of LMt-1 in intestinal or renal 
homogenates revealed similar Cd elution 
profiles. Therefore these compounds are 
probably modified or degraded products of 
CdMt with a molecular weight still in the Mt-
range. The Cd binding to endogenous intestinal 
Mt was very constant at all time points and was 
always slightly higher for CdCl2 than for LMt-1. 
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The present result that after exposure to CdCl2 
or CdMt the majority of the Cd is bound to Mt-
like proteins stands in contrast to the results of 
Ohta and Cherian (1991), who showed that Cd 
after exposure to inorganic Cd was predomi-
nantly bound to high molecular weight proteins. 
However, the intestinal Cd absorption in the 
present study was much lower (0.25 /tg/kg 
tissue) and it can be assumed that the intestinal 
Mt pool is sufficient to retain most of the Cd-
ions (Goon and Klaassen, 1989). If we assume 
that LMt-1 has reached the intestine intact 
(Crews et al., 1989), it can be calculated that the 
amount of LMt-1 taken up by the mucosa was 
approximately 6 /ig/gr tissue. This implies that 
the LMt-1 concentration is much lower than the 
IMt-1 content. In this regard, the in vitro 
experiment with intestinal homogenate showed 
that, similar to the in vitro experiment with the 
renal homogenates, Cd rapidly exchanges 
between various isoforms, depending on the Mt 
concentration ratio. It is thus likely that at least 
part of the Cd from dietary CdMt is exchanged 
towards IMt, before degradation of the LMt 
complex has taken place. Further redistribution 
of Cd only takes place after liberation of Cd2+ 
due to degradation of the Mt. 
Thus, both Mt degradation and the Cd exchange 
are important determinants of the Cd-speciation 
in the tissue. For low levels of exogenous CdMt 
the rapid exchange of Cd2+ towards endogenous 
CdMt is the decisive factor in the disposition, 
making its fate similar to that of inorganic Cd 
salts. 
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Abstract-There is a clear lack of information on the toxicological risk of dietary intake of CdMt. 
The present study was intended to establish dose dependent Cd disposition and to investigate 
differences in renal toxicity after long term dietary exposure to cadmium-metallothionein (CdMt) 
or cadmium chloride (CdCy in rats. Male Wistar rats were fed diets containing 0.3, 3, 30 and 
90 mg Cd/kg diet (0.3, 3, 30, 90 ppm) either as CdMt or as CdCl2 for 10 months. In rats fed 30 
and 90 ppm CdCl2 the Cd concentrations in intestine, liver and kidneys were all higher than in rats 
fed the same doses CdMt and the kidney/liver ratio of Cd concentration was higher with CdMt than 
with CdCl2. At the lower Cd concentrations (0.3 and 3 ppm) no differences in Cd accumulation 
between CdMt and CdCl2 fed groups were observed and the kidney/liver Cd ratio was also similar. 
Rats exposed to 3, 30 and 90 ppm Cd showed a significant increase in Cd concentration in liver and 
kidneys both after 4 and 10 months of exposure. When based on the amount of CdMt per milligram 
Cd in the tissue, rats fed CdMt showed a similar relative CdMt concentration in liver and kidney 
to rats fed CdCl2. First signs of renal injury, indicated by an increase of urinary LDH activity were 
seen 4 months after exposure to 90 ppm CdCl2. After 8 and 10 months the renal effect from 90 ppm 
CdCl2 became more pronounced and urinary enzyme activity of LDH, NAG and ALP were all 
elevated. The only clinical effect of CdMt at the dose level of 90 ppm, was a slight increase in 
urinary GGT activity at 8 and 10 months. Determination of ß2-microglobuline in urine did not 
reveal treatment related changes in any of the groups. Histopathological changes (a.o. glomerulo-
nephrosis and basophilic tubules) were observed after 10 months of exposure in rats fed 30 and 90 
ppm CdCl2. Rats fed 90 ppm CdMt also showed slight histomorphological changes, but the effect 
was less pronounced than from CdCl2 and was mainly restricted to the tubules. Thus, no difference 
was observed in renal disposition between CdMt and CdCl2 after long term exposure to low 
(<3ppm) dietary doses. Since the absolute concentration in the kidney is lower after high doses of 
CdMt than after CdCl2, nephrotoxicity seems to be mainly related to total renal Cd concentrations. 
Therefore the health risk of dietary intake of CdMt at environmentally relevant doses (i.e. < 2 ppm) 
seems not be different from the intake of CdCl2. 
INTRODUCTION exposed to inorganic Cd-salts (Groten et al. , 
1990). This correlates well with the fact that the 
Food is the major source of human Cd exposure intestinal and hepatic uptake of Cd after CdMt 
(Robards and Steele, 1991). Since metallothionein exposure is lower than after exposure to CdCl2 
is one of the main Cd binding ligands in animals (Groten et al. , 1991a). However, in spite of the 
(Webb, 1986; Waalkes and Goering, 1991), Cd in lower total uptake of CdMt, the renal Cd accumu-
food of animal origin will largely be present as lation from CdMt is relatively higher than from 
CdMt. However, most oral toxicity studies have CdCl2 (Maitani et al, 1984; Ohta and Cherian 
been performed with inorganic Cd and there is a 1991). Because of the high kidney to liver ratio of 
clear lack of information on the toxicological risk Cd concentration after oral exposure to CdMt it 
of biologically incorporated Cd, viz. CdMt. It has has been suggested that CdMt can pass the 
been shown that signs of toxicity (e.g., anemia intestinal mucosa and can reach the kidneys at 
and hepatotoxicity) in subacute studies are less least partially intact (Maitani et al., 1984; Ohta 
pronounced in rats exposed to CdMt than in rats and Cherian, 1991). This might have implications 
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for human risk from cadmium absorbed from 
animal products since CdMt is known to be a 
potential nephrotoxic compound after parenteral 
administration (Nordberg et al., 1975; Squibb et 
al., 1979; Sendelbach and Klaassen, 1988). The 
differential disposition of CdCl2 and CdMt 
between liver and kidney is less pronounced at 
lower dietary doses, but still large enough in a 
sub-acute experiment to indicate metabolic 
differences between both Cd-forms (Groten et al., 
1991a). Although the kidneys are the critical organ 
after long-term dietary exposure to cadmium, no 
long term studies have been performed clarifying 
the potential risk of kidney injury due to the 
dietary intake of CdMt. Moreover it is unclear 
whether the differential disposition between 
kidneys and liver occurs after long term exposure 
at environmentally relevant Cd levels in the diet. 
The present study was intended to establish the 
dose dependent Cd disposition and to investigate 
differences in renal toxicity after long term dietary 
exposure to CdMt or CdCl2 in rats. 
Gel-permeation and HPLC analysis (see Groten et 
al., 1990, 1992b) revealed that more than 95% of 
the Cd was bound to pig's metallothionein. 
Diets. A semi-synthetic powdered basal diet was 
composed as described previously (Groten et al., 
1990; 1991a). Four diets consisted of the basal 
diet supplemented with CdCl2 and control liver 
and additional zinc, four other diets consisted of 
the basal diet supplemented with the Cd-enriched 
pig liver described above. The diets, providing 
dietary Cd levels of 0, 0.3, 3, 30, 30 mg/kg, were 
prepared five times during the study and each 
batch was stored in sealed plastic bags for 2 
months in a -20° C freezer. Mineral analysis of the 
test diets revealed that under the experimental 
conditions the actual Cd levels were between 85 
and 95 % of the intended levels (table 1). The 
Ca,P, Zn and Fe content of the diet is of crucial 
importance for the outcome of the study (Groten 
et al, 1991b, 1992a). The Fe, Zn, Ca, P content 
of the diets was respectively 70±20ppm, 
65±10ppm, 0.5 + 0.1% and 0.45 ±0.05%. 
MATERIALS AND METHODS 
Test substance. Cadmium chloride, with a purity 
of at least 99 % as specified by the supplier was 
obtained from Merck-Schuchardt (Hohenbrunn, 
FRG). 
Preparation of CdMt incorporated in pig's liver. 
Thirteen male pigs, initially weighing 76 ± 7.5 
kg, were housed separately in metabolism cages. 
The animals were injected intravenously (vena 
jugularis) with CdCl2, dissolved in saline 
according to the following schedule: on Days 0, 2, 
4, 7, 9, 10, 11 an 12 with 0.6 mg/kg, on Days 
14 and 15 with 1 mg Cd/kg, Day 16 with 1.3 
mg/kg, Days 17, 18 and 20 with 1.5 mg Cd/kg, 
and again on Day 20 and Day 22 with 2.5 mg/kg 
body weight. 
Two days after the last injection the animals were 
killed under pentobarbital anaesthesia and the 
livers were removed. The livers were pooled, 
homogenized, Iyophilized and stored in plastic 
sealed bag at -30° C. Livers obtained from 
untreated pigs (public slaughter house) were 
handled in the same way. Mineral analysis of the 
freeze dried liver samples revealed that the Cd, 
Zn, Fe and Ca content was 2000, 820, 555 and 
190 ppm in the Iyophilized liver of Cd-treated pigs 
and 0.45, 205, 600 and 170 ppm in the liver of 
control pigs. 
Animals and maintenance. Albino, male rats, 
Wistar outbred (Hsd/Cpb:WU), were obtained 
from a colony maintained under SPF-conditions at 
Harlan/CPB (Austerlitz, NL). At the beginning of 
the study the rats were 9-10 weeks old. They were 
housed under conventional conditions in suspended 
stainless-steel cages fitted with a wire-mesh floor 
and front. The room temperature was maintained 
at 22 ± 3 °C and the relative humidity at 40-70% 
with a 12- hr light/dark cycle. During an 
acclimatization period of 10 days the rats were fed 
the basal diet with no further additions. Drinking 
water was supplied in glass bottles which were 
cleaned once weekly. Food and water were 
provided ad libitum. Food/water intake was 
measured by weighing the feeders/bottles. 
Experimental design. The rats were allocated by 
weight into 9 groups of 20 animals using a 
computer-generated random number table. Each 
treatment group (housed in groups of five) 
received one of the nine diets for 10 months. 
Autopsy was performed after 2, 4, 6 and 10 
month of exposure on respectively 3, 6, 3 and all 
remainding rats ( = max. 8). Clinical chemistry 
was performed after 4 and 10 months and urine 
analyses were carried out after 4, 6 and 10 months 
General observations. Food and water 
consumptions were measured 10 times during the 
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study at weekly intervals in order to establish any 
differences in Cd dose between CdMt or CdCl2 
exposed rats. 
Fig. 1. Experimental design of the study. Rats were 
fed for 10 months Cd diets containing 0, 0.3, 3, 30 and 
90ppm Cd as CdCl2 or Cd-MetaOothionein. For further 
details see Materials and methods 
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Clinical chemistry. At autopsy on day 112 and day 
294 heparinized blood samples collected from the 
abdominal aorta of all rats were centifuged at 1250 
g for 15 min, using Sure-sep II dispensers 
(General Diagnostics, The plasma was then 
analysed for alkaline phosphatase (ALP), aspartate 
(ASAT) and alanine amino transferase (ALAT), 7-
glutamyl transpeptidase (GGT), lactate dehydroge-
nase (LDH) activity and for albumin, urea and 
Creatinin. Analyses were performed on a Cobas-
Bio Centrifugal Analyzer using Baker and 
Boehringer reagent kits. 
Urinalysis. On days 106, 218, and 287 six 
rats/group were acclimatized for two days to wire-
mesh metabolic cages. Thereafter, urine was 
collected in ice-cooled beakers for two 24 hrs. 
periods. Water and food was provided ad libitum. 
After collection, urine of both days was pooled, 
vigorously mixed and the following determinations 
were made: volume, pH, creatinine, total protein, 
alkaline phosphatase activity (ALP), lactate 
dehydrogenase activity (LDH) and 7-glutamyl 
transferase activity (GGT), N-Acetyl-ß-D-
glucosaminidase (NAG) activity and ß2-
microglobine. ß2-microglubuline was measured at 
the Catholic University of Louvain (Belgium) 
according to the method of Viau (et al., 1986). 
Except NAG and microglobulin all analyses were 
performed on a Cobas centrifugal analyzer using 
Baker and Boehringer reagent kits. NAG was 
performed colorimetrically using a Boehringer 
reagent kit. Urine concentration ability was tested 
1 week after urinalysis. For that purpose rats were 
deprived of water for 24 hours and urine was 
collected during the last 16 hours of the 
deprivation period to determine volume and 
density. 
Cd analysis and pathology. On day 56 and day 
168 animals of each group were killed by 
exsanguination from the abdominal aorta while 
under light ether anesthesia and necropsied. 
Immediately after evisceration the kidneys, small 
intestine and liver were weighed and the medulla 
of one kidney was removed for metal analysis. 
The intestines were rinsed with phosphate buffered 
saline as described previously (Groten et al., 
1991a) and part of the duodenum and ileum were 
removed for metal analysis. Cd analysis was 
performed as described previously (Groten et al., 
1991b). 
In addition to this procedure, on days 112 and 294 
one liver lobe and cross sectional parts of one 
kidney were fixed in 4% neutral phosphate 
buffered formaldehyde solution. The tissue 
samples were processed and embedded in 
paraplast, sectioned 4 /tm, stained with 
haematoxylin and eosin, and then microscopically 
examined. The rest of the tissue samples were 
frozen in liquid nitrogen and finally stored at 
-80 °C for metallothionein analysis. 
Metallothionein analysis. Samples of liver and 
kidney were thawed and after homogenization with 
a teflon pestle in a 10 mM Tris-HCl buffer (pH 
7.4, 4°C), the homogenates were centrifuged 
(9,000g for 20 min) and the supernatant used for 
CdMt analysis. The tissue level of CdMt was 
determined by the Cd-hemoglobin assay as 
modified by Eaton and Toal (1982). From the 
resulting mean values (duplicate per animal), the 
concentration of Mt was calculated using a molar 
apo-Mt:Cd ratio of 1:7 (Winge and Miklossy, 
1982). Mt concentration was determined after 4 
and 10 months of exposure. 
Statistical Analysis. Data on body weights were 
evaluated by a one way analysis of covariance 
(covariate: body weight at the start of the 
treatment) followed by Dunnet's multiple 
comparisons tests. The laboratory determinations 
and organ weights were evaluated by a one-way 
analysis of variance, followed by Dunnet's mul-
tiple comparison tests. Histopathological changes 
were evaluated by Fisher's exact probability test. 
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RESULTS 
General condition and behaviour of the rats was distribution of Cd to kidneys and liver after 
normal during the study. Body weight gain and feeding of CdCl2 and CdMt. After 10 months a 
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FIG. 2. Time dependent Cd concentrations in small intestine, liver and kidneys after oral exposure to 0.3, 3, 30 and 90ppm CdCl2 
or CdMt. Values represent the mean ± S.D. (n—3, 6, 3 and 8 for respectively month 2, 4, 6, and 10). All values marked with 
an "*" in the groups fed CdMt differ significantly from the groups fed CdCl2 of a corresponding dose. (*o p<0.05, **oo 
p<0.01). Fig.lA=Intestine, 2B=Liver, 2C=Kidneys. 
food consumption were similar in all groups (data 
not shown). Figure 2 shows that feeding of CdCl2 
or CdMt produced a dose- and time-dependent 
increase of the Cd concentration in all organs. At 
the dietary Cd level of 0.3 ppm the time 
dependent increase of the Cd content in the organs 
was less obvious than at the higher dose levels and 
the difference in Cd concentration with the control 
animals was not statistically significant. At dietary 
Cd levels of 0.3 and 3 ppm there were no 
consistent differences in Cd disposition between 
CdCl2 and CdMt. In contrast, at dietary Cd 
concentrations of 30 ppm and 90 ppm the Cd 
disposition in the organs was much higher after 
feeding of CdCl2 than after feeding of CdMt 
(Fig.2). This effect was most pronounced in the 
liver. Figure 3 illustrates the difference in the 
higher Cd concentration was achieved in kidneys 
than liver at all dietary Cd levels. However, the 
ratio of kidney/liver Cd concentration was 
inversely proportional with dose. Thus, as the oral 
dosage increased, more Cd was found in the liver 
and as a result the kidney/liver ratio of Cd 
concentration decreased. Moreover, at the dietary 
concentration of 30 and 90 ppm the Cd ratio was 
higher in rats fed CdMt than in rats fed CdCl2. At 
the lower dietary doses of 3 and 0.3 ppm there 
was no significant difference between both Cd 
forms in differential Cd disposition between liver 
and kidneys. Table 1 shows that the endogenous 
metallothionein concentration of control kidneys 
was almost three times as high as in liver. Tissue 
Mt levels appeared to be rather constant between 
the 4th and 10th month of the experiment. Rats 
exposed to 30 and 90 ppm Cd showed a significant 
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increase in Mt concentration both after 4 and 10 
month of exposure. Mt induction was dose- and 
time-dependent, however the Cd concentration in 
the organs at the dose level of 0.3 ppm was not 
sufficiently high to cause Mt induction. 
2C. kidney 
1 I control 
10 2 
exposure (months) 
Mt induction in liver was higher than in the 
kidneys. This is also illustrated in Fig.4 which 
shows the relationship between the Cd and Mt 
concentration in liver and kidneys after 10 month 
of exposure to CdMt or CdCl2. When based on the 
amount of Mt per milligram Cd in the tissue rats 
fed CdMt showed a similar relative Mt concent-
ration to rats fed CdCl2. 
The first renal changes in the study were seen 
after 4 months of exposure. At that time, rats fed 
90 ppm CdCl2 showed an increase in the LDH 
enzyme activity in the urine (Fig 5). Figure 5 
shows the total mean enzyme excretion per rat per 
24 hours, but similar results were seen when 
enzyme excretion was expressed per amount of 
creatinine or total protein. The mean renal cortical 
Cd concentration in these rats was 80 mg/kg (cf. 
Fig.2). After 8 months of exposure the effect in 
the 90 ppm CdCl2 became more pronounced and 
both LDH and NAG as well as the brush border 
enzyme ALP were elevated in urine samples of the 
rats. At none of the other dose levels any 
significant increase in these urinary enzyme levels 
was observed. It must be emphasized that the 
blood plasma enzyme levels of ALP, LDH, GGT 
did not show any differences between control and 
Cd-treated animals, indicating that the enzymatic 
changes in urine are kidney-related. In rats fed 90 
ppm Cd as CdMt the urinary ALP excretion seems 
to be elevated at all time points, although the 
effect was never statistically significant due to the 
high interindividual variation. The only significant 
clinical effect in urine samples of CdMt treated 
rats was a small (but significant and consistent) 
increase in the GGT activity, an effect which was 
not observed after CdCl2 treatment. In spite of the 
observed enzymuria in the rats fed 90 ppm CdCl2 
none of the rats showed changes in their ability to 
concentrate urine (data not shown). ß2-
microglobulin was measured as a potential early 
indicator of low molecular weight proteinuria 
(Bernard et al, 1991). However, the 
interindividual variation in ^-microglobulin levels 
observed in male rats were too large for this 
measurement to reveal treatment-related changes 
(data not shown). 
Cd in diel (mg/kg diet) 
Fig. 3. The ratio between kidney and liver Cd 
concentrations of rats fed CdCl2 or CdMt for 10 month. 
Values represent the mean ± SE of 8 individually 
calculated Cd ratio's. 
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Table 1. Metallothionein concentrations in liver and kidneys of rats after 4 and 10 month of exposure to CdCl2 
or CdMt. Every value is the mean of 6 rats ± S.D. All values marked with an "*" differ significantly from the 
controls. Values marked with an "o" in the groups fed CdMt differ significantly from the groups fed CdCl2 of a 
corresponding dose (°p<0.05, "°°p<0.1). 
Control 
0.3 ppm CdCl 
3 ppm CdCl 
30 ppm CdCl 
90 ppm CdCl 
0.3 ppm CdMt 
3 ppm CdMt 
30 ppm CdMt 
90 ppm CdMt 
MONTH 4 
Liver 
16.47±2.71 
16.88±2.46 
21.76±5.97 
84.17 + 18.95" 
306.0+78.69** 
17.15 + 1.63 
26.58 + 9.97 
58.53 ±14.74 
111.21+9.84**°° 
Kidney 
47.14±4.35 
48.49±3.51 
55 + 13.39 
158+47.74** 
283.93+64.35** 
55.45 + 39.12 
62.4 + 14.34 
177.64+43.48** 
219.31+28.23**° 
MONTH 10 
Liver 
16.67±3.08 
20.27 + 3.3 
26.8 + 10.26 
190+22.62** 
814+96.56** 
19.57 + 3.13 
25.19+5.43 
101.95 ±49.7**°° 
243+61.3**°° 
kidney 
63.3 + 16.49 
87.7+9.65 
70.81 + 18.41 
267.34 + 4.22** 
545.6 + 273.7** 
77.17 + 8.0 
85.21 + 10.0 
229.59 + 14.3** 
383.27+47.3**° 
FIG. 4. Relationship between Mt concentration and Cd 
accumulation in liver and kidneys of rats fed 0.3, 3, 
30 and 90 ppm as CdCl2 or CdMt for 10 months. Data-
points represent the mean Cd and Mt values of six rats. 
IMt] ug/g tlssu» 
[Cdl mg/kg tissue 
-CdCI2 - o - CdMt 
IMt) ug/g t luu» 
1 10 100 
[Cd] mg/kg tissue 
Histopathological examination of kidneys after 4 
months could not reveal treatment related 
differences. However, after 10 months of exposure 
animals fed 30 ppm CdCl2 showed an increase of 
basophilic tubules in the renal cortex. This effect 
was more pronounced at the 90 ppm level (Fig 6). 
Rats fed 90 ppm CdMt also showed an increase in 
basophilic tubules and there was no significant 
difference in the incidence of basophilic tubuli 
between CdMt and CdCl2. In addition, rats 
exposed to 30 or 90 ppm CdCl2 showed a dose-
related increase in signs of glomerular nephrosis 
(Fig. 6). The effect on the glomerulus was also 
seen in rats fed 90 ppm CdMt, but much less 
pronounced than in rats fed CdCl2. One rat fed 90 
ppm CdCl2 showed focal peyelitis. In liver no 
abnormalities were detected in the highest dose 
groups and moreover plasma ASAT and ALAT 
enzyme activity appeared to be normal. 
DISCUSSION 
In a previous 4-week feeding study in rats it was 
shown that after dietary exposure to CdMt the 
kidney/liver ratio of the Cd concentration is higher 
than after CdCl2 intake (Groten et al., 1991a). 
1000 Moreover, the renal metallothionein and Cd-
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Fig. 5. Urinary enzyme excretion of rats fed 0, 30 and 90ppm CdMt or CdCl2 after 4, 8 and 10 month of exposure. 
Values represent the mean ±SDof6 rats. Values marked with asterisk differ significantly from the control group. 
LDH=Lactate dehydrogenase, GGT=y-glutamyl transpeptidase, ALP=Alkaline phosphatase, NAG=N-acetyl-ß-
glucosaminidase. Co=control, 30/90 Mt=30/90 CdMt, 30/90Cl= 30/90 CdCl2. 
concentration were almost similar for both CdCl2 
and CdMt in spite of the lower intestinal uptake of 
Cd from CdMt. These findings support the theory 
(Cherian et al., 1979; Otha and Cherian, 1991) 
that some of the exogenous CdMt passes the 
intestinal barrier and reaches the kidneys directly. 
Since CdMt is a potent nephrotoxic agent when 
injected intravenously (Nordberg et al., 1975; 
Squibb et al., 1979), this indicates that dietary 
CdMt might be a reason for health concern. 
However, in the same study it was also seen that 
the differences in renal Cd distribution between 
CdMt and CdCl2 became smaller at lower oral 
doses (Groten et al., 1991a). The results of the 
present study show that the difference in renal 
disposition between CdCl2 and CdMt is dose-
dependent and does not occur at low dietary Cd 
doses (0.3 and 3 ppm Cd in diet). This is an 
important result from which the conclusion can be 
drawn that after long term exposure at environ-
mentally relevant dose levels there will be 
no difference in accumulation between inorganic 
and organic Cd. Although the mechanism behind 
the intestinal uptake of Cd is not clear, it is 
assumed that at low oral CdCl2 doses, the majority 
of the Cd will be bound to the endogenous 
metallothionein of the intestine. This CdMt 
complex will be released into the systemic 
circulation and subsequently, similar to 
intravenously injected CdMt (Tanaka et al., 1975), 
will reach the kidneys (Lehman and Klaassen, 
1986; Ohta and Cherian, 1991). It has been shown 
that pre-induction of intestinal Mt with zinc indeed 
causes a higher selective renal Cd accumulation 
(Min et al., 1991). Moreover, the immunological 
identification of intestinal metallothionein in the 
blood plasma (Elsenhans et al., 1991) supports the 
theory that intestinal Mt is indeed released into the 
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Fig. 6A. Control kidney after 295 days, normal 
glomerulus and tubules, H&E staining 
x250 
Fig. 6B. Basophilic tubules (arrow heads) and 
some cellular detritis in lumen of 
tubules in the medullary of a rat 
kidney after 295 days of feeding 90 
ppm CdCl2. 
Fig. 6C. Glomerular nephrosis, consisting of 
sclerosis of Bowmans capsule and the 
mesangium of the glomerular tufts, 
and some basophilic tubules of a rat 
kidney after 295 days of feeding 90 
ppm CdCl2. H&E staining, x250. 
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systemic circulation. After intake of dietary CdMt 
part of this metal-protein complex reaches the 
intestine as a metallothionein-likeprotein (Cherian, 
1979; Crews et al., 1989), where it might be taken 
up by endocytosis (Ohta and Cherain, 1991). The 
remainder of the CdMt however, will be degraded 
(Feldman et al., 1978; Klein et al., 1986) and the 
Cd will presumably follow the usual metabolic 
route and becomes bound to endogenous CdMt. 
Recently it has been shown that after addition of 
exogenous CdMt to homogenates of the intestine, 
the cadmium from exogenous CdMt redistributes 
to endogenous metallothionein. The extent of Cd 
binding to the two Mt isoforms depends on the 
ratio of their concentrations (Groten et al., 1992b). 
This implies that at environmentally relevant Cd 
doses the transport form of CdCl2 and CdMt 
across the intestinal wall is similar, which explains 
the similar Cd disposition observed for both CdCl2 
and CdMt in the present study. In addition, it has 
been shown that iron not only protects against the 
Cd uptake from CdCl2 (Groten et al., 1991a), but 
iron is also effective against the intake of Cd from 
CdMt (Groten et al., 1992a).The fact that iron 
protects against CdMt indicates that Cd from 
dietary CdMt shows the same metabolic behaviour 
as dietary inorganic Cd. 
In the present study there is a clear relationship 
between renal Cd concentration and renal damage. 
Clear signs of renal damage (i.e. enzymuria, 
tubular damage and glomerulo nephrosis) were 
mainly detected in rats exposed to 90 ppm CdCl2 
and all effects became more pronounced during 
the course of the study. Except for the slight 
increase in urinary GGT all other signs of renal 
impairment, as observed after CdCl2 treatment, 
were much less pronounced after feeding of 90 
ppm CdMt. The finding that 90 ppm CdCl2 clearly 
affected the kidneys whereas 90 ppm CdMt does 
not, can be explained by the fact that the renal Cd 
concentration was much lower for CdMt than for 
CdCl2 (after 10 months; 60 and 170 mg/kg tissue 
respectively). However, the renal Cd concentration 
due to feeding of 90 ppm CdMt is almost similar 
to the renal concentration after feeding of 30 ppm 
CdCl2 (after 10 month; 56 mg/kg tissue) and in 
both cases similar slight histomorphological 
changes were observed, but no significant 
enzymuria. This finding implies that in contrast to 
intravenous CdMt and CdCl2 (Sendelbach and 
Klaassen, 1988) renal effects of oral administered 
CdMt and CdCl2 are dependent on the difference 
in degree of Cd accumulation in the tissue. 
In the present study a series of renal functional 
tests have been applied, but some of the tests did 
not reveal renal damage or impairment of the renal 
function. For instance, low molecular weight 
proteinuria is one of the most characteristic signs 
of Cd-induced renal dysfunction (Kjellström et al. 
1986). However in animal studies the 
immmunochemical quantitation of individual 
urinary proteins such as ß2-microglobulin has 
rarely been used (Bernard and Lauwerijs, 1991). 
In the present study it was not possible to measure 
any increases in ß2-microglobulin due to the high 
interindividual variation in excretion between male 
rats of this strain and age. Thus, quantitation of 
LMW proteinuria seems not be the most efficient 
approach to detect renal lesions in aged, male rats. 
In addition, it has been hypothesized that the 
urinary concentration ability and kidney weight are 
more sensitive indicators of nephrotoxcity in 
subacute studies than enzymuria (Kluwe et al., 
1986). The results of the present do not support 
this hypothesis, since the urinary concentration 
ability of the Cd-treated rats was not affected after 
4 months whereas the LDH activity in the urine 
was significantly increased. The enzymuria in rats 
fed 90 ppm CdCl2 became more pronounced after 
8 and 10 months of exposure as was indicated by 
a marked increase of urinary LDH, ALP and 
NAG. The urinary excretion of kidney derived 
enzymes has proved to be a reliable indicator of 
kidney toxicity in rat studies (Watanabe et al., 
1980; Hofmeister et al., 1986; Stonard et al., 
1990). However, there are few data available 
comparing the histopathological changes of Cd 
nephropathy with the values of urinary enzyme 
excretions. In this regard, the oral Cd study of 
Gatta (et al., 1989) might indicate that changes in 
urinary enzyme values are in accordance with 
histological findings. 
The rather unspecific distribution of intracellular 
enzymes such as LDH and NAG along the 
nephron (Guder and Ross, 1984), makes it diffi-
cult to determine the exact site of renal injury, 
although the pathological changes in the 
glomerulus indicated that injury was not only 
restricted to the proximal tubule. In contrast to 
rats fed 90 ppm CdCl2 the rats fed 90 ppm CdMt 
did not show increased LDH or NAG activity 
during that time, but instead these rats showed a 
very slight, but significant increase in urinary 
GGT activity. GGT is similar to ALP a brush 
border enzyme localized on the proximal tubule 
cell, but in contrast to ALP it is localized more 
specifically towards the end (straight part) of the 
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proximal tubule. The effect of oral CdMt on the 
brush border enzyme in the straight part of the 
proximal tubule cell seems to differ from the 
effect of intravenous CdMt since it has been 
shown that effect intravenous CdMt is more 
restricted towards the convoluted part of the 
proximal tubule (Cherian et al., 1976; Webb and 
Etienne, 1977; Dorian et al., 1992). Based on the 
pattern of enzymuria and pathology and in 
agreement with the findings of intravenous CdMt 
studies, it seems however that the effect of dietary 
CdMt is more restricted towards the proximal 
tubule whereas CdCl2 affects both the tubules and 
the glomeruli. 
The most important conclusion which can be 
drawn from the present study is that there is no 
indication that CdMt in spite of its higher 
kidney/liver Cd ratio is more nephrotoxic than 
CdCl2 at high Cd doses. Furthermore, the 
selective renal disposition of dietary CdMt does 
not occur at low dietary doses and the renal Cd 
levels at low dietary Cd doses are similar for both 
Cd forms. Therefore dietary intake of CdMt at 
environmentally relevant doses ( < 2 ppm in diet) 
seems not be more of a health risk than the intake 
of the inorganic form of Cd. 
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SUMMARY AND CONCLUDING REMARKS 
SUMMARY AND CONCLUDING REMARKS 
In Chapter 1 of this thesis a general intro-
duction is presented with a survey of the literatu-
re. It gives a brief overview of the factors invol-
ved in the absorption, metabolism and toxicity of 
Cd after oral intake. 
In short, the main source of environmental 
exposure to cadmium for nonsmokers is food. 
Oral Cd-studies in rodents have shown that the 
Cd-dose, the Cd-speciation and the mineral 
composition of the diet have an enormous impact 
on the final absorption and organ distribution of 
Cd. Although most toxicity studies have been 
performed with inorganic Cd, this is clearly not 
the chemical form in which Cd occurs in the 
diet. In animals one of the main Cd-binding 
ligands is the protein metallothionein, an induci-
ble, cysteine-rich protein of low molecular 
weight. In plants the main Cd-binding ligands 
are phytochelatins, proteins wich are functionally 
analogous to metallothioneins. Metallothioneins 
can survive, at least partially, the gastro-intesti-
nal digestion. It has been suggested that some of 
the exogenous Mt passes the intestinal barrier 
and reaches the kidneys directly. Since CdMt is 
a potent nephrotoxic agent when injected intrave-
nously, this might indicate that dietary CdMt 
gives more reason for health concern than inor-
ganic Cd. However, information on the bioavai-
libility and toxicity of dietary CdMt is currently 
lacking. Therefore the objectives of this thesis 
were: 
- To compare toxicity of inorganic Cd and CdMt 
in rats and in cell cultures of target organs, 
- To compare the dose-dependent kinetics of Cd-
uptake from CdMt and inorganic Cd. 
- To establish differences in metabolic pathways 
between CdMt and CdCl2 to predict disposition 
and toxicity at environmentally relevant doses. 
The studies described in Chapter 2 and 
Chapter 3 examined the toxicity and disposition 
in rats fed diets containing either pig's liver 
incorporated Cd or cadmium salt for 4 weeks. 
For a meaningful interpretation of the results the 
cadmium-binding ligand in pig's liver was first 
identified as a mixture of two metallothionein iso 
forms. The identification was based on mole-
cular weight, Cd-binding properties, heat-stabili-
ty and spectral analysis. It appeared that over 
90% of the Cd present in the pig's liver was 
bound to metallothionein. It was shown that 
signs of toxi-city (e.g. anemia and hepatotoxici-
ty) were less pronounced in rats exposed to 30 
ppm Cd as CdMt than in rats exposed to a simi-
lar dose of inorganic Cd-salt. The fact that CdMt 
is less toxic than CdCl2 correlates well with the 
finding that the intestinal and hepatic uptake of 
Cd after exposure to 30 ppm Cd as CdMt was 
lower than after exposure to 30 ppm Cd as 
CdCl2. However, in spite of the lower total 
uptake of CdMt, the renal Cd accumulation from 
CdMt was relatively higher than from CdCl2. 
Thus, the kidney to liver ratio of Cd concentrati-
on was significantly higher in rats fed CdMt 
than in the rats fed CdCl2. Since it is well 
known that CdMt after intravenous administrati-
on preferentially accumulates in the kidneys, the 
results might suggest that CdMt can pass the 
intestinal barrier and is released in the systemic 
circulation. This was supported by the fact that 
the metallothionein concentration in the kidneys 
in the first week of the experiment was higher 
after exposure to CdMt than after exposure to 
CdCl2. However in the introduction (Chapter 1) 
we have emphasized that rats exposed to low 
doses of CdCl2 show, similar to dietary CdMt, a 
selective renal Cd accumulation, which was 
indicated by their high kidney/liver Cd ratio. 
Indeed, the study of chapter 3 revealed that at 
lower dietary Cd levels (1.5 and 8 ppm), relati-
vely more Cd is deposited in the kidneys than at 
the 30 ppm level. The difference between the 
differential disposition of CdCl2 and CdMt be-
tween kidneys and liver was less pronounced at 
the lower doses, but even at these doses the kid-
ney/liver ratio of Cd is still higher with CdMt 
than with CdCl? In the discussion the question 
was raised of what the impact of Cd redistributi-
on from liver to kidneys will be during long-
term oral intake in the final level of renal intoxi-
cation. This question was adressed to in chapter 
8. 
Chapter 4 presents a comparative study on the 
accumulation and toxicity of CdCl2 and two 
isoforms of CdMt in cell lines and primary 
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cultures of the intestine, liver and kidneys. 
Exogenous CdMt added to the culture medium 
was much less toxic to all cells tested than CdCl2 
and no cell type was specifically sensitive to 
CdMt. Even when the Cd-content of CdMt was 
artificially raised (5 mol Cd/mol Mt), the cells 
were not affected by CdMt treatment. In general 
the difference in cytotoxicity between CdMt and 
CdCl2 corresponds well with the difference in 
cellular uptake of Cd. This is in agreement with 
the in vivo results described in chapter 2, 3 and 
8, showing a difference in toxicity between CdMt 
and CdCl2 due to a difference in uptake and 
organ distribution. 
The studies described in Chapter 5 and 
Chapter 6 deal with the influence of minerals 
on the Cd absorption from CdCl2 and CdMt. 
Most investigations have focused on single Cd-
mineral interactions, and no real attemps have 
been made to compare the actual mineral status 
of other trace elements in the same study. Eight 
minerals were taken into account, all of which 
had been suggested to interact with the Cd accu-
mulation in the body. The mineral combinations 
were chosen such that the effect of individual 
components could be analysed with multiple 
analyses of variance. The protection against Cd-
accumulation and toxicity by mineral combinati-
ons was mainly due to the presence of iron (Fe). 
The question whether the protective effect of 
iron also applies for organic Cd, was examined 
in the study of chapter 6. Rats were fed CdMt 
supplemented with a mineral mixture of Ca/P, 
Zn and Fe which according to the observations 
in chapter 5 was the most effective against Cd 
accumulation. The total uptake of Cd from 
CdMt was significantly decreased although the 
protection of the mineral mixture was lower than 
for CdCl2. Since the Cd accumulation is mainly 
influenced by Fe and not by other minerals, the 
studies of chapter 5 and 6 raise the question 
whether the intestinal transport of Cd in rats is 
specifically mediated by the Fe transfer system. 
The fact that the mineral supplement also pro-
tects against CdMt, albeit less pronounced than 
against CdCl2 might be explained by the partial 
degradation of CdMt in the gastrointestinal tract. 
Once degraded, Cd from CdMt will show the 
same metabolic behaviour as inorganic Cd-salt 
and the uptake in liver and kidneys will be de-
creased by mineral suppletion. However a small 
fraction of the ingested CdMt is not degraded 
and it seems that the mineral supplement does 
not affect the absorption of the intact exogenous 
CdMt, which will then reach the kidneys unham-
pered. This explains why the kidney/liver ratio 
of Cd concentration was higher in the rats fed a 
CdMt diet supplemented with Fe in comparison 
to rats fed a CdCl2 diet supplemented with Fe. 
After addition of the mineral supplement, rats fed 
CdCl2 or CdMt showed relatively more Cd accu-
mulation in the kidneys than in the liver. Since 
addition of the mineral supplement decreases the 
Cd absorption, it will prevent to some extent the 
overload of the intestinal metallothionein pool 
(see chapter 3) and as a consequence the kid-
ney/liver ratio will increase. 
Chapter 7 deals with the metabolic fate of 
endogenous (synthesized by tissue) and exoge-
nous (taken up by tissue) CdMt. Purified Mt 
isoform 1 and 2 from liver and intestine eluted 
as two single peaks on RP-HPLC. However, 
both kidney isoforms eluted as one single peak. 
The fact that renal Mt isoform-2 was not separa-
ted on HPLC and the fact that intestinal Mt-
isoform 2 is hardly present in control rats, offers 
the unique possiblity to study the metabolic fate 
of purified CdMt isoform 1 in intestine and 
kidneys. A rapid exchange of l09Cd from exoge-
nous CdMt (=hepatic 109CdMt isoform 1) to-
wards endogenous CdMt was shown in the 
kidney and the intestinal mucosa after in vivo 
and in vitro addition of exogenous CdMt. The 
Cd redistribution was dependent on the ratio 
between the endogenous and exogenous CdMt 
concentration. Only if the oral or intravenous 
exposure to exogenous CdMt is high enough to 
lead to high exogenous/endogenous CdMt ratio, 
the 109Cd remains principally bound to exogenous 
CdMt in the intestinal mucosa and kidney. If we 
consider that at environmentally relevant Cd 
doses (less than 2 ppm in the diet) the exogenous 
CdMt concentration is much lower than the 
endogenous CdMt content, this implies that at 
low dietary CdMt doses Cd will mainly be bound 
to endogenous, intestinal CdMt and other (high 
molecular weight) Cd binding proteins. 
Finally, a long-term feeding study was perfor-
med and the results are given in Chapter 8. It 
was shown that the kidney/liver ratio of Cd 
concentration was inversely proportional with 
dose. Thus as the oral dosage increased, relati-
vely more Cd was found in the liver than in the 
kidneys. At the dietary concentration of 30 and 
90 ppm the Cd ratio was higher in rats fed 
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CdMt than in rats fed CdCl2. However, at low 
dietary concentrations (0.3 and 3 ppm) the diffe-
rence in renal disposition between CdCl2 and 
CdMt did not occur. The first signs of renal 
injury indicated by slight signs of enzymuria 
were seen in rats exposed to CdCl2. Gradually 
the effects became more severe and histopatholo-
gical changes were observed (i.e. glomerulo-
nephrosis and an increase in basophilic tubules). 
The finding that 90 ppm CdCl2 induced slight 
renal dysfunction whereas 90 ppm CdMt does 
not can be explained by the fact that the renal 
Cd concentration after 10 months was much 
lower for CdMt than for CdCl2 (60 mg/kg tissue 
and 170 mg/kg tissue respectively). These fin-
dings imply that in contrast to intravenous admi-
nistered CdMt and CdCl2 renal effects of oral 
administered CdMt and CdCl2 are dependent on 
the difference in degree of Cd accumulation in 
the tissue. Thus, there is no indication that CdMt 
in spite of its higher kidney/liver Cd ratio at 
high oral doses is more nephrotoxic than CdCl2. 
To discuss the consequences for human consu-
mer it will be essential to take into account 
all metabolic routes. Figure 1 shows in a simpli-
fied model the major metabolic routes of Cd 
after oral intake of CdCl2 or CdMt. The model 
is based on the results of this thesis together 
with available information from the literature. 
Fig 1A depicts the metabolic pathways after oral 
exposure to CdCl2. At low oral CdCl2 doses the 
majority of the Cd will be bound to the endoge-
nous metallothionein of the intestine, which will 
be released in the systemic circulation and then 
be deposited in the kidneys. At a high oral 
CdCl2 dose the available endogenous intestinal 
Mt pool is overloaded and Cd will be bound to 
high molecular plasma proteins and then be 
deposited in the liver. Cd will be bound to hepa-
tic CdMt and with time some of the hepatic 
CdMt will reach the kidneys. 
1A: Intake of CdCI, 1B: Intake of CdMt 
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Fig. 1. Simplified presentation of metabolic pathways for CdCl2 and CdMt after oral exposure in rodents as 
concluded from the studies in this thesis. Arrows marked with a number represent metabolic routes. 
G.I.LUMEN = gastro-intestinal lumen, INT.MUCOSA=Intestinal mucosa, DMT= Dietary MT, IMT= Intestinal 
MT, LMT =hepatic MT, KMT= renal MT, HMW= High molecular weight proteins. 1A. Oral exposure to 
CdCl? At low dose; route 1 < route 2, at high dose; route 1 > route 2. IB. Oral exposure to CdMt: At low 
dose; route 2 > route 1 and route 3 is not present, at high dose; route 1 > route 3 > route 2. 
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Fig. IB. shows the metabolic routes of Cd after 
oral exposure to CdMt. A large part of the 
CdMt will not survive the gastro-intestinal dige-
stion and "liberated" Cd will show the same 
metabolic behaviour as Cd-salts. This explains 
why Fe interacts with the uptake of CdMt. Mo-
reover at low dietary CdMt doses, the Cd from 
dietary CdMt which has reached the intestinal 
mucosa, is quickly redistributed towards endo-
genous CdMt. This implies that at environmen-
tally relevant Cd doses the transport form of 
CdCl2 and CdMt across the intestinal wall is 
similar (cf. Fig 1A). The similar Cd disposition 
observed for both CdCl2 and CdMt in chapter 8 
after long term exposure to low ( < 3 ppm) dieta-
ry doses is in agreement with this theory. At a 
high oral dose of CdMt relatively more CdMt 
will survive the gastro-intestinal digestion and 
more CdMt will reach the intestine intact. In this 
case it is plausible that exogenous CdMt is pre-
sent in excess and Cd will remain bound, at least 
initially, to the dietary CdMt in the intestinal 
mucosa. Subsequently, the dietary CdMt will, 
similar to endogenous CdMt, be released in the 
systemic circulation and taken up in the kidneys. 
Thus at high oral Cd doses the metabolic routes 
of CdCl2 and CdMt will differ. 
The critical renal Cd concentration used in the 
risk assessment of Cd is in part based on labora-
tory animal experiments with inorganic Cd-salts. 
However, man is generally exposed to low diet-
ary levels of organic Cd. In terms of risk assess-
ment for the compound CdMt, the present study 
shows that at low dietary Cd doses, Cd is relea-
sed from dietary CdMt after passage through the 
intestinal tract and uptake in the intestinal muco-
sa. This implies that at environmentally relevant 
oral Cd doses there is no difference in metabolic 
pathways between Cd-salt and CdMt. At high 
doses the metabolic pathways for both Cd-forms 
slightly differ, but the total Cd-uptake from CdMt 
at these levels was lower than for CdCl? 
Although CdMt is more nephrotoxic than inorga-
nic Cd after parenteral administration, we found 
no evidence that CdMt is more nephrotoxic than 
CdCl2 after oral administration. 
Therefore this thesis shows that toxicity data 
obtained from studies with rodents exposed to 
low levels of CdCl2 are also applicable for the 
risk assessment of Cd-intake from CdMt. Another 
important finding was that Cd accumulation from 
organic and inorganic Cd is mainly influenced 
by Fe and not by other minerals. Special consi-
deration should therefore be given to an adequa-
te Fe intake when assessing the health risk of the 
Cd intake. 
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In Hoofdstuk 1 van dit proefschrift wordt een 
algemene inleiding gepresenteerd met hierin een 
overzicht van de literatuur. 
Kort samengevat, de belangrijkste bron van Cd-
blootstelling via het milieu voor niet-rokers is 
voedsel. Orale Cd-studies met knaagdieren heb-
ben aangetoond dat de Cd-dosis, de Cd-speciatie 
en de mineralen samenstelling van het dieet een 
enorme invloed hebben op de uiteindelijke ab-
sorptie en orgaan distributie van Cd. 
Hoewel de meeste toxiciteitsstudies zijn uitge-
voerd met anorganisch Cd, is dit niet de chemi-
sche vorm waarin Cd aanwezig is in het voedsel. 
Een van de belangrijkste Cd-bindende liganden 
in dieren is het eiwit metallothioneïne, een indu-
ceerbaar en cysteïne-rijk eiwit met een laag 
moleculair gewicht. De belangrijkste Cd binden-
de ligande in planten is het phytochelatine, een 
eiwit dat functioneel analoog is aan metallothio-
neïne. Het eiwit metallothioneïne is in staat om 
tenminste gedeeltelijk intact de maag-darm pas-
sage te overbruggen. Gesuggereerd is dat een 
gedeelte van dit exogene Mt de darm-barriere 
passeert en vervolgens rechtstreeks in de nier 
wordt opgenomen. Deze selectieve ophoping van 
CdMt in de nier vindt ook plaats wanneer CdMt 
intraveneus wordt toegediend. Omdat CdMt 
sterk nephrotoxisch is wanneer het intraveneus 
wordt toegediend, kan dit betekenen dat de 
aanwezigheid van CdMt in ons voedsel een 
groter gezondheidsrisico vormt dan tot nu toe 
voor Cd wordt aangenomen op basis van orale 
experimenten met anorganisch Cd. Echter er is 
nauwelijks iets bekend over de biologische be-
schikbaarheid en de toxiciteit van CdMt, zoals 
aanwezig in ons voedsel. De doelstellingen van 
dit proefschrift waren derhalve: 
- Het vergelijken van de toxiciteit van anorg-
anisch Cd en CdMt in de rat en in celcultures 
van de doelwitorganen. 
- Het vergelijken van de dosis-afhankelijke kine-
tiek van Cd opname tussen anorganisch Cd en 
CdMt. 
- Het vaststellen van verschillen in metabole 
routes tussen CdMt en CdCl2 om zodoende de 
dispositie en toxiciteit te kunnen voorspellen 
bij relevante dosis niveau's in het milieu. 
In de studies die in Hoofdstuk 3 en 4 worden 
beschreven, wordt de toxiciteit en dispositie 
bestudeerd in ratten, die gedurende 4 weken 
gevoerd werden met een dieet waarin ofwel 
varkenslever-geincorporeerd Cd aanwezig was 
ofwel Cd zout. Voor een juiste interpretatie van 
de resultaten werd de Cd bindende ligande in de 
varkenslever allereerst geïdentificeerd als een 
mengsel van 2 metallothioneïne isovormen. Deze 
identificatie was gebaseerd op het molecuul 
gewicht, de Cd-bindende eigenschappen, de 
hitte-resistentie en de spectrale analyse. Meer 
dan 90% van het Cd in de varkenslever bleek 
gebonden te zijn aan dit metallothioneïne. 
Aangetoond werd dat de toxiciteitsverschijnselen 
(o.a. anemia en hepatotoxiciteit) minder ernsti-
ger waren in de ratten blootgesteld aan CdMt 
dan in de ratten blootgesteld aan een vergelijk-
bare dosis anorganisch Cd. De lagere toxiciteit 
na blootstelling aan CdMt in vergelijking met 
CdCl2, correleert goed met het feit dat de opna-
me van Cd in de darm en lever na blootstelling 
aan 30 ppm Cd in de vorm van CdMt lager was 
dan na blootstelling aan 30 ppm Cd in de vorm 
van CdCl2. Echter, ondanks de lagere totale 
opname van CdMt, was de Cd stapeling in de 
nier relatief hoger na inname van CdMt dan na 
inname van CdCl2. Dus de verhouding van de 
Cd concentratie tussen nier en lever was signifi-
cant hoger in ratten die gevoerd waren met 
CdMt dan in de ratten, die gevoerd waren met 
CdCl2. Omdat het bekend is dat CdMt na intra-
veneuze toediening voornamelijk ophoopt in de 
nieren, zouden de resultaten suggereren dat 
CdMt de darm barrière kan passeren en vervol-
gens wordt afgegeven aan de systemische circu-
latie. Dit werd ondersteund door het feit dat de 
Mt concentratie in de nieren in de eerste week 
van het experiment hoger was na blootstelling 
aan CdMt dan na blootstelling aan CdCl2. Ech-
ter, in de inleiding hebben we benadrukt dat 
ratten die zijn blootgesteld aan lage dosis CdCl2, 
net als na blootstelling aan CdMt, een selectieve 
accumulatie van Cd vertonen in de nier. De 
studie van hoofdstuk 3 laat inderdaad zien dat bij 
lage Cd levels in het dieet (1.5 en 8 ppm) rela-
tief meer Cd in de nier terechtkomt dan bij een 
hoge orale dosis van 30 ppm. Het verschil in de 
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differentiële dispositie van CdCl2 en CdMt tussen 
lever en nier was kleiner bij lage doses, maar 
zelfs bij die doses is de verhouding tussen de Cd 
concentratie in nier en lever nog steeds hoger na 
CdMt dan na CdCl2 blootstelling. In de discussie 
werd de vraag opgeroepen welk gevolg de Cd 
redistribute vanuit de lever naar de nieren na 
langdurige orale blootstelling zou hebben voor 
het uiteindelijk niveau van nierschade dat bereikt 
zal gaan worden. Deze vraag werd behandeld in 
hoofdstuk 8. 
Hoofdstuk 4 behandelt een vergelijkende studie 
van de accumulatie en toxiciteit van CdCl2 en 2 
isovormen van CdMt in cellijnen en primaire 
celcultures van de dunne darm, lever en nier. 
Exogeen CdMt toegevoegd aan het kweek medi-
um was minder toxisch voor alle geteste celtypen 
dan CdCl2 en geen celtype was speciaal gevoelig 
voor CdMt. Zelfs als het Cd-gehalte van CdMt 
kunstmatig werd verhoogd naar 5 mol Cd/mol 
Mt, beinvloedde dit de viabiliteit van de cellen 
maar nauwelijks. In het algemeen correspondeert 
het verschil in toxiciteit tussen CdMt en CdCl2 
goed met het verschil in cellulaire opname van 
Cd. Dit is in overeenstemming met de in vivo 
resultaten zoals beschreven in hoofstuk 2, 3 en 8 
waarin is aangetoond dat het verschil in toxici-
teit tussen CdMt en CdCl2 een gevolg is van het 
verschil in opname en orgaan distributie. 
De studies beschreven in Hoofdstuk 5 en 6 be-
handelen de invloed van mineralen op de absorp-
tie van Cd na blootstelling aan CdCl2 
of CdMt. De meeste onderzoeken in de litera-
tuur zijn tot nu toe steeds gericht op enkelvou-
dige Cd-mineraal interacties en er zijn geen 
echte pogingen gedaan om meer elementen uit de 
mineralen-huishouding mee te vergelijken in 
dezelfde studie. Acht mineralen werden onder 
loep genomen, waarvan gesuggereerd was dat ze 
interactie vertonen met de Cd accumulatie in het 
lichaam. De mineralen combinaties werden zo 
gekozen dat het effect van de individuele compo-
nenten geanalyseerd kon worden met behulp van 
multi-variantie analyses. De bescherming tegen 
de accumulatie en toxiciteit van Cd ten gevolge 
van mineralen mengsels bleek voornamelijk te 
danken te zijn aan de aanwezigheid van ijzer 
(Fe). De vraag of ijzer ook beschermt tegen de 
opname van organisch Cd, werd onderzocht in 
de studie beschreven in hoofdstuk 6. Ratten wer-
den hierbij gevoerd met CdMt aangevuld met 
een extra mineralen mengsel bestaande uit Ca/P, 
Zn en Fe. Dit mengsel was volgens de bevindin-
gen van hoofdstuk 5 het meest effectief tegen Cd 
accumulatie. De totale Cd opname na blootstel-
ling aan CdMt was significant verlaagd door de 
aanwezigheid van het mineralen supplement, 
hoewel de bescherming van het supplement lager 
was dan na blootstelling aan CdCl2. Omdat de 
Cd accumulatie voornamelijk beinvloed wordt 
door Fe en niet door andere mineralen, roept het 
onderzoek van hoofdstuk 5 en 6 de vraag op in 
hoeverre het transport van Cd over de dunne 
darm specifiek gemedieerd wordt door het trans-
port systeem voor Fe. Het feit dat het mineralen 
supplement ook beschermd tegen CdMt, hoewel 
minder dan tegen CdCl2 zou verklaard kunnen 
worden door het feit dat CdMt voor een gedeelte 
wordt afgebroken gedurende de maag-darm 
passage. Eenmaal gedegradeerd zal Cd uit CdMt 
hetzelfde metabole gedrag vertonen als anorga-
nisch Cd zout en zal door toevoeging van extra 
mineralen de accumulatie in lever en nieren 
verlaagd worden. Echter een klein gedeelte van 
het opgenomen CdMt wordt niet afgebroken en 
het lijkt dat het mineralen supplement de opname 
van dit intact exogeen CdMt niet beïnvloedt 
waardoor dit CdMt ongehinderd de nieren kan 
bereiken. Dit verklaart waarom de verhouding 
tussen de Cd concentratie in de nier en lever 
hoger was in ratten die gevoerd werden met 
CdMt en Fe dan in ratten die gevoerd werden 
met CdCl2 en Fe. Na toevoeging van het minera-
len mengsel vertonen de ratten, die gevoerd 
werden met CdCl2 of CdMt een relatief hogere 
Cd accumulatie in de nier dan in de lever. Om-
dat de toevoeging van het mineralen suplement 
aan het dieet tot een lagere Cd absorptie leidt, 
zal dit gedeeltelijk voorkomen dat de hoeveelheid 
metallothioneine, die voorradig is in de dunne 
darm mucosa, wordt overladen. Als gevolg steeg 
de nier/lever Cd ratio. 
Hoofdstuk 7 behandelt het metabole lot van 
endogeen (gesynthetiseerd door weefsel) en 
exogeen (geabsorbeerd door weefsel) CdMt. 
Gezuiverde Mt isovorm 1 en 2 afkomstig uit 
darm en lever elueren als 2 afzonderlijke pieken 
op RP-HPLC. De beide isovormen uit de nier 
elueren echter als één piek. Het feit dat in de 
nier Mt isovorm-2 niet kon worden gescheiden 
van isovorm 1 en het feit dat Mt-isovorm 2 
nauwelijks aanwezig is in de darm, biedt de 
unieke mogelijkheid om het metabole lot van 
gezuiverde Mt-isovorm 1 te bestuderen in de 
darm en in de nier. Na in vivo en in vitro toe-
128 
diening van exogeen CdMt-1 werd in de nier en 
darm een snelle uitwisseling aangetoond van 
,09Cd van exogeen CdMt (=lever 109CdMt iso-
vorm 1) naar endogeen CdMt. De Cd redistri-
butie was afhankelijk van de verhouding tussen 
de endogene en exogene Mt concentratie. Alleen 
wanneer de orale of de intraveneuze blootstelling 
aan exogeen CdMt hoog genoeg is om tot een 
hoge ratio tussen exogeen en endogeen CdMt te 
leiden, zal l09Cd in principe aan CdMt gebonden 
blijven. 
Als we er vanuit gaan dat bij milieu-relevante 
blootstellingsniveau's (minder dan 2 ppm in het 
voedsel) de exogene CdMt concentratie veel 
lager is dan de endogene CdMt concentratie dan 
betekent dit dat bij lage CdMt doseringen via het 
voedsel, Cd voornamelijk gebonden zal zijn aan 
endogeen Mt en andere (hoog moleculaire) Cd 
bindende eiwitten. 
Tenslotte werd in dit project een langdurige 
voedingsstudie uitgevoerd waarvan de resultaten 
in Hoofdstuk 8 zijn weergegeven. Aangetoond 
werd dat de nier/lever ratio van de Cd concen-
tratie omgekeerd evenredig is met de dosis. Dus, 
wanneer de orale dosis toeneemt, zal relatief 
meer Cd in de lever worden teruggevonden dan 
in de nieren. Bij een Cd-dieet concentratie van 
30 en 90 ppm was de Cd ratio hoger bij de 
dieren, die blootgesteld waren aan CdMt dan bij 
dieren die waren blootgesteld aan CdCl2. Echter 
bij lage Cd concentraties in het dieet (0.3 en 3 
ppm) is er geen verschil in Cd stapeling in de 
nier tussen CdCl2 en CdMt. De eerste verschijn-
selen van nier toxiciteit, aangegeven door een 
lichte vorm van enzymuria werden waargenomen 
in ratten die 4 maanden waren blootgesteld aan 
90 ppm CdCl2. Geleidelijk werden de effecten 
ernstiger en kon ook histopathologische verande-
ringen worden waargenomen (o.a. glomerulo-
nephrosis en een toename in basofiele tubuli). 
De bevinding that 90 ppm CdCl2 aanleiding geeft 
tot duidelijke verschijnselen van nierdysfunctie 
terwijl 90 ppm CdMt dat minder laat zien, kan 
verklaard worden door het feit dat de Cd con-
centratie in de nier lager was na 10 maanden 
blootstelling aan CdMt (60 mg/kg weefsel bij 90 
ppm CdMt en 170 mg/kg bij 90 ppm CdCy. 
Deze resultaten betekenen dat in tegenstelling tot 
intraveneus toegediend CdCl2 of CdMt, de effec-
ten op de nier van oraal toegediend CdMt of 
CdCl2 voornamelijk afhankelijk zijn van het ver-
schil in Cd accumulatie in het weefsel. Dus er is 
geen aanwijzing dat CdMt ondanks de hogere 
nier/lever Cd ratio bij hoge doseringen meer 
niertoxisch is dan CdCl? 
Om de consequenties voor de humane consu-
ment goed te kunnen inschatten is het essentieel 
om met alle metabole routes rekening te houden. 
Figuur 1 toont in een vereenvoudigd schema de 
belangrijkste metabole routes van Cd na orale 
blootstelling aan CdCl2 of CdMt. Het model is 
gebaseerd op de resultaten van dit proefschrift 
samen met beschikbare gegevens uit de litera-
tuur. Fig. IA toont de metabole routes na orale 
blootstellling aan CdCl2. Bij een lage orale dosis 
van CdCl2 zal het merendeel van het Cd gebon-
den worden aan endogeen Mt in de dunne darm. 
Dit Mt komt terecht in de systemische circulatie 
en wordt vervolgens opgenomen in de nieren. 
Bij blootstelling aan een hoge orale dosis aan 
CdCl2 wordt de beschikbare voorraad endogeen 
Mt overladen. Cd zal dan ook gebonden worden 
aan hoog moleculaire plasma eiwitten en komt 
vervolgens in lever terecht. Cd zal worden ge-
bonden aan Mt in de lever en mettertijd zal een 
gedeelte van het CdMt uit de lever in de nieren 
terecht komen. 
Fig. IB toont de metabole routes voor Cd na 
orale blootstelling aan CdMt. Een groot gedeelte 
van het CdMt zal de maag-darm passage niet 
overleven en het vrij gekomen Cd zal hetzelfde 
metabole gedrag vertonen als de Cd zouten. Dit 
verklaart waarom Fe interactie vertoont met de 
opname van CdMt. Bovendien zal bij lage CdMt 
levels in het dieet snel sprake zijn van redistribu-
tie van Cd vanuit exogeen CdMt naar endogeen 
Mt. Dit betekent dat bij relevant blootstellings 
niveau's in het milieu de Cd-transportvorm voor 
CdMt gelijk zal zijn aan CdCl2. Deze theorie 
wordt ondersteund door het feit dat de Cd dispo-
sitie voor beide Cd vormen vergelijkbaar was in 
hoofdstuk 8 na langdurige blootstelling aan lage 
(< 3ppm) dosis in het dieet. Bij een hoge orale 
dosis aan CdMt zal relatief meer CdMt de verte-
ring overleven en zal meer CdMt de dunne darm 
intact bereiken. In dat geval is het mogelijk that 
er een overmaat exogeen CdMt in de darm 
mucosa aanwezig is en dat Cd aanvankelijk 
gebonden blijft aan exogeen CdMt. Vervolgens 
zal dit CdMt afkomstig uit het voedsel worden 
afgegeven aan de systemische circulatie en van-
daaruit de nier bereiken. Dus bij een hoge orale 
Cd dosis zullen de metabole routes voor CdCl2 
en CdMt verschillen. De kritische Cd concen-
tratie in de nier, die gebruikt wordt in de risico 
evaluatie van Cd, is gedeeltelijk gebaseerd op 
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Fig. 1 Vereenvoudigde weergave van metabole routes voor CdCl2 en CdMt na orale blootstelling in knaagdieren 
zoals geconcludeerd uit de studies van dit proefschrift. De pijlen die voorzien zijn van een nummer geven de 
verschillende metabole routes weer. G.1.LUMEN= lumen van maag/darm, INT.MUCOSA = Dunne darm 
mucosa, lMT=Mt dunne darm, LMT=lever Ml, KMT=nier Mt, HMW=eiwil van hoog moleculair eiwit. IA. 
Orale blootstelling aan CdCl? Bij lage dosis; route 1 < route 2, bij hoge dosis; route 1 > route 2. IB Orale 
blootstelling aan CdMt: Bij lage dosis; route 2 > route 1 en route 3 is niet aanwezig, bij hoge dosis; route 1 > 
route 3 > route 2. 
proefdier experimenten met een hoge dosis aan 
CdClr Echter, de mens wordt voornamelijk 
blootgesteld aan een lage dosis organisch Cd. In 
termen van risico-evaluatie voor de verbinding 
CdMt kan met behulp van dit proefschrift de 
conclusie worden getrokken dat bij een lage Cd 
dosis in het dieet Cd wordt vrijgemaakt uit CdMt 
gedurende de maag-darmpassage en na opname 
in de darm mucosa. Dit betekent dat bij rele-
vante orale doses vanuit de omgeving, er geen 
verschil bestaat in metabole routes tussen CdMt 
en CdCl? Bij een hoge dosis zullen de metabole 
routes voor beide Cd-vormen weliswaar iets ver-
schillen, maar de totale Cd-opname na inname 
van CdMt is bij die dosis lager dan na inname 
van CdCl2. 
Hoewel na parenterale toediening CdMt meer 
nephrotoxisch is dan anorganisch Cd, hebben wij 
geen aanwijzingen gevonden dat oraal toege-
diend CdMt ook meer nephrotoxisch zou zijn dan 
CdCl? Dit proefschrift laat derhalve zien dat de 
toxiciteits gegevens, die gebaseerd zijn op studies 
met knaagdieren, blootgesteld aan lage dose-
ringen CdCl2, ook toepasbaar zijn voor de risi-
co-evaluatie na Cd blootstelling via CdMt. Een 
andere belangrijke bevinding is het feit dat de 
Cd accumulatie van organisch en anorganisch 
Cd voornamelijk wordt beïnvloed door Fe en niet 
door andere mineralen. Derhalve dient speciale 
aandacht te worden gegeven aan de Fe opname 
wanneer we het gezondheidsrisico van de inname 
van Cd op een juiste wijze willen inschatten. 
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